Medications for human use with a single active ingredient starting with the letter S-Z.

Médicaments à usage humain contenant un seul ingrédient actif commençant par la lettre S-Z.

Last Update: 2021-05-03
Product Name;
DIN;
Active ingredient(s) and concentration;
Number of active ingredients: Number of active ingredients;
Original market date;
Route(s) of administration;
Dosage form(s);
AHFS;
Schedule;
Company
Monograph
ONSTRYV;
02484668;
safinamide (safinamide mesylate) 100 mg;
2019-07-08;
Oral;
Tablet;
28:36.32 – MONOAMINE OXIDASE B INHIBITORS;
Prescription;
VALEO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97495
ONSTRYV;
02484641;
safinamide (safinamide mesylate) 50 mg;
2019-07-08;
Oral;
Tablet;
28:36.32 – MONOAMINE OXIDASE B INHIBITORS;
Prescription;
VALEO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97492
PMS-SALBUTAMOL;
02208245;
salbutamol (salbutamol sulfate) 0.5 mg / ml;
1996-12-31;
Inhalation;
Solution;
12:12.08.12 – SELECTIVE BETA 2-ADRENERGIC AGONISTS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19761
TEVA-SALBUTAMOL STERINEBS P.F.;
01926934;
salbutamol (salbutamol sulfate) 1 mg / ml;
1992-12-31;
Inhalation;
Solution;
12:12.08.12 – SELECTIVE BETA 2-ADRENERGIC AGONISTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13550
PMS-SALBUTAMOL;
02208229;
salbutamol (salbutamol sulfate) 1 mg / ml;
1996-12-31;
Inhalation;
Solution;
12:12.08.12 – SELECTIVE BETA 2-ADRENERGIC AGONISTS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19763
VENTOLIN I.V. INFUSION SOLUTION 5.0MG SALBUTAMOL IN 5ML (1000MCG/ML);
02213451;
salbutamol (salbutamol sulfate) 1 mg / ml;
1999-05-24;
Intravenous;
Solution;
12:12.08.12 – SELECTIVE BETA 2-ADRENERGIC AGONISTS;
Prescription;
GLAXOSMITHKLINE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43104
AIROMIR;
02232570;
salbutamol (salbutamol sulfate) 100 mcg / act;
1998-08-13;
Inhalation;
Metered-Dose Aerosol;
12:12.08.12 – SELECTIVE BETA 2-ADRENERGIC AGONISTS;
Prescription;
BAUSCH HEALTH, CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=52048
VENTOLIN HFA;
02241497;
salbutamol (salbutamol sulfate) 100 mcg / act;
2001-11-22;
Inhalation;
Metered-Dose Aerosol;
12:12.08.12 – SELECTIVE BETA 2-ADRENERGIC AGONISTS;
Prescription;
GLAXOSMITHKLINE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=65137
APO-SALBUTAMOL HFA;
02245669;
salbutamol (salbutamol sulfate) 100 mcg / act;
2002-08-22;
Inhalation;
Metered-Dose Aerosol;
12:12.08.12 – SELECTIVE BETA 2-ADRENERGIC AGONISTS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=69769
TEVA-SALBUTAMOL HFA;
02326450;
salbutamol (salbutamol sulfate) 100 mcg / act;
2009-12-31;
Inhalation;
Metered-Dose Aerosol;
12:12.08.12 – SELECTIVE BETA 2-ADRENERGIC AGONISTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81180
SALBUTAMOL HFA;
02419858;
salbutamol (salbutamol sulfate) 100 mcg / act;
2014-02-13;
Inhalation;
Metered-Dose Aerosol;
12:12.08.12 – SELECTIVE BETA 2-ADRENERGIC AGONISTS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90447
TEVA-SALBUTAMOL STERINEBS P.F.;
02173360;
salbutamol (salbutamol sulfate) 2 mg / ml;
1995-12-31;
Inhalation;
Solution;
12:12.08.12 – SELECTIVE BETA 2-ADRENERGIC AGONISTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19058
PMS-SALBUTAMOL;
02208237;
salbutamol (salbutamol sulfate) 2 mg / ml;
1996-12-31;
Inhalation;
Solution;
12:12.08.12 – SELECTIVE BETA 2-ADRENERGIC AGONISTS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19762
VENTOLIN NEBULES P.F. – 2.5MG/2.5ML;
02213419;
salbutamol (salbutamol sulfate) 2.5 mg / 2.5 ml;
2000-05-21;
Inhalation;
Solution;
12:12.08.12 – SELECTIVE BETA 2-ADRENERGIC AGONISTS;
Prescription;
GLAXOSMITHKLINE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43100
VENTOLIN DISKUS;
02243115;
salbutamol (salbutamol sulfate) 200 mcg / act;
2001-01-02;
Inhalation;
Powder;
12:12.08.12 – SELECTIVE BETA 2-ADRENERGIC AGONISTS;
Prescription;
GLAXOSMITHKLINE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66984
VENTOLIN RESPIRATOR SOLUTION;
02213486;
salbutamol (salbutamol sulfate) 5 mg / ml;
1998-12-01;
Inhalation;
Solution;
12:12.08.12 – SELECTIVE BETA 2-ADRENERGIC AGONISTS;
Prescription;
GLAXOSMITHKLINE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43108
VENTOLIN NEBULES P.F. – 5MG/2.5ML;
02213427;
salbutamol (salbutamol sulfate) 5 mg / 2.5 ml;
2000-10-02;
Inhalation;
Solution;
12:12.08.12 – SELECTIVE BETA 2-ADRENERGIC AGONISTS;
Prescription;
GLAXOSMITHKLINE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43101
SEREVENT DISKUS (50MCG/DOSE);
02231129;
salmeterol (salmeterol xinafoate) 50 mcg / act;
1998-04-01;
Inhalation;
Powder;
12:12.08.12 – SELECTIVE BETA 2-ADRENERGIC AGONISTS;
Prescription;
GLAXOSMITHKLINE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=50436
TYPHIM VI;
02130955;
salmonella typhi vi capsular polysaccharide vaccine 25 mcg / 0.5 ml;
1995-12-31;
Intramuscular;
Solution;
80:12.00 – VACCINES;
Schedule D;
SANOFI PASTEUR LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=20287
KUVAN;
02350580;
sapropterin dihydrochloride 100 mg;
2010-07-05;
Oral;
Tablet;
92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
Prescription;
BIOMARIN INTERNATIONAL LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83577
KUVAN;
02482207;
sapropterin dihydrochloride 100 mg / sachet;
2019-12-05;
Oral;
Powder;
92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
Prescription;
BIOMARIN INTERNATIONAL LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97268
KUVAN;
02482215;
sapropterin dihydrochloride 500 mg / sachet;
2019-12-05;
Oral;
Powder;
92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
Prescription;
BIOMARIN INTERNATIONAL LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97269
KEVZARA;
02460521;
sarilumab 150 mg / 1.14 ml;
2017-03-29;
Subcutaneous;
Solution;
92:36.00 – DISEASE-MODIFYING ANTIRHEUMATIC AGENTS;
Prescription , Schedule D;
SANOFI-AVENTIS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94796
KEVZARA;
02472961;
sarilumab 150 mg / 1.14 ml;
2018-06-21;
Subcutaneous;
Solution;
92:36.00 – DISEASE-MODIFYING ANTIRHEUMATIC AGENTS;
Prescription , Schedule D;
SANOFI-AVENTIS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96232
KEVZARA;
02460548;
sarilumab 200 mg / 1.14 ml;
2017-02-08;
Subcutaneous;
Solution;
92:36.00 – DISEASE-MODIFYING ANTIRHEUMATIC AGENTS;
Prescription , Schedule D;
SANOFI-AVENTIS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94797
KEVZARA;
02472988;
sarilumab 200 mg / 1.14 ml;
2018-06-21;
Subcutaneous;
Solution;
92:36.00 – DISEASE-MODIFYING ANTIRHEUMATIC AGENTS;
Prescription , Schedule D;
SANOFI-AVENTIS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96233
ENSPRYNG;
02499681;
satralizumab 120 mg / ml;
2020-08-26;
Subcutaneous;
Solution;
92:20.00 – Immunomodulatory Agents;
Prescription , Schedule D;
HOFFMANN-LA ROCHE LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98941
ONGLYZA;
02375842;
saxagliptin (saxagliptin hydrochloride) 2.5 mg;
2011-12-23;
Oral;
Tablet;
68:20.05 – DIPEPTIDYL PEPTIDASE-4 (DPP-4) INHIBITORS;
Prescription;
ASTRAZENECA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86124
SANDOZ SAXAGLIPTIN;
02468603;
saxagliptin (saxagliptin hydrochloride) 2.5 mg;
2021-03-08;
Oral;
Tablet;
68:20.05 – DIPEPTIDYL PEPTIDASE-4 (DPP-4) INHIBITORS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95702
APO-SAXAGLIPTIN;
02507471;
saxagliptin (saxagliptin hydrochloride) 2.5 mg;
2021-03-29;
Oral;
Tablet;
68:20.05 – DIPEPTIDYL PEPTIDASE-4 (DPP-4) INHIBITORS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99686
ONGLYZA;
02333554;
saxagliptin (saxagliptin hydrochloride) 5 mg;
2009-10-29;
Oral;
Tablet;
68:20.05 – DIPEPTIDYL PEPTIDASE-4 (DPP-4) INHIBITORS;
Prescription;
ASTRAZENECA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81917
SANDOZ SAXAGLIPTIN;
02468611;
saxagliptin (saxagliptin hydrochloride) 5 mg;
2021-03-08;
Oral;
Tablet;
68:20.05 – DIPEPTIDYL PEPTIDASE-4 (DPP-4) INHIBITORS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95703
APO-SAXAGLIPTIN;
02507498;
saxagliptin (saxagliptin hydrochloride) 5 mg;
2021-03-29;
Oral;
Tablet;
68:20.05 – DIPEPTIDYL PEPTIDASE-4 (DPP-4) INHIBITORS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99687
SCOPOLAMINE HYDROBROMIDE INJECTION;
02242810;
scopolamine hydrobromide 0.4 mg / ml;
2008-05-31;
Intramuscular , Intravenous , Subcutaneous;
Liquid;
12:08.08 – ANTIMUSCARINICS ANTISPASMODICS;
Ethical;
OMEGA LABORATORIES LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66635
SCOPOLAMINE HYDROBROMIDE INJECTION;
02242811;
scopolamine hydrobromide 0.6 mg / ml;
2008-07-08;
Intramuscular , Intravenous , Subcutaneous;
Liquid;
12:08.08 – ANTIMUSCARINICS ANTISPASMODICS;
Ethical;
OMEGA LABORATORIES LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66636
KANUMA;
02469596;
sebelipase alfa 2 mg / ml;
2018-04-05;
Intravenous;
Solution;
44:00.00 – ENZYMES;
Prescription , Schedule D;
ALEXION PHARMA GMBH
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95840
COSENTYX;
02438070;
secukinumab 150 mg / ml;
2015-04-10;
Subcutaneous;
Solution;
84:92.00 – MISC. SKIN AND MUCOUS MEMBRANE AGENTS;
Prescription , Schedule D;
NOVARTIS PHARMACEUTICALS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92243
SELEGILINE;
02230641;
selegiline hydrochloride 5 mg;
1997-02-13;
Oral;
Tablet;
28:36.32 – MONOAMINE OXIDASE B INHIBITORS;
Prescription;
AA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=49813
MICRO SE;
01986007;
selenium (selenious acid) 40 mcg / ml;
1993-12-31;
Intravenous;
Solution;
40:12.00 – REPLACEMENT PREPARATIONS;
Ethical;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13559
UPTRAVI;
02451190;
selexipag 1000 mcg;
2016-04-21;
Oral;
Tablet;
48:48.00 – VASODILATING AGENTS;
Prescription;
JANSSEN INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93745
UPTRAVI;
02451204;
selexipag 1200 mcg;
2016-04-21;
Oral;
Tablet;
48:48.00 – VASODILATING AGENTS;
Prescription;
JANSSEN INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93746
UPTRAVI;
02451212;
selexipag 1400 mcg;
2016-04-21;
Oral;
Tablet;
48:48.00 – VASODILATING AGENTS;
Prescription;
JANSSEN INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93747
UPTRAVI;
02451220;
selexipag 1600 mcg;
2016-04-21;
Oral;
Tablet;
48:48.00 – VASODILATING AGENTS;
Prescription;
JANSSEN INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93748
UPTRAVI;
02451158;
selexipag 200 mcg;
2016-04-21;
Oral;
Tablet;
48:48.00 – VASODILATING AGENTS;
Prescription;
JANSSEN INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93741
UPTRAVI;
02451166;
selexipag 400 mcg;
2016-04-21;
Oral;
Tablet;
48:48.00 – VASODILATING AGENTS;
Prescription;
JANSSEN INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93742
UPTRAVI;
02451174;
selexipag 600 mcg;
2016-04-21;
Oral;
Tablet;
48:48.00 – VASODILATING AGENTS;
Prescription;
JANSSEN INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93743
UPTRAVI;
02451182;
selexipag 800 mcg;
2016-04-21;
Oral;
Tablet;
48:48.00 – VASODILATING AGENTS;
Prescription;
JANSSEN INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93744
OZEMPIC;
02471469;
semaglutide 1 mg / act;
2018-02-22;
Subcutaneous;
Solution;
68:20.06 – INCRETIN MIMETICS;
Prescription , Schedule D;
NOVO NORDISK CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96058
OZEMPIC;
02471477;
semaglutide 1.34 mg / ml;
2018-02-22;
Subcutaneous;
Solution;
68:20.06 – INCRETIN MIMETICS;
Prescription , Schedule D;
NOVO NORDISK CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96059
RYBELSUS;
02497611;
semaglutide 14 mg;
2020-04-19;
Oral;
Tablet;
68:20.06 – INCRETIN MIMETICS;
Prescription , Schedule D;
NOVO NORDISK CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98742
RYBELSUS;
02497581;
semaglutide 3 mg;
2020-04-19;
Oral;
Tablet;
68:20.06 – INCRETIN MIMETICS;
Prescription , Schedule D;
NOVO NORDISK CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98740
RYBELSUS;
02497603;
semaglutide 7 mg;
2020-04-19;
Oral;
Tablet;
68:20.06 – INCRETIN MIMETICS;
Prescription , Schedule D;
NOVO NORDISK CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98741
ZOLOFT;
01962779;
sertraline (sertraline hydrochloride) 100 mg;
1992-12-31;
Oral;
Capsule;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
UPJOHN CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13392
APO-SERTRALINE;
02238282;
sertraline (sertraline hydrochloride) 100 mg;
1999-09-01;
Oral;
Capsule;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=61678
TEVA-SERTRALINE;
02240481;
sertraline (sertraline hydrochloride) 100 mg;
1999-08-16;
Oral;
Capsule;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=64051
SERTRALINE-100;
02241304;
sertraline (sertraline hydrochloride) 100 mg;
2001-02-15;
Oral;
Capsule;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=64920
PMS-SERTRALINE;
02244840;
sertraline (sertraline hydrochloride) 100 mg;
2002-01-30;
Oral;
Capsule;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=68830
SANDOZ SERTRALINE;
02245161;
sertraline (sertraline hydrochloride) 100 mg;
2002-02-13;
Oral;
Capsule;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=69174
RIVA-SERTRALINE;
02248498;
sertraline (sertraline hydrochloride) 100 mg;
2005-01-10;
Oral;
Capsule;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
LABORATOIRE RIVA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72850
SERTRALINE;
02353547;
sertraline (sertraline hydrochloride) 100 mg;
2010-08-03;
Oral;
Capsule;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83876
SERTRALINE;
02386097;
sertraline (sertraline hydrochloride) 100 mg;
2012-06-10;
Oral;
Capsule;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
SIVEM PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87168
AURO-SERTRALINE;
02390922;
sertraline (sertraline hydrochloride) 100 mg;
2012-10-18;
Oral;
Capsule;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87631
MAR-SERTRALINE;
02399431;
sertraline (sertraline hydrochloride) 100 mg;
2014-01-16;
Oral;
Capsule;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
MARCAN PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88432
MINT-SERTRALINE;
02402408;
sertraline (sertraline hydrochloride) 100 mg;
2013-04-29;
Oral;
Capsule;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
MINT PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88723
BIO-SERTRALINE;
02445069;
sertraline (sertraline hydrochloride) 100 mg;
2016-12-08;
Oral;
Capsule;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
BIOMED PHARMA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93027
PRIVA-SERTRALINE;
02445387;
sertraline (sertraline hydrochloride) 100 mg;
2016-11-23;
Oral;
Capsule;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
PHARMAPAR INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93063
SERTRALINE;
02469642;
sertraline (sertraline hydrochloride) 100 mg;
2018-01-17;
Oral;
Capsule;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95844
AG-SERTRALINE;
02477904;
sertraline (sertraline hydrochloride) 100 mg;
2018-09-06;
Oral;
Capsule;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
ANGITA PHARMA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96811
NRA-SERTRALINE;
02488450;
sertraline (sertraline hydrochloride) 100 mg;
2019-09-04;
Oral;
Capsule;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
NORA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97854
ZOLOFT;
02132702;
sertraline (sertraline hydrochloride) 25 mg;
1995-12-31;
Oral;
Capsule;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
UPJOHN CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18005
APO-SERTRALINE;
02238280;
sertraline (sertraline hydrochloride) 25 mg;
1999-09-01;
Oral;
Capsule;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=61676
TEVA-SERTRALINE;
02240485;
sertraline (sertraline hydrochloride) 25 mg;
1999-08-16;
Oral;
Capsule;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=64055
SERTRALINE-25;
02241302;
sertraline (sertraline hydrochloride) 25 mg;
2001-02-15;
Oral;
Capsule;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=64918
PMS-SERTRALINE;
02244838;
sertraline (sertraline hydrochloride) 25 mg;
2002-01-30;
Oral;
Capsule;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=68828
SANDOZ SERTRALINE;
02245159;
sertraline (sertraline hydrochloride) 25 mg;
2002-02-13;
Oral;
Capsule;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=69170
RIVA-SERTRALINE;
02248496;
sertraline (sertraline hydrochloride) 25 mg;
2005-01-10;
Oral;
Capsule;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
LABORATOIRE RIVA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72848
SERTRALINE;
02353520;
sertraline (sertraline hydrochloride) 25 mg;
2010-08-03;
Oral;
Capsule;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83874
SERTRALINE;
02386070;
sertraline (sertraline hydrochloride) 25 mg;
2012-06-10;
Oral;
Capsule;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
SIVEM PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87166
AURO-SERTRALINE;
02390906;
sertraline (sertraline hydrochloride) 25 mg;
2012-10-18;
Oral;
Capsule;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87629
MAR-SERTRALINE;
02399415;
sertraline (sertraline hydrochloride) 25 mg;
2014-01-16;
Oral;
Capsule;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
MARCAN PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88430
MINT-SERTRALINE;
02402378;
sertraline (sertraline hydrochloride) 25 mg;
2013-04-29;
Oral;
Capsule;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
MINT PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88721
BIO-SERTRALINE;
02445042;
sertraline (sertraline hydrochloride) 25 mg;
2016-11-23;
Oral;
Capsule;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
BIOMED PHARMA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93025
PRIVA-SERTRALINE;
02445352;
sertraline (sertraline hydrochloride) 25 mg;
2016-11-23;
Oral;
Capsule;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
PHARMAPAR INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93058
SERTRALINE;
02469626;
sertraline (sertraline hydrochloride) 25 mg;
2018-01-17;
Oral;
Capsule;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95842
AG-SERTRALINE;
02477882;
sertraline (sertraline hydrochloride) 25 mg;
2018-09-06;
Oral;
Capsule;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
ANGITA PHARMA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96809
NRA-SERTRALINE;
02488434;
sertraline (sertraline hydrochloride) 25 mg;
2019-09-04;
Oral;
Capsule;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
NORA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97852
ZOLOFT;
01962817;
sertraline (sertraline hydrochloride) 50 mg;
1992-12-31;
Oral;
Capsule;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
UPJOHN CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=12662
APO-SERTRALINE;
02238281;
sertraline (sertraline hydrochloride) 50 mg;
1999-09-01;
Oral;
Capsule;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=61677
TEVA-SERTRALINE;
02240484;
sertraline (sertraline hydrochloride) 50 mg;
1999-08-16;
Oral;
Capsule;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=64054
SERTRALINE-50;
02241303;
sertraline (sertraline hydrochloride) 50 mg;
2001-02-15;
Oral;
Capsule;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=64919
PMS-SERTRALINE;
02244839;
sertraline (sertraline hydrochloride) 50 mg;
2002-01-30;
Oral;
Capsule;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=68829
SANDOZ SERTRALINE;
02245160;
sertraline (sertraline hydrochloride) 50 mg;
2002-02-13;
Oral;
Capsule;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=69172
RIVA-SERTRALINE;
02248497;
sertraline (sertraline hydrochloride) 50 mg;
2005-10-01;
Oral;
Capsule;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
LABORATOIRE RIVA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72849
SERTRALINE;
02353539;
sertraline (sertraline hydrochloride) 50 mg;
2010-08-03;
Oral;
Capsule;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83875
SERTRALINE;
02386089;
sertraline (sertraline hydrochloride) 50 mg;
2012-06-10;
Oral;
Capsule;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
SIVEM PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87167
AURO-SERTRALINE;
02390914;
sertraline (sertraline hydrochloride) 50 mg;
2012-10-18;
Oral;
Capsule;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87630
MAR-SERTRALINE;
02399423;
sertraline (sertraline hydrochloride) 50 mg;
2014-01-06;
Oral;
Capsule;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
MARCAN PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88431
MINT-SERTRALINE;
02402394;
sertraline (sertraline hydrochloride) 50 mg;
2013-04-29;
Oral;
Capsule;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
MINT PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88722
BIO-SERTRALINE;
02445050;
sertraline (sertraline hydrochloride) 50 mg;
2016-11-23;
Oral;
Capsule;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
BIOMED PHARMA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93026
PRIVA-SERTRALINE;
02445360;
sertraline (sertraline hydrochloride) 50 mg;
2016-11-23;
Oral;
Capsule;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
PHARMAPAR INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93062
SERTRALINE;
02469634;
sertraline (sertraline hydrochloride) 50 mg;
2018-01-17;
Oral;
Capsule;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95843
AG-SERTRALINE;
02477890;
sertraline (sertraline hydrochloride) 50 mg;
2018-09-06;
Oral;
Capsule;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
ANGITA PHARMA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96810
NRA-SERTRALINE;
02488442;
sertraline (sertraline hydrochloride) 50 mg;
2019-09-04;
Oral;
Capsule;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
NORA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97853
RENVELA;
02485559;
sevelamer carbonate 0.8 g / sachet;
2019-10-25;
Oral;
Powder For Suspension;
40:18.19 – PHOSPHATE-REMOVING AGENTS;
Prescription;
SANOFI-AVENTIS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97579
RENVELA;
02485567;
sevelamer carbonate 2.4 g / sachet;
2019-10-25;
Oral;
Powder For Suspension;
40:18.19 – PHOSPHATE-REMOVING AGENTS;
Prescription;
SANOFI-AVENTIS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97580
RENVELA;
02354586;
sevelamer carbonate 800 mg;
2010-11-25;
Oral;
Tablet;
40:18.19 – PHOSPHATE-REMOVING AGENTS;
Prescription;
SANOFI-AVENTIS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83974
ACCEL-SEVELAMER;
02461501;
sevelamer carbonate 800 mg;
2017-11-08;
Oral;
Tablet;
40:18.19 – PHOSPHATE-REMOVING AGENTS;
Prescription;
ACCEL PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94913
RENAGEL;
02244310;
sevelamer hydrochloride 800 mg;
2001-11-21;
Oral;
Tablet;
40:18.19 – PHOSPHATE-REMOVING AGENTS;
Prescription;
SANOFI-AVENTIS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=68278
SEVORANE AF;
02172763;
sevoflurane 99.97 %;
1995-12-31;
Inhalation;
Liquid;
28:04.16 – INHALATION ANESTHETICS;
Prescription;
ABBVIE CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19497
SEVOFLURANE;
02265974;
sevoflurane 99.97 %;
2007-04-11;
Inhalation;
Liquid;
28:04.16 – INHALATION ANESTHETICS;
Prescription;
BAXTER CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75141
SOJOURN SEVOFLURANE;
02307766;
sevoflurane 99.97 %;
2009-11-18;
Inhalation;
Liquid;
28:04.16 – INHALATION ANESTHETICS;
Prescription;
PIRAMAL CRITICAL CARE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79344
REVATIO;
02341611;
sildenafil (sildenafil citrate) 0.8 mg / ml;
2010-08-31;
Intravenous;
Solution;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
UPJOHN CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82711
VIAGRA;
02239768;
sildenafil (sildenafil citrate) 100 mg;
1999-03-09;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
UPJOHN CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=63250
APO-SILDENAFIL;
02248203;
sildenafil (sildenafil citrate) 100 mg;
2012-11-09;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72539
TEVA-SILDENAFIL;
02308754;
sildenafil (sildenafil citrate) 100 mg;
2012-11-08;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79437
SILDENAFIL;
02317583;
sildenafil (sildenafil citrate) 100 mg;
2013-08-05;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80311
MINT-SILDENAFIL;
02393085;
sildenafil (sildenafil citrate) 100 mg;
2013-02-15;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
MINT PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87833
MAR-SILDENAFIL;
02402548;
sildenafil (sildenafil citrate) 100 mg;
2017-01-11;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
MARCAN PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88737
SILDENAFIL;
02406160;
sildenafil (sildenafil citrate) 100 mg;
2013-06-21;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89089
AURO-SILDENAFIL;
02414384;
sildenafil (sildenafil citrate) 100 mg;
2019-05-17;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89904
SILDENAFIL;
02424320;
sildenafil (sildenafil citrate) 100 mg;
2014-10-07;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90903
M-SILDENAFIL;
02430037;
sildenafil (sildenafil citrate) 100 mg;
2015-06-04;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
MANTRA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91445
PRIVA-SILDENAFIL;
02448807;
sildenafil (sildenafil citrate) 100 mg;
2016-09-21;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
PHARMAPAR INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93454
RIVA-SILDENAFIL;
02452413;
sildenafil (sildenafil citrate) 100 mg;
2016-05-06;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
LABORATOIRE RIVA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93880
PRZ-SILDENAFIL;
02468557;
sildenafil (sildenafil citrate) 100 mg;
2018-05-02;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
PHARMARIS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95698
NRA-SILDENAFIL;
02476819;
sildenafil (sildenafil citrate) 100 mg;
2018-12-04;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
NORA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96718
ACCEL-SILDENAFIL;
02479826;
sildenafil (sildenafil citrate) 100 mg;
2019-08-15;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
ACCEL PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97041
AG-SILDENAFIL;
02480417;
sildenafil (sildenafil citrate) 100 mg;
2018-12-21;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
ANGITA PHARMA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97094
BIO-SILDENAFIL;
02480980;
sildenafil (sildenafil citrate) 100 mg;
2019-07-02;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
BIOMED PHARMA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97103
JAMP SILDENAFIL TABLETS;
02503506;
sildenafil (sildenafil citrate) 100 mg;
2021-01-27;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99297
JAMP-SILDENAFIL;
02405687;
sildenafil (sildenafil citrate) 100.0 mg;
2014-12-05;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89045
REVATIO;
02279401;
sildenafil (sildenafil citrate) 20 mg;
2006-06-12;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
UPJOHN CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76500
TEVA-SILDENAFIL R;
02319500;
sildenafil (sildenafil citrate) 20 mg;
2010-06-09;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80498
PMS-SILDENAFIL R;
02412179;
sildenafil (sildenafil citrate) 20 mg;
2014-11-14;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89674
JAMP-SILDENAFIL R;
02469669;
sildenafil (sildenafil citrate) 20 mg;
2021-02-08;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95846
VIAGRA;
02239766;
sildenafil (sildenafil citrate) 25 mg;
1999-03-09;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
UPJOHN CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=63248
APO-SILDENAFIL;
02248201;
sildenafil (sildenafil citrate) 25 mg;
2012-11-14;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72537
TEVA-SILDENAFIL;
02308738;
sildenafil (sildenafil citrate) 25 mg;
2012-11-08;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79435
SILDENAFIL;
02317559;
sildenafil (sildenafil citrate) 25 mg;
2013-08-05;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80308
AURO-SILDENAFIL;
02414368;
sildenafil (sildenafil citrate) 25 mg;
2019-05-17;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89902
ACCEL-SILDENAFIL;
02479796;
sildenafil (sildenafil citrate) 25 mg;
2019-08-15;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
ACCEL PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97038
AG-SILDENAFIL;
02480395;
sildenafil (sildenafil citrate) 25 mg;
2018-12-21;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
ANGITA PHARMA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97092
JAMP-SILDENAFIL;
02405660;
sildenafil (sildenafil citrate) 25.0 mg;
2014-12-05;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89043
VIAGRA;
02239767;
sildenafil (sildenafil citrate) 50 mg;
1999-03-09;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
UPJOHN CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=63249
APO-SILDENAFIL;
02248202;
sildenafil (sildenafil citrate) 50 mg;
2012-11-14;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72538
TEVA-SILDENAFIL;
02308746;
sildenafil (sildenafil citrate) 50 mg;
2012-11-08;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79436
SILDENAFIL;
02317575;
sildenafil (sildenafil citrate) 50 mg;
2013-08-05;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80310
MINT-SILDENAFIL;
02393077;
sildenafil (sildenafil citrate) 50 mg;
2013-02-15;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
MINT PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87832
SILDENAFIL;
02406152;
sildenafil (sildenafil citrate) 50 mg;
2013-06-21;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89088
AURO-SILDENAFIL;
02414376;
sildenafil (sildenafil citrate) 50 mg;
2019-05-17;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89903
SILDENAFIL;
02424312;
sildenafil (sildenafil citrate) 50 mg;
2014-10-07;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90902
ACCEL-SILDENAFIL;
02479818;
sildenafil (sildenafil citrate) 50 mg;
2019-08-15;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
ACCEL PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97040
AG-SILDENAFIL;
02480409;
sildenafil (sildenafil citrate) 50 mg;
2018-12-21;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
ANGITA PHARMA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97093
JAMP-SILDENAFIL;
02405679;
sildenafil (sildenafil citrate) 50.0 mg;
2014-12-05;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89044
BARRIERE CREAM 20%;
02060841;
silicone 20 %;
1997-04-01;
Topical;
Cream;
84:24.12 – BASIC OINTMENTS AND PROTECTANTS;
Otc;
WELLSPRING PHARMACEUTICAL CANADA CORP
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=27514
RAPAFLO;
02361663;
silodosin 4 mg;
2011-10-26;
Oral;
Capsule;
12:16.04.12 – Selective Alfa-1-Adrenergic Blocking Agents;
Prescription;
ALLERGAN INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84673
SANDOZ SILODOSIN;
02475421;
silodosin 4 mg;
2021-01-08;
Oral;
Capsule;
12:16.04.12 – Selective Alfa-1-Adrenergic Blocking Agents;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96581
RAPAFLO;
02361671;
silodosin 8 mg;
2011-10-26;
Oral;
Capsule;
12:16.04.12 – Selective Alfa-1-Adrenergic Blocking Agents;
Prescription;
ALLERGAN INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84674
SANDOZ SILODOSIN;
02475448;
silodosin 8 mg;
2021-01-08;
Oral;
Capsule;
12:16.04.12 – Selective Alfa-1-Adrenergic Blocking Agents;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96582
SYLVANT;
02435128;
siltuximab 100 mg / vial;
2015-03-03;
Intravenous;
Powder For Solution;
92:44.00 – IMMUNOSUPPRESSIVE AGENTS;
Prescription , Schedule D;
EUSA PHARMA (UK) LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91940
SYLVANT;
02435136;
siltuximab 400 mg / vial;
2015-03-03;
Intravenous;
Powder For Solution;
92:44.00 – IMMUNOSUPPRESSIVE AGENTS;
Prescription , Schedule D;
EUSA PHARMA (UK) LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91941
FLAMAZINE CRM 1%;
00323098;
silver sulfadiazine 1 %;
1974-12-31;
Topical;
Cream;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Prescription;
SMITH & NEPHEW INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=2146
GAS-X EXTRA STRENGTH;
00896675;
simethicone 125 mg;
1991-12-31;
Oral;
Tablet (Chewable);
56:10.00 – ANTIFLATULENTS;
Otc;
GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13362
GAS RELIEF TABLETS;
02328127;
simethicone 125 mg;
2010-03-25;
Oral;
Tablet (Chewable);
56:10.00 – ANTIFLATULENTS;
Otc;
GUARDIAN DRUG COMPANY INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81363
ULTRA STRENGTH PHAZYME 180MG SOFTGELS;
02237698;
simethicone 180 mg;
1998-10-27;
Oral;
Capsule;
56:10.00 – ANTIFLATULENTS;
Otc;
C B FLEET COMPANY INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=61044
OVOL FOR GAS 180 MG CAPSULE;
02239298;
simethicone 180 mg;
1999-03-30;
Oral;
Capsule;
56:10.00 – ANTIFLATULENTS;
Otc;
CHURCH & DWIGHT CANADA CORP
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=62764
ULTRA STRENGTH GAS RELIEF;
02244204;
simethicone 180 mg;
2001-09-01;
Oral;
Capsule;
56:10.00 – ANTIFLATULENTS;
Otc;
VITA HEALTH PRODUCTS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=68167
OVOL FOR GAS 180 MG TABLET;
02247127;
simethicone 180 mg;
2003-05-16;
Oral;
Tablet;
56:10.00 – ANTIFLATULENTS;
Otc;
CHURCH & DWIGHT CANADA CORP
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=71367
GAS X ULTRA STRENGTH;
02300761;
simethicone 180 mg;
2008-02-22;
Oral;
Capsule;
56:10.00 – ANTIFLATULENTS;
Otc;
GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78612
OVOL DROPS;
00013617;
simethicone 40 mg / ml;
1963-12-31;
Oral;
Drops;
56:10.00 – ANTIFLATULENTS;
Otc;
CHURCH & DWIGHT CANADA CORP
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=198
PEDIACOL;
02245510;
simethicone 40 mg / ml;
2004-05-21;
Oral;
Drops;
56:10.00 – ANTIFLATULENTS;
Otc;
EURO-PHARM INTERNATIONAL CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=69597
INFACOL;
02248588;
simethicone 40 mg / ml;
2006-07-27;
Oral;
Suspension;
56:10.00 – ANTIFLATULENTS;
Otc;
LEDA HEALTH INNOVATIONS INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72943
OVOL FOR GAS 80 MG TABLET;
00292990;
simethicone 80 mg;
1974-12-31;
Oral;
Tablet;
56:10.00 – ANTIFLATULENTS;
Otc;
CHURCH & DWIGHT CANADA CORP
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=1889
ZOCOR;
00884332;
simvastatin 10 mg;
1990-12-31;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
ORGANON CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10947
APO-SIMVASTATIN;
02247012;
simvastatin 10 mg;
2002-12-20;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=71246
SIMVASTATIN-10;
02247221;
simvastatin 10 mg;
2003-04-10;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=71463
TEVA-SIMVASTATIN;
02250152;
simvastatin 10 mg;
2004-03-22;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73496
SIMVASTATIN;
02284731;
simvastatin 10 mg;
2009-10-22;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77029
TARO-SIMVASTATIN;
02329158;
simvastatin 10 mg;
2009-07-20;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
SUN PHARMA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81484
MINT-SIMVASTATIN;
02372940;
simvastatin 10 mg;
2011-09-07;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
MINT PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85805
MAR-SIMVASTATIN;
02375044;
simvastatin 10 mg;
2012-12-20;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
MARCAN PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86044
JAMP-SIMVASTATIN;
02375605;
simvastatin 10 mg;
2012-01-09;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86102
SIMVASTATIN;
02386305;
simvastatin 10 mg;
2012-06-11;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
SIVEM PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87188
AURO-SIMVASTATIN;
02405156;
simvastatin 10 mg;
2013-07-08;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88998
PHARMA-SIMVASTATIN;
02469987;
simvastatin 10 mg;
2017-11-29;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95893
AG-SIMVASTATIN;
02480069;
simvastatin 10 mg;
2018-09-06;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
ANGITA PHARMA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97060
BIO-SIMVASTATIN;
02484455;
simvastatin 10 mg;
2019-09-19;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
BIOMED PHARMA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97477
PRIVA-SIMVASTATIN;
02485745;
simvastatin 10 mg;
2019-08-15;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
PHARMAPAR INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97598
ZOCOR;
00884340;
simvastatin 20 mg;
1994-12-31;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
ORGANON CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=16473
APO-SIMVASTATIN;
02247013;
simvastatin 20 mg;
2002-12-20;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=71247
SIMVASTATIN-20;
02247222;
simvastatin 20 mg;
2003-04-10;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=71464
TEVA-SIMVASTATIN;
02250160;
simvastatin 20 mg;
2004-03-22;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73497
PMS-SIMVASTATIN;
02269279;
simvastatin 20 mg;
2005-11-03;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75465
SIMVASTATIN;
02284758;
simvastatin 20 mg;
2009-10-22;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77030
TARO-SIMVASTATIN;
02329166;
simvastatin 20 mg;
2009-07-20;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
SUN PHARMA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81485
MINT-SIMVASTATIN;
02372959;
simvastatin 20 mg;
2011-09-07;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
MINT PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85806
MAR-SIMVASTATIN;
02375052;
simvastatin 20 mg;
2012-12-20;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
MARCAN PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86045
JAMP-SIMVASTATIN;
02375613;
simvastatin 20 mg;
2012-01-09;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86103
SIMVASTATIN;
02386313;
simvastatin 20 mg;
2012-06-12;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
SIVEM PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87189
AURO-SIMVASTATIN;
02405164;
simvastatin 20 mg;
2013-07-08;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88999
PHARMA-SIMVASTATIN;
02469995;
simvastatin 20 mg;
2017-11-29;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95894
AG-SIMVASTATIN;
02480077;
simvastatin 20 mg;
2018-09-06;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
ANGITA PHARMA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97062
BIO-SIMVASTATIN;
02484463;
simvastatin 20 mg;
2019-09-19;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
BIOMED PHARMA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97478
PRIVA-SIMVASTATIN;
02485753;
simvastatin 20 mg;
2019-08-15;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
PHARMAPAR INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97599
ZOCOR;
00884359;
simvastatin 40 mg;
1996-08-14;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
ORGANON CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=46718
APO-SIMVASTATIN;
02247014;
simvastatin 40 mg;
2002-12-20;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=71248
SIMVASTATIN-40;
02247223;
simvastatin 40 mg;
2003-04-10;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=71465
TEVA-SIMVASTATIN;
02250179;
simvastatin 40 mg;
2004-03-22;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73498
PMS-SIMVASTATIN;
02269287;
simvastatin 40 mg;
2005-11-03;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75466
SIMVASTATIN;
02284766;
simvastatin 40 mg;
2009-10-22;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77031
TARO-SIMVASTATIN;
02329174;
simvastatin 40 mg;
2009-07-20;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
SUN PHARMA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81486
MINT-SIMVASTATIN;
02372967;
simvastatin 40 mg;
2011-09-07;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
MINT PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85807
MAR-SIMVASTATIN;
02375060;
simvastatin 40 mg;
2012-12-20;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
MARCAN PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86046
JAMP-SIMVASTATIN;
02375621;
simvastatin 40 mg;
2012-01-09;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86104
SIMVASTATIN;
02386321;
simvastatin 40 mg;
2012-06-11;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
SIVEM PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87190
AURO-SIMVASTATIN;
02405172;
simvastatin 40 mg;
2013-07-08;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88997
PHARMA-SIMVASTATIN;
02470004;
simvastatin 40 mg;
2017-11-29;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95895
AG-SIMVASTATIN;
02480085;
simvastatin 40 mg;
2018-09-06;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
ANGITA PHARMA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97061
BIO-SIMVASTATIN;
02484471;
simvastatin 40 mg;
2019-09-19;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
BIOMED PHARMA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97479
PRIVA-SIMVASTATIN;
02485761;
simvastatin 40 mg;
2019-08-15;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
PHARMAPAR INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97600
APO-SIMVASTATIN;
02247011;
simvastatin 5 mg;
2002-12-20;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=71245
TEVA-SIMVASTATIN;
02250144;
simvastatin 5 mg;
2004-03-22;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73495
PMS-SIMVASTATIN;
02269252;
simvastatin 5 mg;
2005-11-03;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75463
SIMVASTATIN;
02284723;
simvastatin 5 mg;
2009-10-22;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77028
TARO-SIMVASTATIN;
02329131;
simvastatin 5 mg;
2009-07-20;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
SUN PHARMA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81483
MINT-SIMVASTATIN;
02372932;
simvastatin 5 mg;
2011-09-07;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
MINT PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85804
JAMP-SIMVASTATIN;
02375591;
simvastatin 5 mg;
2012-01-09;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86101
SIMVASTATIN;
02386291;
simvastatin 5 mg;
2012-06-11;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
SIVEM PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87187
AURO-SIMVASTATIN;
02405148;
simvastatin 5 mg;
2013-07-08;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88996
PHARMA-SIMVASTATIN;
02469979;
simvastatin 5 mg;
2017-11-29;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95892
AG-SIMVASTATIN;
02480050;
simvastatin 5 mg;
2018-09-06;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
ANGITA PHARMA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97059
APO-SIMVASTATIN;
02247015;
simvastatin 80 mg;
2002-12-20;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=71249
SIMVASTATIN-80;
02247224;
simvastatin 80 mg;
2009-06-15;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=71466
TEVA-SIMVASTATIN;
02250187;
simvastatin 80 mg;
2004-03-22;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73499
PMS-SIMVASTATIN;
02269295;
simvastatin 80 mg;
2005-11-03;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75467
SIMVASTATIN;
02284774;
simvastatin 80 mg;
2009-10-22;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77032
TARO-SIMVASTATIN;
02329182;
simvastatin 80 mg;
2009-07-20;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
SUN PHARMA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81487
MINT-SIMVASTATIN;
02372975;
simvastatin 80 mg;
2011-09-07;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
MINT PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85808
JAMP-SIMVASTATIN;
02375648;
simvastatin 80 mg;
2012-01-09;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86105
SIMVASTATIN;
02386348;
simvastatin 80 mg;
2012-06-11;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
SIVEM PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87191
AURO-SIMVASTATIN;
02405180;
simvastatin 80 mg;
2013-07-08;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89000
PHARMA-SIMVASTATIN;
02470012;
simvastatin 80 mg;
2017-11-29;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95896
AG-SIMVASTATIN;
02480093;
simvastatin 80 mg;
2018-09-06;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
ANGITA PHARMA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97063
KINEVAC;
02228602;
sincalide 5 mcg / vial;
1998-07-08;
Intravenous;
Powder For Solution;
36:34.00 – GALLBLADDER FUNCTION;
Ethical;
BRACCO IMAGING CANADA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=37574
VEREGEN;
02411849;
sinecatechins 10 % / w/w;
2014-07-04;
Topical;
Ointment;
84:04.06 – ANTIVIRALS;
Prescription;
PALADIN LABS INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89643
MAYZENT;
02496429;
siponimod 0.25 mg;
2020-04-24;
Oral;
Tablet;
92:20.00 – Immunomodulatory Agents;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98630
MAYZENT;
02496437;
siponimod 2 mg;
2020-04-24;
Oral;
Tablet;
92:20.00 – Immunomodulatory Agents;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98631
RAPAMUNE;
02247111;
sirolimus 1.0 mg;
2003-03-25;
Oral;
Tablet;
92:44.00 – IMMUNOSUPPRESSIVE AGENTS;
Prescription;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=71350
RAPAMUNE;
02243237;
sirolimus 1.0 mg / ml;
2001-05-15;
Oral;
Solution;
92:44.00 – IMMUNOSUPPRESSIVE AGENTS;
Prescription;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=67127
JANUVIA;
02303922;
sitagliptin (sitagliptin phosphate monohydrate) 100 mg;
2008-01-02;
Oral;
Tablet;
68:20.05 – DIPEPTIDYL PEPTIDASE-4 (DPP-4) INHIBITORS;
Prescription;
MERCK CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78924
JANUVIA;
02388839;
sitagliptin (sitagliptin phosphate monohydrate) 25 mg;
2012-09-17;
Oral;
Tablet;
68:20.05 – DIPEPTIDYL PEPTIDASE-4 (DPP-4) INHIBITORS;
Prescription;
MERCK CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87438
JANUVIA;
02388847;
sitagliptin (sitagliptin phosphate monohydrate) 50 mg;
2012-09-17;
Oral;
Tablet;
68:20.05 – DIPEPTIDYL PEPTIDASE-4 (DPP-4) INHIBITORS;
Prescription;
MERCK CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87439
SODIUM ACETATE INJECTION, USP;
02139529;
sodium acetate 328 mg / ml;
1996-08-14;
Intravenous;
Solution;
40:12.00 – REPLACEMENT PREPARATIONS;
Ethical;
FRESENIUS KABI CANADA LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=31360
SODIUM ACETATE-OMEGA;
02181746;
sodium acetate 328 mg / ml;
1999-05-28;
Intravenous;
Liquid;
40:12.00 – REPLACEMENT PREPARATIONS;
Ethical;
OMEGA LABORATORIES LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=35083
BICART;
02403501;
sodium bicarbonate 1250 g / cartridge;
2013-10-22;
Dialysis;
Powder;
40:34.00* – HEMODIALYSIS SOLUTION;
Ethical;
BAXTER CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88830
SODIUM BICARBONATE INJECTION USP;
00261971;
sodium bicarbonate 42 mg / ml;
1987-12-31;
Intravenous;
Solution;
40:08.00 – ALKALINIZING AGENTS;
Ethical;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=8350
SODIUM BICARBONATE INJECTION, USP;
02486628;
sodium bicarbonate 42 mg / ml;
2019-10-04;
Intravenous;
Solution;
40:08.00 – ALKALINIZING AGENTS;
Ethical;
FRESENIUS KABI CANADA LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97680
HEMA BP-38;
02280884;
sodium bicarbonate 6 kg / container;
2006-07-03;
Dialysis;
Powder;
40:34.00* – HEMODIALYSIS SOLUTION;
Ethical;
CHIEF MEDICAL SUPPLIES LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76654
BIBAG;
02325586;
sodium bicarbonate 650 g / bag;
2009-12-10;
Dialysis;
Powder For Solution;
40:34.00* – HEMODIALYSIS SOLUTION;
Ethical;
FRESENIUS MEDICAL CARE CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81095
HEMACART;
02325772;
sodium bicarbonate 650 g / cartridge;
2009-12-21;
Dialysis;
Powder For Solution;
40:34.00* – HEMODIALYSIS SOLUTION;
Ethical;
CHIEF MEDICAL SUPPLIES LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81113
SODIUM BICARBONATE USP FOR HEMODIALYSIS D12276;
02221616;
sodium bicarbonate 650 g / sachet;
1996-09-10;
Dialysis;
Powder;
40:34.00* – HEMODIALYSIS SOLUTION;
Ethical;
BAXTER CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=37283
800 SODIUM BICARBONATE POWDER;
00774995;
sodium bicarbonate 650 g / 8 l;
1988-12-31;
Dialysis;
Powder For Solution;
40:34.00* – HEMODIALYSIS SOLUTION;
Ethical;
BAXTER CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=8587
BICART;
02403498;
sodium bicarbonate 720 g / cartridge;
2013-09-26;
Dialysis;
Powder;
40:34.00* – HEMODIALYSIS SOLUTION;
Ethical;
BAXTER CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88829
SODIUM BICARBONATE INJECTION USP;
00038083;
sodium bicarbonate 75 mg / ml;
1979-12-31;
Intravenous;
Solution;
40:08.00 – ALKALINIZING AGENTS;
Ethical;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=3837
BICARBONATE CONCENTRATE B38;
02248934;
sodium bicarbonate 80.7 g / l;
2005-07-04;
Dialysis;
Solution;
40:34.00* – HEMODIALYSIS SOLUTION;
Ethical;
CHIEF MEDICAL SUPPLIES LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73309
BICARBONATE CONCENTRATE D17000;
00691623;
sodium bicarbonate 81.3 g / l;
1986-12-31;
Dialysis;
Solution;
40:34.00* – HEMODIALYSIS SOLUTION;
Ethical;
BAXTER CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=6775
SODIUM BICARBONATE INJECTION USP;
00261998;
sodium bicarbonate 84 mg / ml;
1974-12-31;
Intravenous;
Solution;
40:08.00 – ALKALINIZING AGENTS;
Ethical;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=1905
SODIUM BICARBONATE INJECTION USP;
02467585;
sodium bicarbonate 84 mg / ml;
2017-10-20;
Intravenous;
Solution;
40:08.00 – ALKALINIZING AGENTS;
Ethical;
OMEGA LABORATORIES LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95595
SODIUM BICARBONATE INJECTION, USP;
02486636;
sodium bicarbonate 84 mg / ml;
2019-09-17;
Intravenous;
Solution;
40:08.00 – ALKALINIZING AGENTS;
Ethical;
FRESENIUS KABI CANADA LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97681
BIBAG;
02487756;
sodium bicarbonate 900 g / bag;
2020-01-30;
Dialysis;
Powder For Solution;
40:34.00* – HEMODIALYSIS SOLUTION;
Ethical;
FRESENIUS MEDICAL CARE CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97789
BIFLEXY 900;
02428601;
sodium bicarbonate 900 g / cartridge;
2016-08-08;
Dialysis;
Powder For Solution;
40:34.00* – HEMODIALYSIS SOLUTION;
Ethical;
BELLCO SRL
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91307
0.9% SODIUM CHLORIDE INJECTION USP;
01924303;
sodium chloride 0.9 %;
1992-12-31;
Intravenous;
Solution;
40:12.00 – REPLACEMENT PREPARATIONS;
Ethical;
B. BRAUN MEDICAL INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=12185
SODIUM CHLORIDE INJECTION USP;
02311798;
sodium chloride 0.9 % / w/v;
2009-04-06;
Intravenous;
Solution;
40:12.00 – REPLACEMENT PREPARATIONS;
Ethical;
FRESENIUS MEDICAL CARE NORTH AMERICA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79733
1.6% SODIUM CHLORDIE PROCESSING SOLUTION;
00783633;
sodium chloride 1.6 g / 100 ml;
1991-12-31;
Irrigation;
Solution;
40:36.00 – IRRIGATING SOLUTIONS;
Ethical;
BAXTER CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=12169
12% SODIUM CHLORDIE PROCESSING SOLUTION;
00783625;
sodium chloride 12 g / 100 ml;
1991-12-31;
Irrigation;
Solution;
40:36.00 – IRRIGATING SOLUTIONS;
Ethical;
BAXTER CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=12168
SODIUM CHLORIDE INJ 23.4%;
00402230;
sodium chloride 234 mg / ml;
1977-12-31;
Intravenous;
Solution;
40:12.00 – REPLACEMENT PREPARATIONS;
Ethical;
OMEGA LABORATORIES LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=3395
SODIUM CHLORIDE INJECTION, USP;
02139510;
sodium chloride 234 mg / ml;
1984-12-31;
Intravenous;
Solution;
40:12.00 – REPLACEMENT PREPARATIONS;
Ethical;
FRESENIUS KABI CANADA LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18937
SODIUM CHLORIDE 3% INJ;
00060232;
sodium chloride 3 g / 100 ml;
1990-12-31;
Intravenous;
Solution;
40:12.00 – REPLACEMENT PREPARATIONS;
Ethical;
BAXTER CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=11039
SODIUM CHLORIDE INJECTION USP;
00037788;
sodium chloride 4.5 mg / ml;
1960-12-31;
Intravenous;
Solution;
40:12.00 – REPLACEMENT PREPARATIONS;
Ethical;
ICU MEDICAL CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=1736
0.45% SODIUM CHLORIDE INJECTION USP;
01927949;
sodium chloride 4.5 mg / ml;
1993-12-31;
Intravenous;
Solution;
40:12.00 – REPLACEMENT PREPARATIONS;
Ethical;
B. BRAUN MEDICAL INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=14579
SODIUM CHLORIDE 0.45% INJ;
00060186;
sodium chloride 450 mg / 100 ml;
1990-12-31;
Intravenous;
Liquid;
40:12.00 – REPLACEMENT PREPARATIONS;
Ethical;
BAXTER CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10442
5% SODIUM CHLORIDE INJECTION USP;
01928007;
sodium chloride 5 g / 100 ml;
1993-12-31;
Intravenous;
Solution;
40:12.00 – REPLACEMENT PREPARATIONS;
Ethical;
B. BRAUN MEDICAL INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=15492
H.E.L.P. NACI 0.9%;
02373815;
sodium chloride 9 g / l;
2012-03-09;
0-Unassigned;
Solution;
92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
Ethical;
B. BRAUN AVITUM AG
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85903
BACTERIOSTATIC SODIUM CHLORIDE INJECTION USP;
00037818;
sodium chloride 9 mg / ml;
1951-12-31;
Intramuscular , Intravenous , Subcutaneous;
Solution;
40:12.00 – REPLACEMENT PREPARATIONS;
Ethical;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=115
SODIUM CHLORIDE IRRIGATION USP;
00037834;
sodium chloride 9 mg / ml;
1966-12-31;
Intraperitoneal , Irrigation , Topical;
Solution;
40:36.00 – IRRIGATING SOLUTIONS;
Ethical;
ICU MEDICAL CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=228
SODIUM CHLORIDE INJECTION USP;
00037796;
sodium chloride 9 mg / ml;
1967-12-31;
Intramuscular , Intraperitoneal , Intravenous , Subcutaneous;
Solution;
40:12.00 – REPLACEMENT PREPARATIONS;
Ethical;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=817
SODIUM CHLORIDE IRRIGATION USP;
00037826;
sodium chloride 9 mg / ml;
1964-12-31;
Intraperitoneal , Irrigation;
Solution;
40:36.00 – IRRIGATING SOLUTIONS;
Ethical;
ICU MEDICAL CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=1239
SODIUM CHLORIDE BACTERIOSTATIC INJ;
00402249;
sodium chloride 9 mg / ml;
1977-12-31;
Intramuscular , Intravenous , Subcutaneous;
Liquid;
40:12.00 – REPLACEMENT PREPARATIONS;
Ethical;
OMEGA LABORATORIES LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=3396
SODIUM CHLORIDE INJECTION USP;
00037842;
sodium chloride 9 mg / ml;
1980-12-31;
Intravenous;
Solution;
40:12.00 – REPLACEMENT PREPARATIONS;
Ethical;
ICU MEDICAL CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=4092
0.9% SODIUM CHLORIDE INJECTION USP;
02150204;
sodium chloride 9 mg / ml;
1977-12-31;
Intramuscular , Intravenous , Subcutaneous;
Solution;
40:12.00 – REPLACEMENT PREPARATIONS;
Ethical;
OMEGA LABORATORIES LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18136
SODIUM CHLORIDE INJECTION USP 0.9%;
02279754;
sodium chloride 9 mg / ml;
2006-08-17;
Intravenous , Subcutaneous;
Solution;
40:12.00 – REPLACEMENT PREPARATIONS;
Ethical;
FERRING INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76534
SODIUM CHLORIDE INJECTION USP 0.9%;
02304341;
sodium chloride 9 mg / ml;
2008-06-06;
Intramuscular , Intravenous , Subcutaneous;
Solution;
40:50.00* – DILUENTS;
Ethical;
TELIGENT OU
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78963
0.9% SODIUM CHLORIDE IRRIGATION, USP;
00786160;
sodium chloride 900 mg / 100 ml;
1989-12-31;
Irrigation;
Solution;
40:36.00 – IRRIGATING SOLUTIONS;
Ethical;
BAXTER CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=9825
0.9% SODIUM CHLORIDE INJECTION, USP;
00060208;
sodium chloride 900 mg / 100 ml;
1982-12-31;
Intravenous;
Solution;
40:12.00 – REPLACEMENT PREPARATIONS;
Ethical;
BAXTER CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10040
SODIUM CHLORIDE 0.9% INJECTION;
02395150;
sodium chloride 900 mg / 100 ml;
2013-12-10;
Intravenous;
Solution;
40:12.00 – REPLACEMENT PREPARATIONS;
Ethical;
FRESENIUS KABI CANADA LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88027
ANTICOAGULANT SOD CITRATE SOLTN 4GM/100ML;
00060313;
sodium citrate 4 g / 100 ml;
1990-12-31;
0-Unassigned;
Solution;
20:12.04.92 – MISCELLANEOUS ANTICOAGULANTS;
Ethical;
BAXTER CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10497
ANTICOAGULANT SODIUM CITRATE 4% W/V SOLUTION, USP;
02377411;
sodium citrate dihydrate 4 g / 100 ml;
2012-10-01;
0-Unassigned;
Solution;
20:12.04.92 – MISCELLANEOUS ANTICOAGULANTS;
Ethical;
HAEMONETICS CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86313
NIPRIDE;
02361736;
sodium nitroprusside 25 mg / ml;
2011-05-17;
Intravenous;
Solution;
24:08.20 – DIRECT VASODILATORS;
Prescription;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84678
SODIUM NITROPRUSSIDE FOR INJECTION;
02450089;
sodium nitroprusside 25 mg / ml;
2021-04-26;
Intravenous;
Solution;
24:08.20 – DIRECT VASODILATORS;
Prescription;
STERIMAX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93610
SODIUM NITROPRUSSIDE FOR INJECTION;
02479109;
sodium nitroprusside 25 mg / ml;
2019-04-15;
Intravenous;
Solution;
24:08.20 – DIRECT VASODILATORS;
Prescription;
MARCAN PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96981
XYREM;
02268272;
sodium oxybate 500 mg / ml;
2007-08-03;
Oral;
Solution;
28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
Schedule G (Cdsa I);
JAZZ PHARMACEUTICALS IRELAND LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75367
PHEBURANE;
02436663;
sodium phenylbutyrate 483 mg / g;
2015-01-27;
Oral;
Granules;
-;
Prescription;
MEDUNIK CANADA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92099
SOLYSTAT;
00755338;
sodium polystyrene sulfonate 1 g / g;
1988-12-31;
Oral , Rectal;
Powder For Suspension;
40:18.18 – POTASSIUM-REMOVING AGENTS;
Prescription;
PENDOPHARM DIVISION OF PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=8918
KAYEXALATE;
02026961;
sodium polystyrene sulfonate 1 g / g;
1961-12-31;
Oral , Rectal;
Powder For Suspension;
40:18.18 – POTASSIUM-REMOVING AGENTS;
Prescription;
SANOFI-AVENTIS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=17752
ODAN-SODIUM POLYSTYRENE SULFONATE;
02473941;
sodium polystyrene sulfonate 1 g / g;
2018-10-25;
Oral , Rectal;
Powder For Suspension;
40:18.18 – POTASSIUM-REMOVING AGENTS;
Prescription;
ODAN LABORATORIES LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96396
JAMP SODIUM POLYSTYRENE SULFONATE;
02497557;
sodium polystyrene sulfonate 1 g / g;
2021-02-04;
Oral , Rectal;
Powder For Suspension;
40:18.18 – POTASSIUM-REMOVING AGENTS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98738
SOLYSTAT;
00769541;
sodium polystyrene sulfonate 250 mg / ml;
1989-12-31;
Oral;
Suspension;
40:18.18 – POTASSIUM-REMOVING AGENTS;
Prescription;
PENDOPHARM DIVISION OF PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=9611
ODAN-SODIUM POLYSTYRENE SULFONATE;
02473968;
sodium polystyrene sulfonate 250 mg / ml;
2018-12-11;
Oral , Rectal;
Suspension;
40:18.18 – POTASSIUM-REMOVING AGENTS;
Prescription;
ODAN LABORATORIES LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96397
TROMBOJECT 1% INJ 10MG/ML;
00511234;
sodium tetradecyl sulfate 10 mg / ml;
1987-12-31;
Intravenous;
Solution;
24:16.00 – SCLEROSING AGENTS;
Ethical;
OMEGA LABORATORIES LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=8275
TROMBOJECT 3% INJ 30MG/ML;
00511226;
sodium tetradecyl sulfate 30 mg / ml;
1987-12-31;
Intravenous;
Solution;
24:16.00 – SCLEROSING AGENTS;
Ethical;
OMEGA LABORATORIES LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=8274
SODIUM THIOSULFATE INJECTION USP;
02137186;
sodium thiosulfate 250 mg / ml;
1998-07-13;
Intravenous;
Solution;
92:12.00 – ANTIDOTES;
Ethical;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=31283
SEACALPHYX;
02386666;
sodium thiosulfate 250 mg / ml;
2013-01-08;
Intravenous;
Solution;
92:12.00 – ANTIDOTES;
Ethical;
SEAFORD PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87223
SODIUM THIOSULFATE INJECTION USP;
02428393;
sodium thiosulfate 250 mg / ml;
2015-11-23;
Intravenous;
Solution;
92:12.00 – ANTIDOTES;
Ethical;
HOPE PHARMACEUTICALS LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91283
LOKELMA;
02490722;
sodium zirconium cyclosilicate 10 g / sachet;
2019-10-17;
Oral;
Powder For Suspension;
40:18.18 – POTASSIUM-REMOVING AGENTS;
Prescription;
ASTRAZENECA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98078
LOKELMA;
02490714;
sodium zirconium cyclosilicate 5 g / sachet;
2019-10-17;
Oral;
Powder For Suspension;
40:18.18 – POTASSIUM-REMOVING AGENTS;
Prescription;
ASTRAZENECA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98077
SOVALDI;
02418355;
sofosbuvir 400 mg;
2014-01-06;
Oral;
Tablet;
08:18.92 – MISCELLANEOUS ANTIVIRALS;
Prescription;
GILEAD SCIENCES CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90293
VESICARE;
02277271;
solifenacin succinate 10 mg;
2006-06-23;
Oral;
Tablet;
86:12.04 – Antimuscarinics;
Prescription;
ASTELLAS PHARMA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76293
TEVA-SOLIFENACIN;
02397919;
solifenacin succinate 10 mg;
2015-07-30;
Oral;
Tablet;
86:12.04 – Antimuscarinics;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88284
SANDOZ SOLIFENACIN;
02399040;
solifenacin succinate 10 mg;
2015-09-30;
Oral;
Tablet;
86:12.04 – Antimuscarinics;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88395
PMS-SOLIFENACIN;
02417731;
solifenacin succinate 10 mg;
2015-10-28;
Oral;
Tablet;
86:12.04 – Antimuscarinics;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90236
JAMP-SOLIFENACIN;
02424347;
solifenacin succinate 10 mg;
2015-12-29;
Oral;
Tablet;
86:12.04 – Antimuscarinics;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90905
TARO-SOLIFENACIN;
02437996;
solifenacin succinate 10 mg;
2015-12-29;
Oral;
Tablet;
86:12.04 – Antimuscarinics;
Prescription;
SUN PHARMA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92235
AURO-SOLIFENACIN;
02446383;
solifenacin succinate 10 mg;
2016-01-04;
Oral;
Tablet;
86:12.04 – Antimuscarinics;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93172
SOLIFENACIN;
02458152;
solifenacin succinate 10 mg;
2016-10-27;
Oral;
Tablet;
86:12.04 – Antimuscarinics;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94520
SOLIFENACIN;
02458268;
solifenacin succinate 10 mg;
2016-11-03;
Oral;
Tablet;
86:12.04 – Antimuscarinics;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94536
PRZ-SOLIFENACIN;
02493047;
solifenacin succinate 10 mg;
2020-11-13;
Oral;
Tablet;
86:12.04 – Antimuscarinics;
Prescription;
PHARMARIS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98303
VESICARE;
02277263;
solifenacin succinate 5 mg;
2006-06-23;
Oral;
Tablet;
86:12.04 – Antimuscarinics;
Prescription;
ASTELLAS PHARMA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76292
TEVA-SOLIFENACIN;
02397900;
solifenacin succinate 5 mg;
2015-07-30;
Oral;
Tablet;
86:12.04 – Antimuscarinics;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88283
SANDOZ SOLIFENACIN;
02399032;
solifenacin succinate 5 mg;
2015-09-30;
Oral;
Tablet;
86:12.04 – Antimuscarinics;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88394
PMS-SOLIFENACIN;
02417723;
solifenacin succinate 5 mg;
2015-10-28;
Oral;
Tablet;
86:12.04 – Antimuscarinics;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90235
JAMP-SOLIFENACIN;
02424339;
solifenacin succinate 5 mg;
2015-12-29;
Oral;
Tablet;
86:12.04 – Antimuscarinics;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90904
TARO-SOLIFENACIN;
02437988;
solifenacin succinate 5 mg;
2015-12-29;
Oral;
Tablet;
86:12.04 – Antimuscarinics;
Prescription;
SUN PHARMA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92234
AURO-SOLIFENACIN;
02446375;
solifenacin succinate 5 mg;
2016-01-04;
Oral;
Tablet;
86:12.04 – Antimuscarinics;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93171
SOLIFENACIN;
02458144;
solifenacin succinate 5 mg;
2016-10-27;
Oral;
Tablet;
86:12.04 – Antimuscarinics;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94519
SOLIFENACIN;
02458241;
solifenacin succinate 5 mg;
2016-11-03;
Oral;
Tablet;
86:12.04 – Antimuscarinics;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94535
PRZ-SOLIFENACIN;
02493039;
solifenacin succinate 5 mg;
2020-11-13;
Oral;
Tablet;
86:12.04 – Antimuscarinics;
Prescription;
PHARMARIS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98302
GENOTROPIN;
02401746;
somatropin 0.2 mg / syr;
2020-09-17;
Subcutaneous;
Powder For Solution;
68:28.00 – PITUITARY;
Prescription , Schedule D;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88662
GENOTROPIN;
02401754;
somatropin 0.4 mg / syr;
2020-09-17;
Subcutaneous;
Powder For Solution;
68:28.00 – PITUITARY;
Prescription , Schedule D;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88663
GENOTROPIN;
02401762;
somatropin 0.6 mg / syr;
2013-09-18;
Subcutaneous;
Powder For Solution;
68:28.00 – PITUITARY;
Prescription , Schedule D;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88664
GENOTROPIN;
02401770;
somatropin 0.8 mg / syr;
2013-09-18;
Subcutaneous;
Powder For Solution;
68:28.00 – PITUITARY;
Prescription , Schedule D;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88665
GENOTROPIN;
02401789;
somatropin 1 mg / syr;
2013-09-18;
Subcutaneous;
Powder For Solution;
68:28.00 – PITUITARY;
Prescription , Schedule D;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88666
GENOTROPIN;
02401797;
somatropin 1.2 mg / syr;
2013-09-18;
Subcutaneous;
Powder For Solution;
68:28.00 – PITUITARY;
Prescription , Schedule D;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88667
GENOTROPIN;
02401800;
somatropin 1.4 mg / syr;
2013-09-18;
Subcutaneous;
Powder For Solution;
68:28.00 – PITUITARY;
Prescription , Schedule D;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88668
GENOTROPIN;
02401819;
somatropin 1.6 mg / syr;
2013-09-18;
Subcutaneous;
Powder For Solution;
68:28.00 – PITUITARY;
Prescription , Schedule D;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88669
GENOTROPIN;
02401827;
somatropin 1.8 mg / syr;
2013-09-18;
Subcutaneous;
Powder For Solution;
68:28.00 – PITUITARY;
Prescription , Schedule D;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88670
OMNITROPE;
02325071;
somatropin 10 mg / 1.5 ml;
2009-04-20;
Subcutaneous;
Solution;
68:28.00 – PITUITARY;
Prescription , Schedule D;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81049
NORDITROPIN NORDIFLEX;
02334860;
somatropin 10 mg / 1.5 ml;
2014-08-15;
Subcutaneous;
Solution;
68:28.00 – PITUITARY;
Prescription , Schedule D;
NOVO NORDISK CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82049
NUTROPIN AQ NUSPIN 10;
02376393;
somatropin 10 mg / 2 ml;
2012-05-18;
Subcutaneous;
Solution;
68:30.04 – SOMATOTROPIN AGONISTS*;
Prescription , Schedule D;
HOFFMANN-LA ROCHE LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86186
GENOTROPIN;
02401711;
somatropin 12 mg / pen;
2013-09-18;
Subcutaneous;
Powder For Solution;
68:28.00 – PITUITARY;
Prescription , Schedule D;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88660
NORDITROPIN NORDIFLEX;
02334879;
somatropin 15 mg / 1.5 ml;
2014-08-15;
Subcutaneous;
Solution;
68:28.00 – PITUITARY;
Prescription , Schedule D;
NOVO NORDISK CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82050
OMNITROPE;
02459647;
somatropin 15 mg / 1.5 ml;
2017-08-14;
Subcutaneous;
Solution;
68:28.00 – PITUITARY;
Prescription , Schedule D;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94695
GENOTROPIN;
02401835;
somatropin 2 mg / syr;
2013-09-18;
Subcutaneous;
Powder For Solution;
68:28.00 – PITUITARY;
Prescription , Schedule D;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88671
NUTROPIN AQ NUSPIN 20;
02399083;
somatropin 20 mg / 2 ml;
2013-09-09;
Subcutaneous;
Solution;
68:30.04 – SOMATOTROPIN AGONISTS*;
Prescription , Schedule D;
HOFFMANN-LA ROCHE LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88398
SAIZEN;
02237971;
somatropin 5 mg / vial;
1999-10-26;
Intramuscular , Subcutaneous;
Powder For Solution;
68:28.00 – PITUITARY;
Prescription , Schedule D;
EMD SERONO, A DIVISION OF EMD INC., CANADA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=61332
OMNITROPE;
02325063;
somatropin 5 mg / 1.5 ml;
2009-04-20;
Subcutaneous;
Solution;
68:28.00 – PITUITARY;
Prescription , Schedule D;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81048
NORDITROPIN NORDIFLEX;
02334852;
somatropin 5 mg / 1.5 ml;
2014-08-15;
Subcutaneous;
Solution;
68:28.00 – PITUITARY;
Prescription , Schedule D;
NOVO NORDISK CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82048
NUTROPIN AQ NUSPIN 5;
02399091;
somatropin 5 mg / 2 ml;
2013-09-09;
Subcutaneous;
Solution;
68:30.04 – SOMATOTROPIN AGONISTS*;
Prescription , Schedule D;
HOFFMANN-LA ROCHE LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88400
GENOTROPIN;
02401703;
somatropin 5.3 mg / pen;
2013-09-18;
Subcutaneous;
Powder For Solution;
68:28.00 – PITUITARY;
Prescription , Schedule D;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88659
SAIZEN;
02350122;
somatropin 5.83 mg / ml;
2010-12-02;
Subcutaneous;
Solution;
68:28.00 – PITUITARY;
Prescription , Schedule D;
EMD SERONO, A DIVISION OF EMD INC., CANADA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83536
SAIZEN;
02350130;
somatropin 8 mg / ml;
2010-12-02;
Subcutaneous;
Solution;
68:28.00 – PITUITARY;
Prescription , Schedule D;
EMD SERONO, A DIVISION OF EMD INC., CANADA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83537
SAIZEN;
02350149;
somatropin 8 mg / ml;
2010-12-02;
Subcutaneous;
Solution;
68:28.00 – PITUITARY;
Prescription , Schedule D;
EMD SERONO, A DIVISION OF EMD INC., CANADA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83538
ODOMZO;
02500337;
sonidegib (sonidegib phosphate) 200 mg;
2020-12-23;
Oral;
Capsule;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
SUN PHARMA GLOBAL FZE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99003
NEXAVAR;
02284227;
sorafenib (sorafenib tosylate) 200 mg;
2006-07-31;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
BAYER INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76977
APO-SOTALOL – TAB 160MG;
02167794;
sotalol hydrochloride 160 mg;
1995-12-31;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18779
PMS-SOTALOL – 160 MG;
02238327;
sotalol hydrochloride 160 mg;
1998-07-22;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=61730
RIVA-SOTALOL;
02272172;
sotalol hydrochloride 160 mg;
2016-07-15;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
LABORATOIRE RIVA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75770
JAMP-SOTALOL;
02368625;
sotalol hydrochloride 160 mg;
2011-10-20;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85360
APO-SOTALOL 80MG TABLETS;
02210428;
sotalol hydrochloride 80 mg;
1996-12-31;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=20002
PMS-SOTALOL – 80 MG;
02238326;
sotalol hydrochloride 80 mg;
1998-07-22;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=61729
RIVA-SOTALOL;
02272164;
sotalol hydrochloride 80 mg;
2010-06-04;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
LABORATOIRE RIVA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75769
JAMP-SOTALOL;
02368617;
sotalol hydrochloride 80 mg;
2011-10-20;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85359
INTRALIPID 20%;
02065673;
soybean oil 20 % / w/v;
1995-12-31;
Intravenous;
Emulsion;
40:20.00 – CALORIC AGENTS;
Ethical;
FRESENIUS KABI CANADA LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18647
ROVAMYCINE 500 CAPSULE 1500000 UNIT;
01927817;
spiramycin 1500000 unit;
1957-12-31;
Oral;
Capsule;
08:12.12 – MACROLIDES;
Prescription;
ODAN LABORATORIES LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=12601
ROVAMYCINE 250 CAPSULE 750000 UNIT;
01927825;
spiramycin 750000 unit;
1957-12-31;
Oral;
Capsule;
08:12.12 – MACROLIDES;
Prescription;
ODAN LABORATORIES LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13090
ALDACTONE 100 MG;
00285455;
spironolactone 100 mg;
1975-12-31;
Oral;
Tablet;
24:32.20 – MINERALOCORTICOID (ALDOSTERONE) RECEPTOR ANTAGONISTS;
Prescription;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=2145
TEVA-SPIRONOLACTONE;
00613223;
spironolactone 100 mg;
1984-12-31;
Oral;
Tablet;
24:32.20 – MINERALOCORTICOID (ALDOSTERONE) RECEPTOR ANTAGONISTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=5647
MINT-SPIRONOLACTONE;
02488159;
spironolactone 100 mg;
2020-02-06;
Oral;
Tablet;
24:32.20 – MINERALOCORTICOID (ALDOSTERONE) RECEPTOR ANTAGONISTS;
Prescription;
MINT PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97826
ALDACTONE 25 MG;
00028606;
spironolactone 25 mg;
1959-12-31;
Oral;
Tablet;
24:32.20 – MINERALOCORTICOID (ALDOSTERONE) RECEPTOR ANTAGONISTS;
Prescription;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=1403
TEVA-SPIRONOLACTONE;
00613215;
spironolactone 25 mg;
1984-12-31;
Oral;
Tablet;
24:32.20 – MINERALOCORTICOID (ALDOSTERONE) RECEPTOR ANTAGONISTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=5646
MINT-SPIRONOLACTONE;
02488140;
spironolactone 25 mg;
2020-02-06;
Oral;
Tablet;
24:32.20 – MINERALOCORTICOID (ALDOSTERONE) RECEPTOR ANTAGONISTS;
Prescription;
MINT PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97825
ITULATEK;
02498073;
standardized allergen extract – white birch (betula verrucosa) 12 unit;
2020-09-28;
Sublingual;
Tablet;
92:05.00* – ALLERGENIC EXTRACTS;
Prescription , Schedule D;
ALK-ABELLO A/S
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98787
STANDARDIZED CAT HAIR AP;
02217457;
standardized cat hair acetone precipitated 10000 unit / ml;
1998-08-28;
Intradermal , Subcutaneous;
Solution;
92:05.00* – ALLERGENIC EXTRACTS;
Schedule D;
JUBILANT HOLLISTERSTIER LLC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43218
ALLERGENIC EXTRACT – STANDARDIZED GRASS POLLEN – KENTUCKY BLUE/JUNE;
02242666;
standardized kentucky blue/june grass pollen 100000 unit / ml;
2000-10-30;
Intracutaneous , Subcutaneous;
Liquid;
92:05.00* – ALLERGENIC EXTRACTS;
Schedule D;
GREER LABORATORIES INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66455
ALLERGENIC EXTRACT – STANDARDIZED JUNE GRASS POLLEN;
02325454;
standardized kentucky blue/june grass pollen 100000 unit / ml;
2009-07-30;
Intradermal , Subcutaneous , Percutaneous;
Liquid;
92:05.00* – ALLERGENIC EXTRACTS;
Schedule D;
ALK-ABELLO INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81083
ALLERGENIC EXTRACT – STANDARDIZED GRASS POLLEN – MEADOW FESCUE;
02242672;
standardized meadow fescue grass pollen 100000 unit / ml;
2000-10-30;
Intracutaneous , Subcutaneous;
Liquid;
92:05.00* – ALLERGENIC EXTRACTS;
Schedule D;
GREER LABORATORIES INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66461
ALLERGENIC EXTRACT – STANDARDIZED MEADOW FESCUE GRASS POLLEN;
02325527;
standardized meadow fescue grass pollen 100000 unit / ml;
2009-07-30;
Intradermal , Subcutaneous , Percutaneous;
Liquid;
92:05.00* – ALLERGENIC EXTRACTS;
Schedule D;
ALK-ABELLO INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81090
ALLERGENIC EXTRACT – STANDARDIZED GRASS POLLEN – ORCHARD;
02242674;
standardized orchard grass pollen 100000 unit / ml;
2000-10-31;
Intracutaneous , Subcutaneous;
Liquid;
92:05.00* – ALLERGENIC EXTRACTS;
Schedule D;
GREER LABORATORIES INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66463
ALLERGENIC EXTRACT – STANDARDIZED ORCHARD GRASS POLLEN;
02325489;
standardized orchard grass pollen 100000 unit / ml;
2009-07-30;
Intradermal , Subcutaneous , Percutaneous;
Liquid;
92:05.00* – ALLERGENIC EXTRACTS;
Schedule D;
ALK-ABELLO INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81086
ALLERGENIC EXTRACT – STANDARDIZED GRASS POLLEN – PERENNIAL RYE;
02242676;
standardized perennial rye grass pollen 100000 unit / ml;
2000-10-30;
Intracutaneous , Subcutaneous;
Liquid;
92:05.00* – ALLERGENIC EXTRACTS;
Schedule D;
GREER LABORATORIES INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66465
ALLERGENIC EXTRACT – STANDARDIZED PERENNNIAL RYE GRASS POLLEN;
02325500;
standardized perennial rye grass pollen 100000 unit / ml;
2009-07-30;
Intradermal , Subcutaneous , Percutaneous;
Liquid;
92:05.00* – ALLERGENIC EXTRACTS;
Schedule D;
ALK-ABELLO INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81088
ALLERGENIC EXTRACT – STANDARDIZED GRASS POLLEN – RED TOP;
02242670;
standardized redtop grass pollen 100000 unit / ml;
2000-10-30;
Intracutaneous , Subcutaneous;
Liquid;
92:05.00* – ALLERGENIC EXTRACTS;
Schedule D;
GREER LABORATORIES INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66459
ALLERGENIC EXTRACT – STANDARDIZED REDTOP GRASS POLLEN;
02325497;
standardized redtop grass pollen 100000 unit / ml;
2009-07-30;
Intradermal , Subcutaneous , Percutaneous;
Liquid;
92:05.00* – ALLERGENIC EXTRACTS;
Schedule D;
ALK-ABELLO INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81087
RAGWITEK;
02423723;
standardized short ragweed pollen allergenic extract 12 unit;
2014-04-29;
Sublingual;
Tablet (Orally Disintegrating);
92:05.00* – ALLERGENIC EXTRACTS;
Prescription , Schedule D;
ALK-ABELLO A/S
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90842
ALLERGENIC EXTRACT – STANDARDIZED GRASS POLLEN – SWEET VERNAL;
02242668;
standardized sweet vernal grass pollen 100000 unit / ml;
2000-10-30;
Intracutaneous , Subcutaneous;
Liquid;
92:05.00* – ALLERGENIC EXTRACTS;
Schedule D;
GREER LABORATORIES INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66457
ALLERGENIC EXTRACT – STANDARDIZED SWEET VERNAL GRASS POLLEN;
02325519;
standardized sweet vernal grass pollen 100000 unit / ml;
2009-07-30;
Intradermal , Subcutaneous , Percutaneous;
Liquid;
92:05.00* – ALLERGENIC EXTRACTS;
Schedule D;
ALK-ABELLO INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81089
ALLERGENIC EXTRACT – STANDARDIZED GRASS POLLEN – TIMOTHY;
02242664;
standardized timothy grass pollen 100000 unit / ml;
2000-10-30;
Intracutaneous , Subcutaneous;
Liquid;
92:05.00* – ALLERGENIC EXTRACTS;
Schedule D;
GREER LABORATORIES INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66453
ALLERGENIC EXTRACT – STANDARDIZED TIMOTHY GRASS POLLEN;
02325470;
standardized timothy grass pollen 100000 unit / ml;
2009-07-30;
Intradermal , Subcutaneous , Percutaneous;
Liquid;
92:05.00* – ALLERGENIC EXTRACTS;
Schedule D;
ALK-ABELLO INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81085
GRASTEK;
02418304;
standardized timothy grass pollen 2800 unit;
2014-01-14;
Sublingual;
Tablet (Orally Disintegrating);
92:05.00* – ALLERGENIC EXTRACTS;
Prescription , Schedule D;
ALK-ABELLO A/S
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90288
DIACOMIT;
02398958;
stiripentol 250 mg;
2013-05-01;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
BIOCODEX SAS
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88386
DIACOMIT;
02398974;
stiripentol 250 mg / sachet;
2013-05-01;
Oral;
Powder For Suspension;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
BIOCODEX SAS
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88388
DIACOMIT;
02398966;
stiripentol 500 mg;
2013-05-01;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
BIOCODEX SAS
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88387
STREPTOMYCIN FOR INJECTION USP;
02243660;
streptomycin (streptomycin sulfate) 1 g / vial;
2001-10-15;
Intramuscular;
Powder For Solution;
08:12.02 – AMINOGLYCOSIDES;
Prescription;
STERIMAX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=67590
QUELICIN;
00038172;
succinylcholine chloride 20 mg / ml;
1952-12-31;
Intravenous;
Solution;
12:20.20 – NEUROMUSCULAR BLOCKING AGENTS;
Prescription;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=227
SUCCINYLCHOLINE CHLORIDE INJECTION USP;
02422336;
succinylcholine chloride 20 mg / ml;
2014-09-30;
Intravenous;
Solution;
12:20.20 – NEUROMUSCULAR BLOCKING AGENTS;
Prescription;
TELIGENT OU
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90702
SUCCINYLCHOLINE CHLORIDE INJECTION, USP;
02501783;
succinylcholine chloride 20 mg / ml;
2020-09-29;
Intravenous;
Solution;
12:20.20 – NEUROMUSCULAR BLOCKING AGENTS;
Prescription;
DR REDDY’S LABORATORIES LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99139
TEVA-SUCRALFATE;
02045702;
sucralfate 1 g;
1993-12-31;
Oral;
Tablet;
56:28.32 – PROTECTANTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=14504
APO-SUCRALFATE – TAB 1G;
02125250;
sucralfate 1 g;
1994-12-31;
Oral;
Tablet;
56:28.32 – PROTECTANTS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=16656
SULCRATE;
02100622;
sucralfate 1 g;
1995-12-31;
Oral;
Tablet;
56:28.32 – PROTECTANTS;
Prescription;
APTALIS PHARMA CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=17250
SULCRATE SUSPENSION PLUS;
02103567;
sucralfate 1 g / 5 ml;
1995-12-31;
Oral;
Suspension;
56:28.32 – PROTECTANTS;
Prescription;
APTALIS PHARMA CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=17852
SUFENTANIL CITRATE INJECTION USP;
02244147;
sufentanil (sufentanil citrate) 50 mcg / ml;
2001-08-01;
Intravenous , Epidural;
Solution;
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=68108
SUFENTANIL CITRATE INJECTION USP;
02442213;
sufentanil (sufentanil citrate) 50 mcg / ml;
2016-10-18;
Intravenous , Epidural;
Solution;
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
STERIMAX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92657
BRIDION;
02451816;
sugammadex (sugammadex sodium) 100 mg / ml;
2016-02-19;
Intravenous;
Solution;
92:12.00 – ANTIDOTES;
Prescription;
MERCK CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93817
PMS-SULFASALAZINE 500MG/TAB USP;
00598461;
sulfasalazine 500 mg;
1984-12-31;
Oral;
Tablet;
08:12.20 – SULFONAMIDES;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=5728
PMS-SULFASALAZINE-E.C. TAB 500MG;
00598488;
sulfasalazine 500 mg;
1984-12-31;
Oral;
Tablet (Enteric-Coated);
08:12.20 – SULFONAMIDES;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=5864
SALAZOPYRIN TAB 500MG;
02064480;
sulfasalazine 500 mg;
1995-12-31;
Oral;
Tablet;
08:12.20 – SULFONAMIDES;
Prescription;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=17416
SALAZOPYRIN EN-TABS 500 MG;
02064472;
sulfasalazine 500 mg;
1995-12-31;
Oral;
Tablet (Enteric-Coated);
08:12.20 – SULFONAMIDES;
Prescription;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=17417
SONOVUE;
02287684;
sulfur hexafluoride 8 mcl / ml;
2016-09-22;
Intravenous;
Powder For Suspension;
36:89.00* – OTHER DIAGNOSTIC AGENTS;
Ethical;
BRACCO IMAGING CANADA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77308
TEVA-SULINDAC;
00745588;
sulindac 150 mg;
1988-12-31;
Oral;
Tablet;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=9238
TEVA-SULINDAC;
00745596;
sulindac 200 mg;
1988-12-31;
Oral;
Tablet;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=9239
IMITREX NASAL SPRAY;
02230420;
sumatriptan (sumatriptan hemisulfate) 20 mg / act;
1997-02-19;
Nasal;
Spray;
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
GLAXOSMITHKLINE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=49290
IMITREX NASAL SPRAY;
02230418;
sumatriptan (sumatriptan hemisulfate) 5 mg / act;
1997-02-19;
Nasal;
Spray;
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
GLAXOSMITHKLINE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=49288
IMITREX DF – TAB 100MG;
02212161;
sumatriptan (sumatriptan succinate) 100 mg;
1997-02-11;
Oral;
Tablet;
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
GLAXOSMITHKLINE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43077
TEVA-SUMATRIPTAN;
02239367;
sumatriptan (sumatriptan succinate) 100 mg;
2005-09-30;
Oral;
Tablet;
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=62836
PMS-SUMATRIPTAN;
02256444;
sumatriptan (sumatriptan succinate) 100 mg;
2005-08-24;
Oral;
Tablet;
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74165
ACT SUMATRIPTAN;
02257904;
sumatriptan (sumatriptan succinate) 100 mg;
2005-08-24;
Oral;
Tablet;
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74313
SANDOZ SUMATRIPTAN;
02263033;
sumatriptan (sumatriptan succinate) 100 mg;
2005-08-24;
Oral;
Tablet;
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74844
APO-SUMATRIPTAN;
02268396;
sumatriptan (sumatriptan succinate) 100 mg;
2005-08-24;
Oral;
Tablet;
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75378
MYLAN-SUMATRIPTAN;
02268922;
sumatriptan (sumatriptan succinate) 100 mg;
2005-08-24;
Oral;
Tablet;
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
MYLAN PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75432
SUMATRIPTAN;
02286548;
sumatriptan (sumatriptan succinate) 100 mg;
2010-04-05;
Oral;
Tablet;
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77199
TEVA-SUMATRIPTAN DF;
02286831;
sumatriptan (sumatriptan succinate) 100 mg;
2006-10-30;
Oral;
Tablet;
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77229
SUMATRIPTAN;
02324660;
sumatriptan (sumatriptan succinate) 100 mg;
2009-06-15;
Oral;
Tablet;
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81010
SUMATRIPTAN DF;
02385589;
sumatriptan (sumatriptan succinate) 100 mg;
2012-06-10;
Oral;
Tablet;
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
SIVEM PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87119
PMS-SUMATRIPTAN;
02256428;
sumatriptan (sumatriptan succinate) 25 mg;
2005-08-24;
Oral;
Tablet;
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74163
MYLAN-SUMATRIPTAN;
02268906;
sumatriptan (sumatriptan succinate) 25 mg;
2005-08-24;
Oral;
Tablet;
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
MYLAN PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75430
TEVA-SUMATRIPTAN DF;
02286815;
sumatriptan (sumatriptan succinate) 25 mg;
2006-10-30;
Oral;
Tablet;
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77227
IMITREX DF – TAB 50MG;
02212153;
sumatriptan (sumatriptan succinate) 50 mg;
1998-02-11;
Oral;
Tablet;
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
GLAXOSMITHKLINE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43076
PMS-SUMATRIPTAN;
02256436;
sumatriptan (sumatriptan succinate) 50 mg;
2005-08-24;
Oral;
Tablet;
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74164
SANDOZ SUMATRIPTAN;
02263025;
sumatriptan (sumatriptan succinate) 50 mg;
2005-08-24;
Oral;
Tablet;
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74843
APO-SUMATRIPTAN;
02268388;
sumatriptan (sumatriptan succinate) 50 mg;
2005-08-24;
Oral;
Tablet;
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75377
MYLAN-SUMATRIPTAN;
02268914;
sumatriptan (sumatriptan succinate) 50 mg;
2005-08-24;
Oral;
Tablet;
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
MYLAN PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75431
SUMATRIPTAN;
02286521;
sumatriptan (sumatriptan succinate) 50 mg;
2010-04-05;
Oral;
Tablet;
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77198
TEVA-SUMATRIPTAN DF;
02286823;
sumatriptan (sumatriptan succinate) 50 mg;
2006-10-30;
Oral;
Tablet;
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77228
SUMATRIPTAN;
02324652;
sumatriptan (sumatriptan succinate) 50 mg;
2009-06-15;
Oral;
Tablet;
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81009
SUMATRIPTAN DF;
02385570;
sumatriptan (sumatriptan succinate) 50 mg;
2012-06-10;
Oral;
Tablet;
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
SIVEM PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87118
IMITREX;
02212188;
sumatriptan (sumatriptan succinate) 6 mg / 0.5 ml;
1999-08-30;
Subcutaneous;
Liquid;
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
GLAXOSMITHKLINE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43078
TARO-SUMATRIPTAN;
02361698;
sumatriptan (sumatriptan succinate) 6 mg / 0.5 ml;
2011-06-06;
Subcutaneous;
Solution;
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
TARO PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84675
SUTENT;
02280795;
sunitinib (sunitinib malate) 12.5 mg;
2006-06-22;
Oral;
Capsule;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76647
SUTENT;
02280809;
sunitinib (sunitinib malate) 25 mg;
2006-06-22;
Oral;
Capsule;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76648
SUTENT;
02280817;
sunitinib (sunitinib malate) 50 mg;
2006-06-22;
Oral;
Capsule;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76649
SANDOZ TACROLIMUS;
02416816;
tacrolimus (tacrolimus monohydrate) 0.5 mg;
2014-06-11;
Oral;
Capsule (Immediate Release);
92:44.00 – IMMUNOSUPPRESSIVE AGENTS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90142
SANDOZ TACROLIMUS;
02416824;
tacrolimus (tacrolimus monohydrate) 1 mg;
2013-11-25;
Oral;
Capsule (Immediate Release);
92:44.00 – IMMUNOSUPPRESSIVE AGENTS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90143
SANDOZ TACROLIMUS;
02416832;
tacrolimus (tacrolimus monohydrate) 5 mg;
2013-11-25;
Oral;
Capsule (Immediate Release);
92:44.00 – IMMUNOSUPPRESSIVE AGENTS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90144
PROTOPIC;
02244149;
tacrolimus 0.03 % / w/w;
2001-09-06;
Topical;
Ointment;
84:92.00 – MISC. SKIN AND MUCOUS MEMBRANE AGENTS;
Prescription;
LEO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=68110
PROTOPIC;
02244148;
tacrolimus 0.1 % / w/w;
2001-09-06;
Topical;
Ointment;
84:92.00 – MISC. SKIN AND MUCOUS MEMBRANE AGENTS;
Prescription;
LEO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=68109
PROGRAF;
02243144;
tacrolimus 0.5 mg;
2001-04-02;
Oral;
Capsule;
92:44.00 – IMMUNOSUPPRESSIVE AGENTS;
Prescription;
ASTELLAS PHARMA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=67015
ADVAGRAF;
02296462;
tacrolimus 0.5 mg;
2008-04-09;
Oral;
Capsule (Extended Release);
92:44.00 – IMMUNOSUPPRESSIVE AGENTS;
Prescription;
ASTELLAS PHARMA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78179
ENVARSUS PA;
02485877;
tacrolimus 0.75 mg;
2019-04-17;
Oral;
Tablet (Extended-Release);
92:44.00 – IMMUNOSUPPRESSIVE AGENTS;
Prescription;
ENDO VENTURES LTD.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97609
PROGRAF;
02175991;
tacrolimus 1 mg;
1996-08-14;
Oral;
Capsule;
92:44.00 – IMMUNOSUPPRESSIVE AGENTS;
Prescription;
ASTELLAS PHARMA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=44211
ADVAGRAF;
02296470;
tacrolimus 1 mg;
2008-04-09;
Oral;
Capsule (Extended Release);
92:44.00 – IMMUNOSUPPRESSIVE AGENTS;
Prescription;
ASTELLAS PHARMA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78180
ENVARSUS PA;
02485885;
tacrolimus 1 mg;
2019-04-17;
Oral;
Tablet (Extended-Release);
92:44.00 – IMMUNOSUPPRESSIVE AGENTS;
Prescription;
ENDO VENTURES LTD.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97610
ADVAGRAF;
02331667;
tacrolimus 3 mg;
2010-04-05;
Oral;
Capsule (Extended Release);
92:44.00 – IMMUNOSUPPRESSIVE AGENTS;
Prescription;
ASTELLAS PHARMA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81736
ENVARSUS PA;
02485893;
tacrolimus 4 mg;
2019-04-17;
Oral;
Tablet (Extended-Release);
92:44.00 – IMMUNOSUPPRESSIVE AGENTS;
Prescription;
ENDO VENTURES LTD.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97611
PROGRAF;
02175983;
tacrolimus 5 mg;
1996-08-14;
Oral;
Capsule;
92:44.00 – IMMUNOSUPPRESSIVE AGENTS;
Prescription;
ASTELLAS PHARMA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=44210
ADVAGRAF;
02296489;
tacrolimus 5 mg;
2008-04-09;
Oral;
Capsule (Extended Release);
92:44.00 – IMMUNOSUPPRESSIVE AGENTS;
Prescription;
ASTELLAS PHARMA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78181
PROGRAF;
02176009;
tacrolimus 5 mg / ml;
1996-08-14;
Intravenous;
Solution;
92:44.00 – IMMUNOSUPPRESSIVE AGENTS;
Prescription;
ASTELLAS PHARMA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=44212
CIALIS;
02248088;
tadalafil 10 mg;
2003-12-11;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
ELI LILLY CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72410
PMS-TADALAFIL;
02409437;
tadalafil 10 mg;
2016-07-12;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89414
MYLAN-TADALAFIL;
02410656;
tadalafil 10 mg;
2016-07-12;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
MYLAN PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89532
APO-TADALAFIL;
02422107;
tadalafil 10 mg;
2016-07-12;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90682
AURO-TADALAFIL;
02435934;
tadalafil 10 mg;
2016-07-14;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92027
TEVA-TADALAFIL;
02440164;
tadalafil 10 mg;
2016-07-12;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92454
JAMP-TADALAFIL;
02451840;
tadalafil 10 mg;
2016-07-13;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93820
MAR-TADALAFIL;
02452251;
tadalafil 10 mg;
2016-07-13;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
MARCAN PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93849
RAN-TADALAFIL;
02452103;
tadalafil 10 mg;
2016-07-12;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
RANBAXY PHARMACEUTICALS CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93853
PRIVA-TADALAFIL;
02452499;
tadalafil 10 mg;
2016-07-13;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
PHARMAPAR INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93887
TADALAFIL;
02455366;
tadalafil 10 mg;
2016-09-09;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94217
CIALIS;
02296888;
tadalafil 2.5 mg;
2008-01-18;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
ELI LILLY CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78223
PMS-TADALAFIL;
02409410;
tadalafil 2.5 mg;
2016-07-12;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89412
MYLAN-TADALAFIL;
02410621;
tadalafil 2.5 mg;
2016-07-12;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
MYLAN PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89530
APO-TADALAFIL;
02422085;
tadalafil 2.5 mg;
2016-07-12;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90680
AURO-TADALAFIL;
02435896;
tadalafil 2.5 mg;
2016-07-14;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92025
TEVA-TADALAFIL;
02440148;
tadalafil 2.5 mg;
2016-07-12;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92452
RAN-TADALAFIL;
02452081;
tadalafil 2.5 mg;
2016-07-12;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
RANBAXY PHARMACEUTICALS CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93852
CIALIS;
02248089;
tadalafil 20 mg;
2003-11-25;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
ELI LILLY CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72411
ADCIRCA;
02338327;
tadalafil 20 mg;
2010-01-19;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
ELI LILLY CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82395
PMS-TADALAFIL;
02409445;
tadalafil 20 mg;
2016-07-12;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89415
MYLAN-TADALAFIL;
02410664;
tadalafil 20 mg;
2016-07-12;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
MYLAN PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89533
APO-TADALAFIL PAH;
02421933;
tadalafil 20 mg;
2015-10-15;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90663
APO-TADALAFIL;
02422115;
tadalafil 20 mg;
2016-07-12;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90683
AURO-TADALAFIL;
02435942;
tadalafil 20 mg;
2016-07-14;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92028
TEVA-TADALAFIL;
02440172;
tadalafil 20 mg;
2016-07-12;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92455
MINT-TADALAFIL;
02451697;
tadalafil 20 mg;
2016-07-14;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
MINT PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93793
JAMP-TADALAFIL;
02451859;
tadalafil 20 mg;
2016-07-13;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93821
MAR-TADALAFIL;
02452243;
tadalafil 20 mg;
2016-07-13;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
MARCAN PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93850
RAN-TADALAFIL;
02452111;
tadalafil 20 mg;
2016-07-15;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
RANBAXY PHARMACEUTICALS CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93854
PRIVA-TADALAFIL;
02452502;
tadalafil 20 mg;
2016-07-13;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
PHARMAPAR INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93888
RIVA-TADALAFIL;
02454742;
tadalafil 20 mg;
2016-07-13;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
LABORATOIRE RIVA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94143
TADALAFIL;
02455374;
tadalafil 20 mg;
2016-08-11;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94218
AG-TADALAFIL;
02481421;
tadalafil 20 mg;
2019-11-21;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
ANGITA PHARMA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97175
CIALIS;
02296896;
tadalafil 5 mg;
2008-01-18;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
ELI LILLY CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78224
PMS-TADALAFIL;
02409429;
tadalafil 5 mg;
2016-07-12;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89413
MYLAN-TADALAFIL;
02410648;
tadalafil 5 mg;
2016-07-12;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
MYLAN PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89531
APO-TADALAFIL;
02422093;
tadalafil 5 mg;
2016-07-12;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90681
AURO-TADALAFIL;
02435926;
tadalafil 5 mg;
2016-07-14;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92026
TEVA-TADALAFIL;
02440156;
tadalafil 5 mg;
2016-07-12;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92453
MINT-TADALAFIL;
02451670;
tadalafil 5 mg;
2016-07-14;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
MINT PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93791
JAMP-TADALAFIL;
02451832;
tadalafil 5 mg;
2016-07-13;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93819
MAR-TADALAFIL;
02452278;
tadalafil 5 mg;
2016-07-13;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
MARCAN PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93848
RAN-TADALAFIL;
02452073;
tadalafil 5 mg;
2016-07-12;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
RANBAXY PHARMACEUTICALS CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93851
PRIVA-TADALAFIL;
02452480;
tadalafil 5 mg;
2016-07-13;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
PHARMAPAR INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93886
RIVA-TADALAFIL;
02454726;
tadalafil 5 mg;
2016-07-13;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
LABORATOIRE RIVA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94141
TADALAFIL;
02455358;
tadalafil 5 mg;
2016-08-11;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94216
VYNDAQEL;
02495732;
tafamidis meglumine 20 mg;
2020-04-07;
Oral;
Capsule;
24:04.92 – MISCELLANEOUS CARDIAC DRUGS;
Prescription;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98563
ELELYSO;
02425637;
taliglucerase alfa 200 unit / vial;
2014-09-08;
Intravenous;
Powder For Solution;
44:00.00 – ENZYMES;
Prescription , Schedule D;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91027
APO-TAMOX TAB 10MG;
00812404;
tamoxifen (tamoxifen citrate) 10 mg;
1989-12-31;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10664
TEVA-TAMOXIFEN;
00851965;
tamoxifen (tamoxifen citrate) 10 mg;
1990-12-31;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10790
APO-TAMOX TAB 20MG;
00812390;
tamoxifen (tamoxifen citrate) 20 mg;
1989-12-31;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10762
TEVA-TAMOXIFEN;
00851973;
tamoxifen (tamoxifen citrate) 20 mg;
1990-12-31;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10791
NOLVADEX-D TAB 20MG;
02048485;
tamoxifen (tamoxifen citrate) 20 mg;
1995-12-31;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
ASTRAZENECA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18639
FLOMAX CR;
02270102;
tamsulosin hydrochloride 0.4 mg;
2005-10-11;
Oral;
Tablet (Extended-Release);
12:16.04.12 – Selective Alfa-1-Adrenergic Blocking Agents;
Prescription;
BOEHRINGER INGELHEIM (CANADA) LTD LTEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75550
SANDOZ TAMSULOSIN;
02319217;
tamsulosin hydrochloride 0.4 mg;
2014-03-19;
Oral;
Capsule (Sustained-Release);
12:16.04.12 – Selective Alfa-1-Adrenergic Blocking Agents;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80468
SANDOZ TAMSULOSIN CR;
02340208;
tamsulosin hydrochloride 0.4 mg;
2011-01-04;
Oral;
Tablet (Extended-Release);
12:16.04.12 – Selective Alfa-1-Adrenergic Blocking Agents;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82577
APO-TAMSULOSIN CR;
02362406;
tamsulosin hydrochloride 0.4 mg;
2012-02-09;
Oral;
Tablet (Extended-Release);
12:16.04.12 – Selective Alfa-1-Adrenergic Blocking Agents;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84741
TEVA-TAMSULOSIN CR;
02368242;
tamsulosin hydrochloride 0.4 mg;
2013-09-04;
Oral;
Tablet (Extended-Release);
12:16.04.12 – Selective Alfa-1-Adrenergic Blocking Agents;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85321
TAMSULOSIN CR;
02413612;
tamsulosin hydrochloride 0.4 mg;
2013-11-21;
Oral;
Tablet (Extended-Release);
12:16.04.12 – Selective Alfa-1-Adrenergic Blocking Agents;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89826
TAMSULOSIN CR;
02427117;
tamsulosin hydrochloride 0.4 mg;
2014-07-24;
Oral;
Tablet (Extended-Release);
12:16.04.12 – Selective Alfa-1-Adrenergic Blocking Agents;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91164
TAMSULOSIN CR;
02429667;
tamsulosin hydrochloride 0.4 mg;
2014-10-08;
Oral;
Tablet (Extended-Release);
12:16.04.12 – Selective Alfa-1-Adrenergic Blocking Agents;
Prescription;
SIVEM PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91411
RATIO-TAMSULOSIN;
02294265;
tamsulosin hydrochloride 0.4 mg / cap;
2007-04-27;
Oral;
Capsule (Sustained-Release);
12:16.04.12 – Selective Alfa-1-Adrenergic Blocking Agents;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77961
NUCYNTA IR;
02378299;
tapentadol (tapentadol hydrochloride) 100 mg;
2012-03-20;
Oral;
Tablet (Immediate Release);
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
ENDO VENTURES LTD.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86411
NUCYNTA EXTENDED-RELEASE;
02415585;
tapentadol (tapentadol hydrochloride) 100 mg;
2014-04-16;
Oral;
Tablet (Extended-Release);
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
ENDO VENTURES LTD.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90017
NUCYNTA EXTENDED-RELEASE;
02415593;
tapentadol (tapentadol hydrochloride) 150 mg;
2014-04-16;
Oral;
Tablet (Extended-Release);
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
ENDO VENTURES LTD.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90018
NUCYNTA EXTENDED-RELEASE;
02415607;
tapentadol (tapentadol hydrochloride) 200 mg;
2014-04-16;
Oral;
Tablet (Extended-Release);
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
ENDO VENTURES LTD.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90019
NUCYNTA EXTENDED-RELEASE;
02415615;
tapentadol (tapentadol hydrochloride) 250 mg;
2014-04-16;
Oral;
Tablet (Extended-Release);
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
ENDO VENTURES LTD.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90020
NUCYNTA IR;
02378272;
tapentadol (tapentadol hydrochloride) 50 mg;
2012-03-20;
Oral;
Tablet (Immediate Release);
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
ENDO VENTURES LTD.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86409
NUCYNTA EXTENDED-RELEASE;
02415577;
tapentadol (tapentadol hydrochloride) 50 mg;
2014-04-16;
Oral;
Tablet (Extended-Release);
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
ENDO VENTURES LTD.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90016
NUCYNTA IR;
02378280;
tapentadol (tapentadol hydrochloride) 75 mg;
2012-03-20;
Oral;
Tablet (Immediate Release);
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
ENDO VENTURES LTD.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86410
TAZORAC;
02230784;
tazarotene 0.05 %;
1997-04-10;
Topical;
Gel;
84:92.00 – MISC. SKIN AND MUCOUS MEMBRANE AGENTS;
Prescription;
ALLERGAN INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=50053
TAZORAC;
02243894;
tazarotene 0.05 %;
2001-08-31;
Topical;
Cream;
84:92.00 – MISC. SKIN AND MUCOUS MEMBRANE AGENTS;
Prescription;
ALLERGAN INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=67835
TAZORAC;
02230785;
tazarotene 0.1 %;
1997-04-10;
Topical;
Gel;
84:92.00 – MISC. SKIN AND MUCOUS MEMBRANE AGENTS;
Prescription;
ALLERGAN INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=50054
TAZORAC;
02243895;
tazarotene 0.1 %;
2001-08-31;
Topical;
Cream;
84:92.00 – MISC. SKIN AND MUCOUS MEMBRANE AGENTS;
Prescription;
ALLERGAN INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=67836
REVESTIVE;
02445727;
teduglutide 5 mg / vial;
2015-10-28;
Subcutaneous;
Kit , Powder For Solution;
56:92.00 – MISCELLANEOUS GI DRUGS;
Prescription , Schedule D;
TAKEDA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93100
VIBATIV;
02330725;
telavancin (telavancin hydrochloride) 750 mg / vial;
2016-01-06;
Intravenous;
Powder For Solution;
08:12.28.16 – GLYCOPEPTIDES;
Prescription;
PENDOPHARM DIVISION OF PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81648
MICARDIS 40MG TAB;
02240769;
telmisartan 40 mg;
1999-09-01;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
BOEHRINGER INGELHEIM (CANADA) LTD LTEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=64358
TEVA-TELMISARTAN;
02320177;
telmisartan 40 mg;
2012-01-09;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80562
SANDOZ TELMISARTAN;
02375958;
telmisartan 40 mg;
2012-01-04;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86141
JAMP TELMISARTAN;
02386755;
telmisartan 40 mg;
2020-12-29;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87235
TELMISARTAN;
02388944;
telmisartan 40 mg;
2012-07-20;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87447
TELMISARTAN;
02390345;
telmisartan 40 mg;
2012-07-26;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
SIVEM PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87579
TELMISARTAN;
02395223;
telmisartan 40 mg;
2012-11-22;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88034
ACH-TELMISARTAN;
02407485;
telmisartan 40 mg;
2014-03-12;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
ACCORD HEALTHCARE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89217
AURO-TELMISARTAN;
02453568;
telmisartan 40 mg;
2016-04-08;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94012
MINT-TELMISARTAN;
02486369;
telmisartan 40 mg;
2020-04-16;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
MINT PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97657
PMS-TELMISARTAN;
02499622;
telmisartan 40 mg;
2021-03-25;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98935
MICARDIS 80MG TAB;
02240770;
telmisartan 80 mg;
1999-09-01;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
BOEHRINGER INGELHEIM (CANADA) LTD LTEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=64359
TEVA-TELMISARTAN;
02320185;
telmisartan 80 mg;
2012-01-09;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80563
SANDOZ TELMISARTAN;
02375966;
telmisartan 80 mg;
2012-01-04;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86142
JAMP TELMISARTAN;
02386763;
telmisartan 80 mg;
2020-12-29;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87236
TELMISARTAN;
02388952;
telmisartan 80 mg;
2012-07-20;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87448
TELMISARTAN;
02390353;
telmisartan 80 mg;
2012-07-26;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
SIVEM PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87580
TELMISARTAN;
02395231;
telmisartan 80 mg;
2012-11-22;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88035
ACH-TELMISARTAN;
02407493;
telmisartan 80 mg;
2014-03-12;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
ACCORD HEALTHCARE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89218
AURO-TELMISARTAN;
02453576;
telmisartan 80 mg;
2016-04-08;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94013
MINT-TELMISARTAN;
02486377;
telmisartan 80 mg;
2020-03-18;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
MINT PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97658
PMS-TELMISARTAN;
02499630;
telmisartan 80 mg;
2021-03-25;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98936
XERMELO;
02481553;
telotristat ethyl (telotristat etiprate) 250 mg;
2018-12-07;
Oral;
Tablet;
56:08.00 – ANTIDIARRHEA AGENTS;
Prescription;
IPSEN BIOPHARMACEUTICALS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97200
RESTORIL;
00604453;
temazepam 15 mg;
1980-12-31;
Oral;
Capsule;
28:24.08 – BENZODIAZEPINES;
Targeted (Cdsa Iv);
AA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=5616
RESTORIL;
00604461;
temazepam 30 mg;
1980-12-31;
Oral;
Capsule;
28:24.08 – BENZODIAZEPINES;
Targeted (Cdsa Iv);
AA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=5618
TEMODAL;
02241095;
temozolomide 100 mg;
1999-11-12;
Oral;
Capsule;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
MERCK CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=64698
ACH-TEMOZOLOMIDE;
02389827;
temozolomide 100 mg;
2012-07-25;
Oral;
Capsule;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
ACCORD HEALTHCARE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87530
ACT TEMOZOLOMIDE;
02395282;
temozolomide 100 mg;
2012-11-07;
Oral;
Capsule;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88039
TARO-TEMOZOLOMIDE;
02443511;
temozolomide 100 mg;
2015-07-23;
Oral;
Capsule;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
TARO PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92820
TEMODAL;
02312794;
temozolomide 140 mg;
2009-02-21;
Oral;
Capsule;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
MERCK CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79831
ACH-TEMOZOLOMIDE;
02389835;
temozolomide 140 mg;
2012-07-25;
Oral;
Capsule;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
ACCORD HEALTHCARE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87531
ACT TEMOZOLOMIDE;
02395290;
temozolomide 140 mg;
2012-11-07;
Oral;
Capsule;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88040
TARO-TEMOZOLOMIDE;
02443538;
temozolomide 140 mg;
2015-07-23;
Oral;
Capsule;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
TARO PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92821
TEMODAL;
02241094;
temozolomide 20 mg;
1999-11-12;
Oral;
Capsule;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
MERCK CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=64697
ACH-TEMOZOLOMIDE;
02389819;
temozolomide 20 mg;
2012-07-25;
Oral;
Capsule;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
ACCORD HEALTHCARE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87529
ACT TEMOZOLOMIDE;
02395274;
temozolomide 20 mg;
2012-11-07;
Oral;
Capsule;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88038
TARO-TEMOZOLOMIDE;
02443481;
temozolomide 20 mg;
2015-07-23;
Oral;
Capsule;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
TARO PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92818
TEMODAL;
02241096;
temozolomide 250 mg;
1999-11-12;
Oral;
Capsule;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
MERCK CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=64699
ACH-TEMOZOLOMIDE;
02389851;
temozolomide 250 mg;
2012-07-25;
Oral;
Capsule;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
ACCORD HEALTHCARE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87533
ACT TEMOZOLOMIDE;
02395312;
temozolomide 250 mg;
2012-11-07;
Oral;
Capsule;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88042
TARO-TEMOZOLOMIDE;
02443554;
temozolomide 250 mg;
2015-07-23;
Oral;
Capsule;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
TARO PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92823
TEMODAL;
02241093;
temozolomide 5 mg;
1999-11-12;
Oral;
Capsule;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
MERCK CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=64696
ACH-TEMOZOLOMIDE;
02438119;
temozolomide 5 mg;
2016-01-13;
Oral;
Capsule;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
ACCORD HEALTHCARE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92249
ACT TEMOZOLOMIDE;
02441160;
temozolomide 5 mg;
2015-12-08;
Oral;
Capsule;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92553
TARO-TEMOZOLOMIDE;
02443473;
temozolomide 5 mg;
2015-07-23;
Oral;
Capsule;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
TARO PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92817
TORISEL;
02304104;
temsirolimus 25 mg / ml;
2008-01-11;
Intravenous;
Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78941
IBSRELA;
02498049;
tenapanor (tenapanor hydrochloride) 50 mg;
2020-11-23;
Oral;
Tablet;
-;
Prescription;
KNIGHT THERAPEUTICS INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98784
TNKASE;
02244826;
tenecteplase 50 mg / vial;
2001-10-18;
Intravenous;
Powder For Solution;
20:12.20 – THROMBOLYTIC AGENTS;
Prescription , Schedule D;
HOFFMANN-LA ROCHE LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=68816
VEMLIDY;
02464241;
tenofovir alafenamide (tenofovir alafenamide hemifumarate) 25 mg;
2017-06-20;
Oral;
Tablet;
08:18.08.20 – NUCLEOSIDE AND NUCLEOTIDE REVERSE TRANSCRIPTASE INHIBITORS;
Prescription;
GILEAD SCIENCES CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95241
VIREAD;
02247128;
tenofovir disoproxil fumarate 300 mg;
2004-03-15;
Oral;
Tablet;
08:18.08.20 – NUCLEOSIDE AND NUCLEOTIDE REVERSE TRANSCRIPTASE INHIBITORS;
Prescription;
GILEAD SCIENCES CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=71368
TEVA-TENOFOVIR;
02403889;
tenofovir disoproxil fumarate 300 mg;
2017-07-26;
Oral;
Tablet;
08:18.08.20 – NUCLEOSIDE AND NUCLEOTIDE REVERSE TRANSCRIPTASE INHIBITORS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88865
APO-TENOFOVIR;
02451980;
tenofovir disoproxil fumarate 300 mg;
2017-07-26;
Oral;
Tablet;
08:18.08.20 – NUCLEOSIDE AND NUCLEOTIDE REVERSE TRANSCRIPTASE INHIBITORS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93838
MYLAN-TENOFOVIR DISOPROXIL;
02452634;
tenofovir disoproxil fumarate 300 mg;
2017-07-31;
Oral;
Tablet;
08:18.08.20 – NUCLEOSIDE AND NUCLEOTIDE REVERSE TRANSCRIPTASE INHIBITORS;
Prescription;
MYLAN PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93899
PMS-TENOFOVIR;
02453940;
tenofovir disoproxil fumarate 300 mg;
2018-04-25;
Oral;
Tablet;
08:18.08.20 – NUCLEOSIDE AND NUCLEOTIDE REVERSE TRANSCRIPTASE INHIBITORS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94047
AURO-TENOFOVIR;
02460173;
tenofovir disoproxil fumarate 300 mg;
2017-07-26;
Oral;
Tablet;
08:18.08.20 – NUCLEOSIDE AND NUCLEOTIDE REVERSE TRANSCRIPTASE INHIBITORS;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94747
NAT-TENOFOVIR;
02472511;
tenofovir disoproxil fumarate 300 mg;
2018-03-15;
Oral;
Tablet;
08:18.08.20 – NUCLEOSIDE AND NUCLEOTIDE REVERSE TRANSCRIPTASE INHIBITORS;
Prescription;
NATCO PHARMA (CANADA) INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96182
JAMP-TENOFOVIR;
02479087;
tenofovir disoproxil fumarate 300 mg;
2018-10-24;
Oral;
Tablet;
08:18.08.20 – NUCLEOSIDE AND NUCLEOTIDE REVERSE TRANSCRIPTASE INHIBITORS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96979
APO-TERAZOSIN;
02234502;
terazosin (terazosin hydrochloride) 1 mg;
1997-09-26;
Oral;
Tablet;
24:20.00 – ALPHA-ADRENERGIC BLOCKING AGENTS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=55839
PMS-TERAZOSIN;
02243518;
terazosin (terazosin hydrochloride) 1 mg;
2001-02-23;
Oral;
Tablet;
24:20.00 – ALPHA-ADRENERGIC BLOCKING AGENTS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=67437
TERAZOSIN;
02350475;
terazosin (terazosin hydrochloride) 1 mg;
2010-05-12;
Oral;
Tablet;
24:20.00 – ALPHA-ADRENERGIC BLOCKING AGENTS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83568
APO-TERAZOSIN;
02234505;
terazosin (terazosin hydrochloride) 10 mg;
1997-09-26;
Oral;
Tablet;
24:20.00 – ALPHA-ADRENERGIC BLOCKING AGENTS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=55842
PMS-TERAZOSIN;
02243521;
terazosin (terazosin hydrochloride) 10 mg;
2001-02-23;
Oral;
Tablet;
24:20.00 – ALPHA-ADRENERGIC BLOCKING AGENTS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=67440
TERAZOSIN;
02350505;
terazosin (terazosin hydrochloride) 10 mg;
2010-05-12;
Oral;
Tablet;
24:20.00 – ALPHA-ADRENERGIC BLOCKING AGENTS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83571
APO-TERAZOSIN;
02234503;
terazosin (terazosin hydrochloride) 2 mg;
1997-09-26;
Oral;
Tablet;
24:20.00 – ALPHA-ADRENERGIC BLOCKING AGENTS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=55840
TERAZOSIN-2;
02237477;
terazosin (terazosin hydrochloride) 2 mg;
1998-06-02;
Oral;
Tablet;
24:20.00 – ALPHA-ADRENERGIC BLOCKING AGENTS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=60811
PMS-TERAZOSIN;
02243519;
terazosin (terazosin hydrochloride) 2 mg;
2001-02-23;
Oral;
Tablet;
24:20.00 – ALPHA-ADRENERGIC BLOCKING AGENTS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=67438
TERAZOSIN;
02350483;
terazosin (terazosin hydrochloride) 2 mg;
2010-05-12;
Oral;
Tablet;
24:20.00 – ALPHA-ADRENERGIC BLOCKING AGENTS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83569
TEVA-TERAZOSIN;
02230807;
terazosin (terazosin hydrochloride) 5 mg;
1998-02-09;
Oral;
Tablet;
24:20.00 – ALPHA-ADRENERGIC BLOCKING AGENTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=50071
APO-TERAZOSIN;
02234504;
terazosin (terazosin hydrochloride) 5 mg;
1997-09-26;
Oral;
Tablet;
24:20.00 – ALPHA-ADRENERGIC BLOCKING AGENTS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=55841
TERAZOSIN-5;
02237478;
terazosin (terazosin hydrochloride) 5 mg;
1998-06-02;
Oral;
Tablet;
24:20.00 – ALPHA-ADRENERGIC BLOCKING AGENTS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=60812
PMS-TERAZOSIN;
02243520;
terazosin (terazosin hydrochloride) 5 mg;
2001-02-23;
Oral;
Tablet;
24:20.00 – ALPHA-ADRENERGIC BLOCKING AGENTS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=67439
TERAZOSIN;
02350491;
terazosin (terazosin hydrochloride) 5 mg;
2010-05-12;
Oral;
Tablet;
24:20.00 – ALPHA-ADRENERGIC BLOCKING AGENTS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83570
LAMISIL TAB 250MG;
02031116;
terbinafine (terbinafine hydrochloride) 250 mg;
1993-12-31;
Oral;
Tablet;
08:14.04 – ALLYLAMINES;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13990
APO-TERBINAFINE;
02239893;
terbinafine (terbinafine hydrochloride) 250 mg;
2000-05-16;
Oral;
Tablet;
08:14.04 – ALLYLAMINES;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=63385
TERBINAFINE-250;
02242735;
terbinafine (terbinafine hydrochloride) 250 mg;
2008-03-07;
Oral;
Tablet;
08:14.04 – ALLYLAMINES;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66543
ACT TERBINAFINE;
02254727;
terbinafine (terbinafine hydrochloride) 250 mg;
2005-02-11;
Oral;
Tablet;
08:14.04 – ALLYLAMINES;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73989
RIVA-TERBINAFINE;
02262924;
terbinafine (terbinafine hydrochloride) 250 mg;
2005-02-10;
Oral;
Tablet;
08:14.04 – ALLYLAMINES;
Prescription;
LABORATOIRE RIVA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74833
PMS-TERBINAFINE;
02294273;
terbinafine (terbinafine hydrochloride) 250 mg;
2009-06-19;
Oral;
Tablet;
08:14.04 – ALLYLAMINES;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77963
AURO-TERBINAFINE;
02320134;
terbinafine (terbinafine hydrochloride) 250 mg;
2011-05-30;
Oral;
Tablet;
08:14.04 – ALLYLAMINES;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80558
TERBINAFINE;
02353121;
terbinafine (terbinafine hydrochloride) 250 mg;
2010-07-26;
Oral;
Tablet;
08:14.04 – ALLYLAMINES;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83835
TERBINAFINE;
02385279;
terbinafine (terbinafine hydrochloride) 250 mg;
2012-06-10;
Oral;
Tablet;
08:14.04 – ALLYLAMINES;
Prescription;
SIVEM PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87091
LAMISIL CRM 1%;
02031094;
terbinafine hydrochloride 1 %;
1993-12-31;
Topical;
Cream;
84:04.08.04 – ALLYLAMINES;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=14532
LAMISIL;
02238703;
terbinafine hydrochloride 1 % / w/w;
1999-01-05;
Topical;
Spray;
84:04.08.04 – ALLYLAMINES;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=62135
BRICANYL TURBUHALER;
00786616;
terbutaline sulfate 0.5 mg / act;
1990-12-31;
Inhalation;
Powder (Metered Dose);
12:12.08.12 – SELECTIVE BETA 2-ADRENERGIC AGONISTS;
Prescription;
ASTRAZENECA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10665
TARO-TERCONAZOLE CREAM;
02247651;
terconazole 0.4 %;
2004-09-21;
Vaginal;
Cream;
84:04.08.08 – AZOLES;
Prescription;
TARO PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=71914
AUBAGIO;
02416328;
teriflunomide 14 mg;
2013-11-15;
Oral;
Tablet;
92:20.00 – Immunomodulatory Agents;
Prescription;
SANOFI GENZYME, A DIVISION OF SANOFI-AVENTIS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90088
TEVA-TERIPARATIDE INJECTION;
02486423;
teriparatide (teriparatide acetate) 250 mcg / ml;
2020-07-08;
Subcutaneous;
Solution;
68:24.08 – PARATHYROID AGENTS , 92:22.00 – BONE ANABOLIC AGENTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97663
FORTEO;
02254689;
teriparatide 250 mcg / ml;
2004-07-15;
Subcutaneous;
Solution;
68:24.08 – PARATHYROID AGENTS , 92:22.00 – BONE ANABOLIC AGENTS;
Prescription , Schedule D;
ELI LILLY CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73983
OSNUVO;
02495589;
teriparatide 250 mcg / ml;
2020-10-27;
Subcutaneous;
Solution;
68:24.08 – PARATHYROID AGENTS , 92:22.00 – BONE ANABOLIC AGENTS;
Prescription , Schedule D;
AVIR PHARMA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98548
EGRIFTA;
02438712;
tesamorelin (tesamorelin acetate) 1 mg / vial;
2015-06-23;
Subcutaneous;
Kit , Powder For Solution;
68:30.04 – SOMATOTROPIN AGONISTS*;
Prescription;
THERATECHNOLOGIES INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92311
ANDROGEL;
02245345;
testosterone 1 %;
2002-05-06;
Transdermal;
Gel;
68:08.00 – ANDROGENS;
Schedule G (Cdsa Iv);
BGP PHARMA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=69384
ANDROGEL;
02245346;
testosterone 1 %;
2002-05-06;
Transdermal;
Gel;
68:08.00 – ANDROGENS;
Schedule G (Cdsa Iv);
BGP PHARMA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=69385
TESTIM 1%;
02280248;
testosterone 1 %;
2007-04-17;
Transdermal;
Gel;
68:08.00 – ANDROGENS;
Schedule G (Cdsa Iv);
PALADIN LABS INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76591
TARO-TESTOSTERONE GEL;
02463792;
testosterone 1 %;
2017-10-31;
Transdermal;
Gel;
68:08.00 – ANDROGENS;
Schedule G (Cdsa Iv);
TARO PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95189
TARO-TESTOSTERONE GEL;
02463806;
testosterone 1 %;
2017-10-31;
Transdermal;
Gel;
68:08.00 – ANDROGENS;
Schedule G (Cdsa Iv);
TARO PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95190
ANDROGEL;
02249499;
testosterone 12.5 mg / act;
2004-09-20;
Transdermal;
Gel;
68:08.00 – ANDROGENS;
Schedule G (Cdsa Iv);
BGP PHARMA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73432
ANDRODERM;
02239653;
testosterone 2.5 mg / 24 hour;
2000-12-19;
Transdermal;
Patch;
68:08.00 – ANDROGENS;
Schedule G (Cdsa Iv);
ALLERGAN INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=63125
ANDRODERM;
02245972;
testosterone 5 mg / 24 hour;
2002-09-24;
Transdermal;
Patch;
68:08.00 – ANDROGENS;
Schedule G (Cdsa Iv);
ALLERGAN INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=70098
DEPO-TESTOSTERONE INJ 100MG/ML;
00030783;
testosterone cypionate 100 mg / ml;
1953-12-31;
Intramuscular;
Solution;
68:08.00 – ANDROGENS;
Schedule G (Cdsa Iv);
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=1398
TARO-TESTOSTERONE CYPIONATE INJECTION;
02496003;
testosterone cypionate 100 mg / ml;
2020-10-20;
Intramuscular;
Solution;
68:08.00 – ANDROGENS;
Schedule G (Cdsa Iv);
TARO PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98589
DELATESTRYL;
00029246;
testosterone enanthate 200 mg / ml;
1955-12-31;
Intramuscular;
Solution;
68:08.00 – ANDROGENS;
Schedule G (Cdsa Iv);
BAUSCH HEALTH, CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=1275
PMS-TESTOSTERONE;
02322498;
testosterone undecanoate 40 mg;
2009-10-08;
Oral;
Capsule;
68:08.00 – ANDROGENS;
Schedule G (Cdsa Iv);
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80793
TARO-TESTOSTERONE;
02421186;
testosterone undecanoate 40 mg;
2014-09-02;
Oral;
Capsule;
68:08.00 – ANDROGENS;
Schedule G (Cdsa Iv);
TARO PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90578
HYPERTET S/D;
02230697;
tetanus immunoglobulin (human) 250 unit / dose;
1997-07-08;
Intramuscular;
Solution;
80:04.00 – SERUMS;
Schedule D;
GRIFOLS THERAPEUTICS LLC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=49957
NITOMAN;
02199270;
tetrabenazine 25 mg;
1996-12-09;
Oral;
Tablet;
28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
Prescription;
BAUSCH HEALTH, CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=42959
PMS-TETRABENAZINE;
02402424;
tetrabenazine 25 mg;
2013-02-26;
Oral;
Tablet;
28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88726
APO-TETRABENAZINE;
02407590;
tetrabenazine 25 mg;
2013-11-01;
Oral;
Tablet;
28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89232
TETRABENAZINE TABLETS;
02410338;
tetrabenazine 25 mg;
2013-08-29;
Oral;
Tablet;
28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
Prescription;
STERIMAX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89497
AMETOP GEL 4%;
02230575;
tetracaine (tetracaine hydrochloride) 40 mg / g;
1998-03-16;
Topical;
Gel;
84:08.00 – ANTIPRURITICS AND LOCAL ANESTHETICS;
Ethical;
VALEO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=49664
MINIMS TETRACAINE HYDROCHLORIDE;
02148528;
tetracaine hydrochloride 0.5 % / w/v;
1995-12-31;
Ophthalmic;
Drops;
52:16.00 – LOCAL ANESTHETICS;
Otc;
BAUSCH HEALTH, CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18751
MINIMS TETRACAINE HYDROCHLORIDE;
02148544;
tetracaine hydrochloride 1 % / w/v;
1995-12-31;
Ophthalmic;
Drops;
52:16.00 – LOCAL ANESTHETICS;
Otc;
BAUSCH HEALTH, CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18749
SYNACTHEN DEPOT;
00253952;
tetracosactide (tetracosactide zinc hydroxide) 1 mg / ml;
1973-12-31;
Intramuscular;
Suspension;
36:04.00 – ADRENOCORTICAL INSUFFICIENCY , 68:04.00 – ADRENALS;
Prescription;
ATNAHS PHARMA UK LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=3725
CORTROSYN INJ 0.25MG;
00022381;
tetracosactide 0.25 mg / vial;
1974-12-31;
Intramuscular , Intravenous;
Powder For Solution;
36:04.00 – ADRENOCORTICAL INSUFFICIENCY , 68:28.00 – PITUITARY;
Prescription;
AMPHASTAR PHARMACEUTICALS, INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=1954
TETRACYCLINE;
00580929;
tetracycline hydrochloride 250 mg;
1983-12-31;
Oral;
Capsule;
08:12.24 – TETRACYCLINES;
Prescription;
AA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=5293
VISINE ORIGINAL;
01942425;
tetrahydrozoline hydrochloride 0.05 %;
1960-12-31;
Ophthalmic;
Drops;
52:32.00 – VASOCONSTRICTORS;
Otc;
JOHNSON & JOHNSON INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=42015
ORIGINAL EYE DROPS;
02273446;
tetrahydrozoline hydrochloride 0.05 % / w/v;
2006-06-05;
Ophthalmic;
Solution;
52:32.00 – VASOCONSTRICTORS;
Otc;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75893
THALOMID;
02355205;
thalidomide 100 mg;
2011-02-17;
Oral;
Capsule;
92:20.00 – Immunomodulatory Agents;
Prescription;
CELGENE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84046
THALOMID;
02355221;
thalidomide 200 mg;
2011-02-17;
Oral;
Capsule;
92:20.00 – Immunomodulatory Agents;
Prescription;
CELGENE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84048
THALOMID;
02355191;
thalidomide 50 mg;
2010-11-01;
Oral;
Capsule;
92:20.00 – Immunomodulatory Agents;
Prescription;
CELGENE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84045
AA-THEO LA;
00692689;
theophylline 100 mg;
1993-12-31;
Oral;
Tablet (Extended-Release);
86:16.00 – RESPIRATORY SMOOTH MUSCLE RELAXANTS;
Prescription;
AA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=14033
AA-THEO LA;
00692697;
theophylline 200 mg;
1993-12-31;
Oral;
Tablet (Extended-Release);
86:16.00 – RESPIRATORY SMOOTH MUSCLE RELAXANTS;
Prescription;
AA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=14032
AA-THEO LA;
00692700;
theophylline 300 mg;
1993-12-31;
Oral;
Tablet (Extended-Release);
86:16.00 – RESPIRATORY SMOOTH MUSCLE RELAXANTS;
Prescription;
AA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=14031
THEO ER;
02360101;
theophylline 400 mg;
2011-06-23;
Oral;
Tablet (Extended-Release);
86:16.00 – RESPIRATORY SMOOTH MUSCLE RELAXANTS;
Prescription;
AA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84507
THEO ER;
02360128;
theophylline 600 mg;
2011-06-23;
Oral;
Tablet (Extended-Release);
86:16.00 – RESPIRATORY SMOOTH MUSCLE RELAXANTS;
Prescription;
AA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84508
ELIXIR DE THEOPHYLLINE;
00627410;
theophylline 80 mg / 15 ml;
1985-12-31;
Oral;
Elixir;
86:16.00 – RESPIRATORY SMOOTH MUSCLE RELAXANTS;
Prescription;
LABORATOIRE ATLAS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=6170
VITAMIN B1;
00816078;
thiamine hydrochloride 100 mg / ml;
1989-12-31;
Intramuscular , Intravenous;
Solution;
88:08.00 – VITAMIN B COMPLEX;
Ethical;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10063
THIAMIJECT INJECTION – LIQ IM IV 100MG/ML;
02193221;
thiamine hydrochloride 100 mg / ml;
1998-07-16;
Intramuscular , Intravenous;
Liquid;
88:08.00 – VITAMIN B COMPLEX;
Ethical;
OMEGA LABORATORIES LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=35700
LANVIS;
00282081;
thioguanine 40 mg;
1974-12-31;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
ASPEN PHARMACARE CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=1812
TEPADINA;
02462702;
thiotepa 100 mg / vial;
2017-10-31;
Intravenous;
Powder For Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
ADIENNE SA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95051
TEPADINA;
02462680;
thiotepa 15 mg / vial;
2017-11-06;
Intravenous;
Powder For Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
ADIENNE SA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95050
THYROID TAB 125MG;
00023965;
thyroid 125 mg;
1951-12-31;
Oral;
Tablet;
68:36.04 – THYROID AGENTS;
Prescription;
ERFA CANADA 2012 INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=774
THYROID TAB 30MG;
00023949;
thyroid 30 mg;
1951-12-31;
Oral;
Tablet;
68:36.04 – THYROID AGENTS;
Prescription;
ERFA CANADA 2012 INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=772
THYROID TAB 60MG;
00023957;
thyroid 60 mg;
1951-12-31;
Oral;
Tablet;
68:36.04 – THYROID AGENTS;
Prescription;
ERFA CANADA 2012 INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=773
THYROGEN;
02246016;
thyrotropin alfa 0.9 mg / vial;
2002-08-12;
Intramuscular;
Powder For Solution;
36:60.00 – THYROID FUNCTION;
Prescription , Schedule D;
SANOFI GENZYME, A DIVISION OF SANOFI-AVENTIS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=70142
TEVA-TIAPROFENIC ACID;
02179679;
tiaprofenic acid 200 mg;
1996-12-31;
Oral;
Tablet;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19720
TEVA-TIAPROFENIC ACID;
02179687;
tiaprofenic acid 300 mg;
1996-12-31;
Oral;
Tablet;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19722
TIBELLA;
02488361;
tibolone 2.5 mg;
2020-07-29;
Oral;
Tablet;
68:16.00 – ESTROGENS,ANTIESTROGENS,ESTROGEN AGONIST-ANTAGONISTS;
Schedule G (Cdsa Iv);
BIOSYENT PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97847
BRILINTA;
02455005;
ticagrelor 60 mg;
2016-06-13;
Oral;
Tablet;
20:12.18 – PLATELET AGGREGATION INHIBITORS;
Prescription;
ASTRAZENECA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94181
BRILINTA;
02368544;
ticagrelor 90 mg;
2011-06-01;
Oral;
Tablet;
20:12.18 – PLATELET AGGREGATION INHIBITORS;
Prescription;
ASTRAZENECA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85352
TYGACIL;
02285401;
tigecycline 50 mg / vial;
2006-11-30;
Intravenous;
Powder For Solution;
08:12.24.12 – GLYCYLCYCLINES;
Prescription;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77090
TIGECYCLINE;
02409356;
tigecycline 50 mg / vial;
2014-10-23;
Intravenous;
Powder For Solution;
08:12.24.12 – GLYCYLCYCLINES;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89406
SANDOZ TIMOLOL;
02166712;
timolol (timolol maleate) 0.25 %;
1995-12-31;
Ophthalmic;
Solution;
52:40.08 – BETA-ADRENERGIC AGENTS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19252
TIMOLOL MALEATE-EX;
02242275;
timolol (timolol maleate) 0.25 %;
2003-04-30;
Ophthalmic;
Solution (Extended Release);
52:40.08 – BETA-ADRENERGIC AGENTS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=65975
TIMOPTIC;
00451207;
timolol (timolol maleate) 0.5 %;
1979-12-31;
Ophthalmic;
Solution;
52:40.08 – BETA-ADRENERGIC AGENTS;
Prescription;
ELVIUM LIFE SCIENCES
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=3186
APO-TIMOP;
00755834;
timolol (timolol maleate) 0.5 %;
1988-12-31;
Ophthalmic;
Solution;
52:40.08 – BETA-ADRENERGIC AGENTS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=8959
TIMOPTIC-XE;
02171899;
timolol (timolol maleate) 0.5 %;
1995-12-31;
Ophthalmic;
Solution (Extended Release);
52:40.08 – BETA-ADRENERGIC AGENTS;
Prescription;
ELVIUM LIFE SCIENCES
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18778
SANDOZ TIMOLOL;
02166720;
timolol (timolol maleate) 0.5 %;
1995-12-31;
Ophthalmic;
Solution;
52:40.08 – BETA-ADRENERGIC AGENTS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19242
TIMOLOL MALEATE-EX;
02242276;
timolol (timolol maleate) 0.5 %;
2003-04-30;
Ophthalmic;
Solution (Extended Release);
52:40.08 – BETA-ADRENERGIC AGENTS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=65976
JAMP-TIMOLOL;
02447800;
timolol (timolol maleate) 0.5 %;
2015-11-20;
Ophthalmic;
Solution;
52:40.08 – BETA-ADRENERGIC AGENTS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93340
TIMOLOL;
00755850;
timolol maleate 10 mg;
1988-12-31;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
AA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=8590
TIMOLOL;
00755869;
timolol maleate 20 mg;
1988-12-31;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
AA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=8591
TIMOLOL;
00755842;
timolol maleate 5 mg;
1988-12-31;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
AA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=8589
INNOHEP;
02167840;
tinzaparin sodium 10000 unit / ml;
1995-12-31;
Subcutaneous;
Solution;
20:12.04.16 – HEPARINS;
Prescription;
LEO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19202
INNOHEP;
02229755;
tinzaparin sodium 10000 unit / ml;
1997-07-31;
Subcutaneous;
Solution;
20:12.04.16 – HEPARINS;
Prescription;
LEO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=47983
INNOHEP;
02358158;
tinzaparin sodium 10000 unit / ml;
2011-09-09;
Subcutaneous;
Solution;
20:12.04.16 – HEPARINS;
Prescription;
LEO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84321
INNOHEP;
02358166;
tinzaparin sodium 10000 unit / ml;
2011-12-10;
Subcutaneous;
Solution;
20:12.04.16 – HEPARINS;
Prescription;
LEO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84322
INNOHEP;
02429470;
tinzaparin sodium 12000 unit / 0.6 ml;
2014-09-30;
Subcutaneous;
Solution;
20:12.04.16 – HEPARINS;
Prescription;
LEO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91393
INNOHEP;
02429489;
tinzaparin sodium 16000 unit / 0.8 ml;
2014-09-30;
Subcutaneous;
Solution;
20:12.04.16 – HEPARINS;
Prescription;
LEO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91394
INNOHEP;
02229515;
tinzaparin sodium 20000 unit / ml;
1997-02-28;
Subcutaneous;
Solution;
20:12.04.16 – HEPARINS;
Prescription;
LEO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=47420
INNOHEP;
02231478;
tinzaparin sodium 20000 unit / ml;
1997-09-23;
Subcutaneous;
Solution;
20:12.04.16 – HEPARINS;
Prescription;
LEO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=50802
INNOHEP;
02358174;
tinzaparin sodium 20000 unit / ml;
2011-09-16;
Subcutaneous;
Solution;
20:12.04.16 – HEPARINS;
Prescription;
LEO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84323
INNOHEP;
02358182;
tinzaparin sodium 20000 unit / ml;
2011-09-13;
Subcutaneous;
Solution;
20:12.04.16 – HEPARINS;
Prescription;
LEO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84324
INNOHEP;
02429462;
tinzaparin sodium 8000 unit / 0.4 ml;
2014-09-30;
Subcutaneous;
Solution;
20:12.04.16 – HEPARINS;
Prescription;
LEO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91392
SPIRIVA;
02246793;
tiotropium (tiotropium bromide monohydrate) 18 mcg;
2002-11-21;
Inhalation;
Capsule;
12:08.08 – ANTIMUSCARINICS ANTISPASMODICS;
Prescription;
BOEHRINGER INGELHEIM (CANADA) LTD LTEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=70993
SPIRIVA RESPIMAT;
02435381;
tiotropium (tiotropium bromide monohydrate) 2.5 mcg / act;
2014-12-19;
Inhalation;
Solution;
12:08.08 – ANTIMUSCARINICS ANTISPASMODICS;
Prescription;
BOEHRINGER INGELHEIM (CANADA) LTD LTEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91971
APTIVUS;
02273322;
tipranavir 250 mg;
2005-12-01;
Oral;
Capsule;
08:18.08.08 – HIV PROTEASE INHIBITORS;
Prescription;
BOEHRINGER INGELHEIM (CANADA) LTD LTEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75881
AGGRASTAT;
02240706;
tirofiban (tirofiban hydrochloride) 12.5 mg / 250 ml;
2002-05-01;
Intravenous;
Solution;
20:12.18 – PLATELET AGGREGATION INHIBITORS;
Prescription;
CIPHER PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=64293
KYMRIAH;
02480514;
tisagenlecleucel 600000000 cells;
2019-05-24;
Intravenous;
Suspension;
-;
Prescription , Schedule D;
NOVARTIS PHARMACEUTICALS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97104
TIZANIDINE;
02259893;
tizanidine (tizanidine hydrochloride) 4 mg;
2004-11-17;
Oral;
Tablet;
12:20.04 – CENTRALLY ACTING SKELETAL MUSCLE RELAXANTS;
Prescription;
AA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74515
TOBRAMYCIN FOR INJECTION;
00533688;
tobramycin (tobramycin sulfate) 1.2 g / vial;
1983-12-31;
Intravenous;
Powder For Solution;
08:12.02 – AMINOGLYCOSIDES;
Prescription;
FRESENIUS KABI CANADA LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=5402
TOBRAMYCIN INJECTION USP;
02241209;
tobramycin (tobramycin sulfate) 10 mg / ml;
1999-12-20;
Intramuscular , Intravenous;
Solution;
08:12.02 – AMINOGLYCOSIDES;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=64815
TOBI;
02239630;
tobramycin (tobramycin sulfate) 300 mg / 5 ml;
1999-04-28;
Inhalation;
Solution;
08:12.02 – AMINOGLYCOSIDES;
Prescription;
BGP PHARMA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=63101
TOBRAMYCIN INHALATION SOLUTION;
02443368;
tobramycin (tobramycin sulfate) 300 mg / 5 ml;
2016-02-26;
Inhalation;
Solution;
08:12.02 – AMINOGLYCOSIDES;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92802
TOBRAMYCIN INJECTION;
02230640;
tobramycin (tobramycin sulfate) 40 mg / ml;
1997-05-21;
Intramuscular , Intravenous;
Solution;
08:12.02 – AMINOGLYCOSIDES;
Prescription;
FRESENIUS KABI CANADA LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=49817
TOBRAMYCIN INJECTION USP;
02241210;
tobramycin (tobramycin sulfate) 40 mg / ml;
1999-12-20;
Intramuscular , Intravenous;
Solution;
08:12.02 – AMINOGLYCOSIDES;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=64816
TOBRAMYCIN INJECTION USP;
02502372;
tobramycin (tobramycin sulfate) 40 mg / ml;
2021-02-17;
Intramuscular , Intravenous;
Solution;
08:12.02 – AMINOGLYCOSIDES;
Prescription;
STERIMAX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99195
TEVA-TOBRAMYCIN;
02389622;
tobramycin (tobramycin sulfate) 60 mg / ml;
2016-02-03;
Inhalation;
Solution;
08:12.02 – AMINOGLYCOSIDES;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87512
SANDOZ TOBRAMYCIN;
02241755;
tobramycin 0.3 %;
2000-08-21;
Ophthalmic;
Solution;
52:04.04 – ANTIBACTERIALS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=65418
TOBREX;
00513962;
tobramycin 0.3 % / w/v;
1981-12-31;
Ophthalmic;
Solution;
52:04.04 – ANTIBACTERIALS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=4571
TOBREX;
00614254;
tobramycin 0.3 % / w/w;
1984-12-31;
Ophthalmic;
Ointment;
52:04.04 – ANTIBACTERIALS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=5707
TOBI PODHALER;
02365154;
tobramycin 28 mg;
2011-05-12;
Inhalation;
Capsule;
08:12.02 – AMINOGLYCOSIDES;
Prescription;
BGP PHARMA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85000
ACTEMRA;
02424770;
tocilizumab 162 mg / 0.9 ml;
2014-05-30;
Subcutaneous;
Solution;
92:36.00 – DISEASE-MODIFYING ANTIRHEUMATIC AGENTS;
Prescription , Schedule D;
HOFFMANN-LA ROCHE LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90943
ACTEMRA;
02483327;
tocilizumab 162 mg / 0.9 ml;
2019-01-15;
Subcutaneous;
Solution;
92:36.00 – DISEASE-MODIFYING ANTIRHEUMATIC AGENTS;
Prescription , Schedule D;
HOFFMANN-LA ROCHE LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97376
ACTEMRA;
02350106;
tocilizumab 200 mg / 10 ml;
2010-05-26;
Intravenous;
Solution;
92:36.00 – DISEASE-MODIFYING ANTIRHEUMATIC AGENTS;
Prescription , Schedule D;
HOFFMANN-LA ROCHE LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83534
ACTEMRA;
02350114;
tocilizumab 400 mg / 20 ml;
2010-05-26;
Intravenous;
Solution;
92:36.00 – DISEASE-MODIFYING ANTIRHEUMATIC AGENTS;
Prescription , Schedule D;
HOFFMANN-LA ROCHE LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83535
ACTEMRA;
02350092;
tocilizumab 80 mg / 4 ml;
2010-05-26;
Intravenous;
Solution;
92:36.00 – DISEASE-MODIFYING ANTIRHEUMATIC AGENTS;
Prescription , Schedule D;
HOFFMANN-LA ROCHE LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83533
XELJANZ;
02480786;
tofacitinib (tofacitinib citrate) 10 mg;
2019-01-30;
Oral;
Tablet;
92:36.00 – DISEASE-MODIFYING ANTIRHEUMATIC AGENTS;
Prescription;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97137
XELJANZ XR;
02470608;
tofacitinib (tofacitinib citrate) 11 mg;
2018-03-29;
Oral;
Tablet (Extended-Release);
92:36.00 – DISEASE-MODIFYING ANTIRHEUMATIC AGENTS;
Prescription;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95960
XELJANZ;
02423898;
tofacitinib (tofacitinib citrate) 5 mg;
2014-06-03;
Oral;
Tablet;
92:36.00 – DISEASE-MODIFYING ANTIRHEUMATIC AGENTS;
Prescription;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90863
PROCLEARZ ANTIFUNGAL LIQUID;
02078341;
tolnaftate 1 %;
1998-10-09;
Topical;
Solution;
84:04.08.40 – THIOCARBAMATES;
Otc;
PROFOOT INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=27993
TOLNAFTATE CREAM USP, 1%;
02226707;
tolnaftate 1 %;
2010-03-10;
Topical;
Cream;
84:04.08.40 – THIOCARBAMATES;
Otc;
TARO PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=37941
FLEXITOL MEDICATED ANTI-FUNGAL CREAM;
02295873;
tolnaftate 1 %;
2008-09-12;
Topical;
Cream;
84:04.08.40 – THIOCARBAMATES;
Otc;
LACORIUM HEALTH INTERNATIONAL PTY LTD.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78123
TINACTIN CHILL LIQUID SPRAY;
02319314;
tolnaftate 1 %;
2009-07-15;
Topical;
Aerosol;
84:04.08.40 – THIOCARBAMATES;
Otc;
BAYER INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80479
TINACTIN;
00576034;
tolnaftate 1 % / w/w;
1965-12-31;
Topical;
Cream;
84:04.08.40 – THIOCARBAMATES;
Otc;
BAYER INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=41608
TINACTIN POWDER;
00576042;
tolnaftate 1 % / w/w;
1965-12-31;
Topical;
Powder;
84:04.08.40 – THIOCARBAMATES;
Otc;
BAYER INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=41611
TINACTIN AEROSOL POWDER;
00576050;
tolnaftate 1 % / w/w;
1983-12-31;
Topical;
Aerosol , Powder;
84:04.08.40 – THIOCARBAMATES;
Otc;
BAYER INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=41612
DR. SCHOLL’S ATHLETE’S FOOT SPRAY POWDER;
01919245;
tolnaftate 1 % / w/w;
1989-12-31;
Topical;
Aerosol , Powder;
84:04.08.40 – THIOCARBAMATES;
Otc;
SCHOLL’S WELLNESS COMPANY
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=41933
ODOR-EATERS;
02244777;
tolnaftate 1 % / w/w;
2002-03-07;
Topical;
Aerosol;
84:04.08.40 – THIOCARBAMATES;
Otc;
BLISTEX CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=68767
TINACTIN CHILL DEODORANT POWDER SPRAY;
02319276;
tolnaftate 1 % / w/w;
2009-07-18;
Topical;
Aerosol , Powder;
84:04.08.40 – THIOCARBAMATES;
Otc;
BAYER INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80475
FOOTWORKS HEALTHY ANTIFUNGAL SPRAY FOR ATHLETE’S FOOT;
02375397;
tolnaftate 1 % / w/w;
2012-02-29;
Topical;
Spray;
84:04.08.40 – THIOCARBAMATES;
Otc;
THE AVON COMPANY CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86080
FORMULA 3;
02413760;
tolnaftate 1 % / w/w;
2014-01-16;
Topical;
Solution;
84:04.08.40 – THIOCARBAMATES;
Otc;
THE TETRA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89839
FOOT CARE FOAM;
02431718;
tolnaftate 1 % / w/w;
2015-09-30;
Topical;
Aerosol, Foam;
84:04.08.40 – THIOCARBAMATES;
Otc;
NSC PHARMA GMBH & CO.KG
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91618
FUNGIFOAM ANTIFUNGAL;
02480166;
tolnaftate 1 % / w/w;
2019-04-02;
Topical;
Cream;
84:04.08.40 – THIOCARBAMATES;
Otc;
THE TETRA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97070
DETROL;
02239064;
tolterodine tartrate 1 mg;
1998-11-26;
Oral;
Tablet;
86:12.04 – Antimuscarinics;
Prescription;
UPJOHN CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=62518
TEVA-TOLTERODINE;
02299593;
tolterodine tartrate 1 mg;
2015-12-16;
Oral;
Tablet;
86:12.04 – Antimuscarinics;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78497
MINT-TOLTERODINE;
02423308;
tolterodine tartrate 1 mg;
2015-12-16;
Oral;
Tablet;
86:12.00 – GENITOURINARY SMOOTH MUSCLE RELAXANTS;
Prescription;
MINT PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90805
DETROL;
02239065;
tolterodine tartrate 2 mg;
1998-11-23;
Oral;
Tablet;
86:12.04 – Antimuscarinics;
Prescription;
UPJOHN CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=62519
DETROL LA;
02244612;
tolterodine tartrate 2 mg;
2002-03-26;
Oral;
Capsule (Extended Release);
86:12.04 – Antimuscarinics;
Prescription;
UPJOHN CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=68599
TEVA-TOLTERODINE LA;
02412195;
tolterodine tartrate 2 mg;
2015-12-16;
Oral;
Capsule (Extended Release);
86:12.04 – Antimuscarinics;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89676
SANDOZ TOLTERODINE LA;
02413140;
tolterodine tartrate 2 mg;
2015-12-16;
Oral;
Capsule (Extended Release);
86:12.04 – Antimuscarinics;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89782
MINT-TOLTERODINE;
02423316;
tolterodine tartrate 2 mg;
2015-12-16;
Oral;
Tablet;
86:12.00 – GENITOURINARY SMOOTH MUSCLE RELAXANTS;
Prescription;
MINT PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90806
DETROL LA;
02244613;
tolterodine tartrate 4 mg;
2002-03-26;
Oral;
Capsule (Extended Release);
86:12.04 – Antimuscarinics;
Prescription;
UPJOHN CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=68600
TEVA-TOLTERODINE LA;
02412209;
tolterodine tartrate 4 mg;
2015-12-16;
Oral;
Capsule (Extended Release);
86:12.04 – Antimuscarinics;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89677
SANDOZ TOLTERODINE LA;
02413159;
tolterodine tartrate 4 mg;
2015-12-16;
Oral;
Capsule (Extended Release);
86:12.04 – Antimuscarinics;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89783
SAMSCA;
02370468;
tolvaptan 15 mg;
2011-09-22;
Oral;
Tablet;
40:28.28 – VASOPRESSIN ANTAGONISTS;
Prescription;
OTSUKA PHARMACEUTICAL CO LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85561
SAMSCA;
02370476;
tolvaptan 30 mg;
2011-09-22;
Oral;
Tablet;
40:28.28 – VASOPRESSIN ANTAGONISTS;
Prescription;
OTSUKA PHARMACEUTICAL CO LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85562
TOPAMAX 100MG;
02230894;
topiramate 100 mg;
1997-03-25;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
JANSSEN INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=50172
TEVA-TOPIRAMATE;
02248861;
topiramate 100 mg;
2005-09-14;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73233
PMS-TOPIRAMATE;
02263009;
topiramate 100 mg;
2005-09-14;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74841
MYLAN-TOPIRAMATE;
02263378;
topiramate 100 mg;
2005-09-14;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
MYLAN PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74875
APO-TOPIRAMATE;
02279630;
topiramate 100 mg;
2006-04-21;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76524
PRO-TOPIRAMATE;
02313669;
topiramate 100 mg;
2008-10-27;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79916
MINT-TOPIRAMATE;
02315653;
topiramate 100 mg;
2008-10-01;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
MINT PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80118
AURO-TOPIRAMATE;
02345838;
topiramate 100 mg;
2011-11-28;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83125
TOPIRAMATE;
02356864;
topiramate 100 mg;
2010-10-06;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84198
TOPIRAMATE;
02389487;
topiramate 100 mg;
2012-07-20;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
SIVEM PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87499
ACH-TOPIRAMATE;
02395746;
topiramate 100 mg;
2012-12-14;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
ACCORD HEALTHCARE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88080
TOPIRAMATE TABLETS USP;
02430800;
topiramate 100 mg;
2014-11-14;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
ACCORD HEALTHCARE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91524
SANDOZ TOPIRAMATE TABLETS;
02431815;
topiramate 100 mg;
2014-10-31;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91629
JAMP-TOPIRAMATE;
02435616;
topiramate 100 mg;
2015-02-06;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91995
AG-TOPIRAMATE;
02475944;
topiramate 100 mg;
2018-07-26;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
ANGITA PHARMA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96681
TOPAMAX;
02239907;
topiramate 15 mg;
1999-06-11;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
JANSSEN INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=63399
TOPAMAX 200MG;
02230896;
topiramate 200 mg;
1997-03-25;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
JANSSEN INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=50174
TEVA-TOPIRAMATE;
02248862;
topiramate 200 mg;
2005-11-25;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73234
PMS-TOPIRAMATE;
02263017;
topiramate 200 mg;
2005-09-14;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74842
MYLAN-TOPIRAMATE;
02263386;
topiramate 200 mg;
2005-09-14;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
MYLAN PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74876
APO-TOPIRAMATE;
02279649;
topiramate 200 mg;
2006-04-21;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76525
PRO-TOPIRAMATE;
02313677;
topiramate 200 mg;
2008-10-27;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79917
MINT-TOPIRAMATE;
02315661;
topiramate 200 mg;
2008-10-01;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
MINT PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80119
AURO-TOPIRAMATE;
02345846;
topiramate 200 mg;
2011-11-28;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83126
TOPIRAMATE;
02356872;
topiramate 200 mg;
2010-10-06;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84199
ACH-TOPIRAMATE;
02395754;
topiramate 200 mg;
2012-11-29;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
ACCORD HEALTHCARE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88081
TOPIRAMATE TABLETS USP;
02430819;
topiramate 200 mg;
2014-11-14;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
ACCORD HEALTHCARE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91525
SANDOZ TOPIRAMATE TABLETS;
02431823;
topiramate 200 mg;
2014-10-31;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91630
JAMP-TOPIRAMATE;
02435624;
topiramate 200 mg;
2015-02-06;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91996
TOPAMAX 25MG;
02230893;
topiramate 25 mg;
1997-03-25;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
JANSSEN INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=50171
TOPAMAX;
02239908;
topiramate 25 mg;
1999-06-11;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
JANSSEN INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=63400
TEVA-TOPIRAMATE;
02248860;
topiramate 25 mg;
2005-09-14;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73232
PMS-TOPIRAMATE;
02262991;
topiramate 25 mg;
2005-09-14;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74840
MYLAN-TOPIRAMATE;
02263351;
topiramate 25 mg;
2005-09-14;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
MYLAN PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74874
APO-TOPIRAMATE;
02279614;
topiramate 25 mg;
2006-04-21;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76522
PRO-TOPIRAMATE;
02313650;
topiramate 25 mg;
2008-10-27;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79915
MINT-TOPIRAMATE;
02315645;
topiramate 25 mg;
2008-10-02;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
MINT PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80117
AURO-TOPIRAMATE;
02345803;
topiramate 25 mg;
2011-11-28;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83123
TOPIRAMATE;
02356856;
topiramate 25 mg;
2010-10-06;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84197
TOPIRAMATE;
02389460;
topiramate 25 mg;
2012-07-20;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
SIVEM PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87497
ACH-TOPIRAMATE;
02395738;
topiramate 25 mg;
2012-11-29;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
ACCORD HEALTHCARE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88079
TOPIRAMATE TABLETS USP;
02430797;
topiramate 25 mg;
2014-11-14;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
ACCORD HEALTHCARE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91523
SANDOZ TOPIRAMATE TABLETS;
02431807;
topiramate 25 mg;
2014-10-31;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91628
JAMP-TOPIRAMATE;
02435608;
topiramate 25 mg;
2015-02-06;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91994
AG-TOPIRAMATE;
02475936;
topiramate 25 mg;
2018-07-26;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
ANGITA PHARMA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96680
PMS-TOPIRAMATE;
02312085;
topiramate 50 mg;
2008-06-17;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79760
TOPOTECAN HYDROCHLORIDE FOR INJECTION;
02379422;
topotecan (topotecan hydrochloride) 1 mg / ml;
2012-03-27;
Intravenous;
Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86529
TOPOTECAN INJECTION;
02390981;
topotecan (topotecan hydrochloride) 1 mg / ml;
2014-02-05;
Intravenous;
Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87637
TOPOTECAN HYDROCHLORIDE FOR INJECTION;
02396378;
topotecan (topotecan hydrochloride) 1 mg / ml;
2013-11-21;
Intravenous;
Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
ACCORD HEALTHCARE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88140
TEVA-TOPOTECAN;
02441071;
topotecan (topotecan hydrochloride) 4 mg / vial;
2015-11-17;
Intravenous;
Powder For Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92544
PFIZER-BIONTECH COVID-19 VACCINE;
02509210;
tozinameran 30 mcg / 0.3 ml;
2020-12-14;
Intramuscular;
Suspension;
-;
Covid-19 – Io – Authorization , Schedule D;
BIONTECH MANUFACTURING GMBH
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99852
YONDELIS;
02351528;
trabectedin 1 mg / vial;
2010-08-05;
Intravenous;
Powder For Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
VALEO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83679
TRIDURAL;
02296381;
tramadol hydrochloride 100 mg;
2007-08-14;
Oral;
Tablet (Extended-Release);
28:08.08 – OPIATE AGONISTS;
Prescription;
PALADIN LABS INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78172
RALIVIA;
02299194;
tramadol hydrochloride 100 mg;
2007-10-25;
Oral;
Tablet (Extended-Release);
28:08.08 – OPIATE AGONISTS;
Prescription;
VALEANT CANADA LP/VALEANT CANADA S.E.C.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78458
ZYTRAM XL;
02360349;
tramadol hydrochloride 100 mg;
2011-03-02;
Oral;
Tablet (Extended-Release);
28:08.08 – OPIATE AGONISTS;
Prescription;
PURDUE PHARMA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84531
DURELA;
02373017;
tramadol hydrochloride 100 mg;
2012-03-19;
Oral;
Capsule (Extended Release);
28:08.08 – OPIATE AGONISTS;
Prescription;
CIPHER PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85814
TARO-TRAMADOL ER;
02450429;
tramadol hydrochloride 100 mg;
2016-03-07;
Oral;
Tablet (Extended-Release);
28:08.08 – OPIATE AGONISTS;
Prescription;
TARO PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93657
ZYTRAM XL;
02286424;
tramadol hydrochloride 150 mg;
2006-12-07;
Oral;
Tablet (Extended-Release);
28:08.08 – OPIATE AGONISTS;
Prescription;
PURDUE PHARMA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77188
ZYTRAM XL;
02286432;
tramadol hydrochloride 200 mg;
2006-12-07;
Oral;
Tablet (Extended-Release);
28:08.08 – OPIATE AGONISTS;
Prescription;
PURDUE PHARMA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77189
TRIDURAL;
02296403;
tramadol hydrochloride 200 mg;
2007-08-14;
Oral;
Tablet (Extended-Release);
28:08.08 – OPIATE AGONISTS;
Prescription;
PALADIN LABS INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78173
RALIVIA;
02299208;
tramadol hydrochloride 200 mg;
2007-10-25;
Oral;
Tablet (Extended-Release);
28:08.08 – OPIATE AGONISTS;
Prescription;
VALEANT CANADA LP/VALEANT CANADA S.E.C.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78459
DURELA;
02373025;
tramadol hydrochloride 200 mg;
2012-03-19;
Oral;
Capsule (Extended Release);
28:08.08 – OPIATE AGONISTS;
Prescription;
CIPHER PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85815
TARO-TRAMADOL ER;
02450437;
tramadol hydrochloride 200 mg;
2016-05-27;
Oral;
Tablet (Extended-Release);
28:08.08 – OPIATE AGONISTS;
Prescription;
TARO PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93658
ZYTRAM XL;
02286440;
tramadol hydrochloride 300 mg;
2006-12-07;
Oral;
Tablet (Extended-Release);
28:08.08 – OPIATE AGONISTS;
Prescription;
PURDUE PHARMA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77190
TRIDURAL;
02296411;
tramadol hydrochloride 300 mg;
2007-08-14;
Oral;
Tablet (Extended-Release);
28:08.08 – OPIATE AGONISTS;
Prescription;
PALADIN LABS INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78174
RALIVIA;
02299216;
tramadol hydrochloride 300 mg;
2007-10-25;
Oral;
Tablet (Extended-Release);
28:08.08 – OPIATE AGONISTS;
Prescription;
VALEANT CANADA LP/VALEANT CANADA S.E.C.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78460
DURELA;
02373033;
tramadol hydrochloride 300 mg;
2012-03-19;
Oral;
Capsule (Extended Release);
28:08.08 – OPIATE AGONISTS;
Prescription;
CIPHER PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85816
TARO-TRAMADOL ER;
02450445;
tramadol hydrochloride 300 mg;
2016-05-27;
Oral;
Tablet (Extended-Release);
28:08.08 – OPIATE AGONISTS;
Prescription;
TARO PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93659
ZYTRAM XL;
02286459;
tramadol hydrochloride 400 mg;
2006-12-07;
Oral;
Tablet (Extended-Release);
28:08.08 – OPIATE AGONISTS;
Prescription;
PURDUE PHARMA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77191
APO-TRAMADOL;
02426153;
tramadol hydrochloride 50 mg;
2014-06-23;
Oral;
Tablet;
28:08.08 – OPIATE AGONISTS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91076
AURO-TRAMADOL;
02479672;
tramadol hydrochloride 50 mg;
2019-04-11;
Oral;
Tablet;
28:08.08 – OPIATE AGONISTS;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97034
MAR-TRAMADOL;
02480859;
tramadol hydrochloride 50 mg;
2019-07-18;
Oral;
Tablet;
28:08.08 – OPIATE AGONISTS;
Prescription;
MARCAN PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97151
SANDOZ TRAMADOL;
02493764;
tramadol hydrochloride 50 mg;
2021-03-26;
Oral;
Tablet;
28:08.08 – OPIATE AGONISTS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98375
ZYTRAM XL;
02360322;
tramadol hydrochloride 75 mg;
2011-03-02;
Oral;
Tablet (Extended-Release);
28:08.08 – OPIATE AGONISTS;
Prescription;
PURDUE PHARMA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84529
MEKINIST;
02409623;
trametinib 0.5 mg;
2013-08-28;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89431
MEKINIST;
02409658;
trametinib 2 mg;
2013-08-28;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89433
MAVIK;
02231457;
trandolapril 0.5 mg;
1998-01-28;
Oral;
Capsule;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
BGP PHARMA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=50773
SANDOZ TRANDOLAPRIL;
02325721;
trandolapril 0.5 mg;
2018-07-12;
Oral;
Capsule;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81109
PMS-TRANDOLAPRIL;
02357755;
trandolapril 0.5 mg;
2018-05-18;
Oral;
Capsule;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84285
TEVA-TRANDOLAPRIL;
02415429;
trandolapril 0.5 mg;
2018-09-26;
Oral;
Capsule;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90003
AURO-TRANDOLAPRIL;
02471868;
trandolapril 0.5 mg;
2018-09-27;
Oral;
Capsule;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96106
MAVIK;
02231459;
trandolapril 1 mg;
1998-01-07;
Oral;
Capsule;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
BGP PHARMA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=50775
SANDOZ TRANDOLAPRIL;
02325748;
trandolapril 1 mg;
2018-07-12;
Oral;
Capsule;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81110
PMS-TRANDOLAPRIL;
02357763;
trandolapril 1 mg;
2018-05-18;
Oral;
Capsule;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84286
TEVA-TRANDOLAPRIL;
02415437;
trandolapril 1 mg;
2018-09-26;
Oral;
Capsule;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90004
AURO-TRANDOLAPRIL;
02471876;
trandolapril 1 mg;
2018-09-27;
Oral;
Capsule;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96109
TRANDOLAPRIL;
02488698;
trandolapril 1 mg;
2019-07-09;
Oral;
Capsule;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97878
MAVIK;
02231460;
trandolapril 2 mg;
1998-01-14;
Oral;
Capsule;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
BGP PHARMA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=50776
SANDOZ TRANDOLAPRIL;
02325756;
trandolapril 2 mg;
2018-07-12;
Oral;
Capsule;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81111
PMS-TRANDOLAPRIL;
02357771;
trandolapril 2 mg;
2018-05-18;
Oral;
Capsule;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84287
TEVA-TRANDOLAPRIL;
02415445;
trandolapril 2 mg;
2018-09-26;
Oral;
Capsule;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90005
AURO-TRANDOLAPRIL;
02471884;
trandolapril 2 mg;
2018-09-27;
Oral;
Capsule;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96110
TRANDOLAPRIL;
02488701;
trandolapril 2 mg;
2019-07-09;
Oral;
Capsule;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97879
MAVIK;
02239267;
trandolapril 4 mg;
2003-11-01;
Oral;
Capsule;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
BGP PHARMA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=62731
SANDOZ TRANDOLAPRIL;
02325764;
trandolapril 4 mg;
2018-07-12;
Oral;
Capsule;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81112
PMS-TRANDOLAPRIL;
02357798;
trandolapril 4 mg;
2018-05-20;
Oral;
Capsule;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84288
TEVA-TRANDOLAPRIL;
02415453;
trandolapril 4 mg;
2018-09-26;
Oral;
Capsule;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90006
AURO-TRANDOLAPRIL;
02471892;
trandolapril 4 mg;
2018-09-27;
Oral;
Capsule;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96111
TRANDOLAPRIL;
02488728;
trandolapril 4 mg;
2019-07-09;
Oral;
Capsule;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97880
CYKLOKAPRON 100 MG/ML;
02064413;
tranexamic acid 100 mg / ml;
1995-12-31;
Intravenous;
Solution;
20:28.16 – HEMOSTATICS;
Prescription;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18371
TRANEXAMIC ACID INJECTION BP;
02246365;
tranexamic acid 100 mg / ml;
2002-10-29;
Intravenous;
Solution;
20:28.16 – HEMOSTATICS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=70531
TRANEXAMIC ACID INJECTION BP;
02386933;
tranexamic acid 100 mg / ml;
2012-11-15;
Intravenous;
Solution;
20:28.16 – HEMOSTATICS;
Prescription;
STERIMAX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87251
TRANEXAMIC ACID INJECTION;
02392763;
tranexamic acid 100 mg / ml;
2013-03-27;
Intravenous;
Solution;
20:28.16 – HEMOSTATICS;
Prescription;
OMEGA LABORATORIES LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87801
ERFA-TRANEXAMIC;
02457431;
tranexamic acid 100 mg / ml;
2017-07-31;
Intravenous;
Solution;
20:28.16 – HEMOSTATICS;
Prescription;
ERFA CANADA 2012 INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94449
CYKLOKAPRON 500 MG;
02064405;
tranexamic acid 500 mg;
1995-12-31;
Oral;
Tablet;
20:28.16 – HEMOSTATICS;
Prescription;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18072
TRANEXAMIC ACID TABLETS;
02401231;
tranexamic acid 500 mg;
2013-02-13;
Oral;
Tablet;
20:28.16 – HEMOSTATICS;
Prescription;
STERIMAX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88596
GD-TRANEXAMIC ACID;
02409097;
tranexamic acid 500 mg;
2014-03-07;
Oral;
Tablet;
20:28.16 – HEMOSTATICS;
Prescription;
GENMED A DIVISION OF PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89382
MAR-TRANEXAMIC ACID;
02496232;
tranexamic acid 500 mg;
2020-06-04;
Oral;
Tablet;
20:28.16 – HEMOSTATICS;
Prescription;
MARCAN PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98610
PARNATE;
01919598;
tranylcypromine (tranylcypromine sulfate) 10 mg;
1992-12-31;
Oral;
Tablet;
28:16.04.12 – MONOAMINE OXIDASE INHIBITORS;
Prescription;
GLAXOSMITHKLINE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=15231
OGIVRI;
02474425;
trastuzumab 150 mg / vial;
2019-06-06;
Intravenous;
Powder For Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription , Schedule D;
BGP PHARMA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96453
TRAZIMERA;
02483475;
trastuzumab 150 mg / vial;
2019-10-22;
Intravenous;
Powder For Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription , Schedule D;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97383
HERZUMA;
02506211;
trastuzumab 150 mg / vial;
2021-02-25;
Intravenous;
Powder For Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription , Schedule D;
CELLTRION HEALTHCARE CO LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99555
KANJINTI;
02496690;
trastuzumab 420 mg / vial;
2020-04-16;
Intravenous;
Kit , Powder For Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription , Schedule D;
AMGEN CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98651
HERCEPTIN;
02240692;
trastuzumab 440 mg / vial;
1999-08-23;
Intravenous;
Powder For Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription , Schedule D;
HOFFMANN-LA ROCHE LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=64277
HERZUMA;
02480794;
trastuzumab 440 mg / vial;
2019-12-11;
Intravenous;
Kit , Powder For Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription , Schedule D;
CELLTRION HEALTHCARE CO LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97138
TRAZIMERA;
02483467;
trastuzumab 440 mg / vial;
2019-10-22;
Intravenous;
Powder For Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription , Schedule D;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97382
HERCEPTIN SC;
02480697;
trastuzumab 600 mg / 5 ml;
2018-10-12;
Subcutaneous;
Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription , Schedule D;
HOFFMANN-LA ROCHE LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97124
KADCYLA;
02412365;
trastuzumab emtansine 100 mg / vial;
2013-10-09;
Intravenous;
Powder For Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription , Schedule D;
HOFFMANN-LA ROCHE LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89698
KADCYLA;
02473224;
trastuzumab emtansine 160 mg / vial;
2018-10-24;
Intravenous;
Powder For Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription , Schedule D;
HOFFMANN-LA ROCHE LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96263
IZBA;
02457997;
travoprost 0.003 % / w/v;
2017-02-06;
Ophthalmic;
Solution;
52:40.28 – PROSTAGLANDIN ANALOGS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94502
TRAVATAN Z;
02318008;
travoprost 0.004 % / w/v;
2008-11-10;
Ophthalmic;
Solution;
52:40.28 – PROSTAGLANDIN ANALOGS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80351
SANDOZ TRAVOPROST;
02413167;
travoprost 0.004 % / w/v;
2014-08-15;
Ophthalmic;
Solution;
52:40.28 – PROSTAGLANDIN ANALOGS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89784
PMS TRAZODONE HCL TAB 100MG;
01937235;
trazodone hydrochloride 100 mg;
1993-12-31;
Oral;
Tablet;
28:16.04.24 – SEROTONIN MODULATORS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13780
APO-TRAZODONE TABLETS 100MG;
02147645;
trazodone hydrochloride 100 mg;
1995-12-31;
Oral;
Tablet;
28:16.04.24 – SEROTONIN MODULATORS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18045
TEVA-TRAZODONE;
02144271;
trazodone hydrochloride 100 mg;
1995-01-18;
Oral;
Tablet;
28:16.04.24 – SEROTONIN MODULATORS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18190
TRAZODONE-100;
02164361;
trazodone hydrochloride 100 mg;
1996-12-31;
Oral;
Tablet;
28:16.04.24 – SEROTONIN MODULATORS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19937
TRAZODONE;
02348780;
trazodone hydrochloride 100 mg;
2010-04-30;
Oral;
Tablet;
28:16.04.24 – SEROTONIN MODULATORS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83412
APO-TRAZODONE D TABLETS 150MG;
02147653;
trazodone hydrochloride 150 mg;
1995-12-31;
Oral;
Tablet;
28:16.04.24 – SEROTONIN MODULATORS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18040
TEVA-TRAZODONE;
02144298;
trazodone hydrochloride 150 mg;
1995-01-18;
Oral;
Tablet;
28:16.04.24 – SEROTONIN MODULATORS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18189
TRAZODONE-150 D;
02164388;
trazodone hydrochloride 150 mg;
1996-12-31;
Oral;
Tablet;
28:16.04.24 – SEROTONIN MODULATORS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19938
TRAZODONE;
02348799;
trazodone hydrochloride 150 mg;
2010-04-30;
Oral;
Tablet;
28:16.04.24 – SEROTONIN MODULATORS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83413
PMS TRAZODONE HCL TAB 50MG;
01937227;
trazodone hydrochloride 50 mg;
1993-12-31;
Oral;
Tablet;
28:16.04.24 – SEROTONIN MODULATORS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=4241
APO-TRAZODONE TABLETS 50MG;
02147637;
trazodone hydrochloride 50 mg;
1995-12-31;
Oral;
Tablet;
28:16.04.24 – SEROTONIN MODULATORS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18046
TEVA-TRAZODONE;
02144263;
trazodone hydrochloride 50 mg;
1995-12-31;
Oral;
Tablet;
28:16.04.24 – SEROTONIN MODULATORS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18191
TRAZODONE-50;
02164353;
trazodone hydrochloride 50 mg;
1996-12-31;
Oral;
Tablet;
28:16.04.24 – SEROTONIN MODULATORS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19936
TRAZODONE;
02348772;
trazodone hydrochloride 50 mg;
2010-04-30;
Oral;
Tablet;
28:16.04.24 – SEROTONIN MODULATORS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83411
PMS-TRAZODONE;
02237339;
trazodone hydrochloride 75 mg;
1998-02-17;
Oral;
Tablet;
28:16.04.24 – SEROTONIN MODULATORS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=60663
REMODULIN;
02246552;
treprostinil (treprostinil sodium) 1 mg / ml;
2004-04-30;
Intravenous , Subcutaneous;
Solution;
48:48.00 – VASODILATING AGENTS;
Prescription;
UNITED THERAPEUTICS CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=70735
REMODULIN;
02246555;
treprostinil (treprostinil sodium) 10 mg / ml;
2004-04-30;
Intravenous , Subcutaneous;
Solution;
48:48.00 – VASODILATING AGENTS;
Prescription;
UNITED THERAPEUTICS CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=70738
REMODULIN;
02246553;
treprostinil (treprostinil sodium) 2.5 mg / ml;
2004-04-30;
Intravenous , Subcutaneous;
Solution;
48:48.00 – VASODILATING AGENTS;
Prescription;
UNITED THERAPEUTICS CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=70736
REMODULIN;
02246554;
treprostinil (treprostinil sodium) 5 mg / ml;
2004-04-30;
Intravenous , Subcutaneous;
Solution;
48:48.00 – VASODILATING AGENTS;
Prescription;
UNITED THERAPEUTICS CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=70737
VITAMIN A ACID;
01926462;
tretinoin 0.01 %;
1983-12-31;
Topical;
Gel;
84:16.00 – CELL STIMULANTS AND PROLIFERANTS;
Prescription;
BAUSCH HEALTH, CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=12753
STIEVA-A;
00657204;
tretinoin 0.01 % / w/w;
1986-12-31;
Topical;
Cream;
84:16.00 – CELL STIMULANTS AND PROLIFERANTS;
Prescription;
GLAXOSMITHKLINE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=6619
VITAMIN A ACID;
01926470;
tretinoin 0.025 %;
1986-12-31;
Topical;
Gel;
84:16.00 – CELL STIMULANTS AND PROLIFERANTS;
Prescription;
BAUSCH HEALTH, CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=12754
STIEVA-A;
00578576;
tretinoin 0.025 % / w/w;
1983-12-31;
Topical;
Cream;
84:16.00 – CELL STIMULANTS AND PROLIFERANTS;
Prescription;
GLAXOSMITHKLINE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=5168
RETIN-A;
00443816;
tretinoin 0.025 % / w/w;
1991-12-31;
Topical;
Gel;
84:16.00 – CELL STIMULANTS AND PROLIFERANTS;
Prescription;
BAUSCH HEALTH, CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=11153
RETIN-A MICRO;
02264633;
tretinoin 0.04 % / w/w;
2005-08-30;
Topical;
Gel;
84:16.00 – CELL STIMULANTS AND PROLIFERANTS;
Prescription;
BAUSCH HEALTH, CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75010
VITAMIN A ACID;
01926489;
tretinoin 0.05 %;
1978-12-31;
Topical;
Gel;
84:16.00 – CELL STIMULANTS AND PROLIFERANTS;
Prescription;
BAUSCH HEALTH, CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=12544
STIEVA-A;
00518182;
tretinoin 0.05 % / w/w;
1981-12-31;
Topical;
Cream;
84:16.00 – CELL STIMULANTS AND PROLIFERANTS;
Prescription;
GLAXOSMITHKLINE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=4220
RETIN-A;
00443794;
tretinoin 0.05 % / w/w;
1991-12-31;
Topical;
Cream;
84:16.00 – CELL STIMULANTS AND PROLIFERANTS;
Prescription;
BAUSCH HEALTH, CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=11152
RETIN-A MICRO;
02243914;
tretinoin 0.1 % / w/w;
2001-08-01;
Topical;
Gel;
84:16.00 – CELL STIMULANTS AND PROLIFERANTS;
Prescription;
BAUSCH HEALTH, CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=67856
VESANOID;
02145839;
tretinoin 10 mg;
1995-12-31;
Oral;
Capsule;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
CHEPLAPHARM ARZNEIMITTEL GMBH
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18080
ORACORT DENTAL PASTE 0.1%;
01964054;
triamcinolone acetonide .1 %;
1992-12-31;
Dental;
Paste;
84:06.00 – ANTI-INFLAMMATORY AGENTS;
Prescription;
TARO PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13360
TRIADERM CRM 0.1%;
00716960;
triamcinolone acetonide 0.1 %;
1979-12-31;
Topical;
Cream;
84:06.00 – ANTI-INFLAMMATORY AGENTS;
Prescription;
TARO PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=8573
ARISTOCORT R;
02194031;
triamcinolone acetonide 0.1 % / w/w;
1997-04-14;
Topical;
Ointment;
84:06.00 – ANTI-INFLAMMATORY AGENTS;
Prescription;
BAUSCH HEALTH, CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=35783
ARISTOCORT R;
02194058;
triamcinolone acetonide 0.1 % / w/w;
1996-10-10;
Topical;
Cream;
84:06.00 – ANTI-INFLAMMATORY AGENTS;
Prescription;
BAUSCH HEALTH, CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=35784
ARISTOCORT C;
02194066;
triamcinolone acetonide 0.5 % / w/w;
1997-10-21;
Topical;
Cream;
84:06.00 – ANTI-INFLAMMATORY AGENTS;
Prescription;
BAUSCH HEALTH, CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=35785
KENALOG-10 INJECTION 10MG/ML;
01999761;
triamcinolone acetonide 10 mg / ml;
1966-12-31;
Intra-Articular , Intrabursal , Intradermal , Intrasynovial;
Suspension;
68:04.00 – ADRENALS;
Prescription;
BRISTOL-MYERS SQUIBB CANADA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=15482
TRIAMCINOLONE ACETONIDE INJECTABLE SUSPENSION USP;
01977563;
triamcinolone acetonide 40 mg / ml;
1993-12-31;
Intra-Articular , Intramuscular;
Suspension;
68:04.00 – ADRENALS;
Prescription;
STERIMAX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13998
KENALOG-40 INJECTION 40MG/ML;
01999869;
triamcinolone acetonide 40 mg / ml;
1973-12-31;
Intra-Articular , Intramuscular;
Suspension;
68:04.00 – ADRENALS;
Prescription;
BRISTOL-MYERS SQUIBB CANADA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=15481
TRIESENCE;
02368676;
triamcinolone acetonide 40 mg / ml;
2012-08-22;
Intravitreal;
Suspension;
52:08.08 – CORTICOSTEROIDS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85366
NASACORT AQ;
02213834;
triamcinolone acetonide 55 mcg / act;
1996-12-31;
Nasal;
Spray, Metered Dose;
52:08.08 – CORTICOSTEROIDS;
Prescription;
SANOFI CONSUMER HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19807
NASACORT ALLERGY 24HR;
02417510;
triamcinolone acetonide 55 mcg / act;
2015-07-06;
Nasal;
Spray, Metered Dose;
52:08.08 – CORTICOSTEROIDS;
Otc;
SANOFI CONSUMER HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90220
APO-TRIAMCINOLONE AQ;
02437635;
triamcinolone acetonide 55 mcg / act;
2016-06-15;
Nasal;
Spray, Metered Dose;
52:08.08 – CORTICOSTEROIDS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92202
TRISPAN;
02470632;
triamcinolone hexacetonide 20 mg / ml;
2018-10-04;
Intra-Articular , Periarticular , Intrasynovial;
Suspension;
68:04.00 – ADRENALS;
Prescription;
MEDEXUS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95963
TRIAZOLAM;
00808571;
triazolam 0.25 mg;
1989-12-31;
Oral;
Tablet;
28:24.08 – BENZODIAZEPINES;
Targeted (Cdsa Iv);
AA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=9575
CROWN ANTISEPTIC HAND SOAP;
02143968;
triclosan .3 %;
1994-12-31;
Topical;
Liquid;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
CROWN CHEMICAL PRODUCTS INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=17953
ADASEPT LIQ 0.5%;
00266507;
triclosan .5 %;
1973-12-31;
Topical;
Liquid;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
ODAN LABORATORIES LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=1668
ORASOFT 3;
02238001;
triclosan 0.2 %;
1999-07-01;
Topical;
Liquid;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
MEGA-LAB MANUFACTURING CO LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=61379
TC ANTIBACTERIAL LOTION SOAP;
02319128;
triclosan 0.2 % / w/w;
2010-05-06;
Topical;
Lotion;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
RUBBERMAID COMMERCIAL PRODUCTS LLC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80459
BACTI-STAT 0.3%;
00779237;
triclosan 0.3 %;
1991-12-31;
Topical;
Liquid;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
ECOLAB CO
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=11537
ANTISEPTIC HAND SOAP LIQ 0.3%;
01972286;
triclosan 0.3 %;
1992-12-31;
Topical;
Liquid;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
INLAND/ALCARE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13357
SIMPLY BOTANICAL SENSATION SOOTHING SKIN;
02238288;
triclosan 0.3 %;
2002-11-26;
Topical;
Liquid;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
GERMIPHENE CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=61685
BACTI-STAT AE;
02238676;
triclosan 0.3 %;
1998-10-23;
Topical;
Liquid;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
ECOLAB CO
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=62107
PROVON MEDICATED LOTION SOAP WITH TRICLOSAN;
02240142;
triclosan 0.3 %;
2000-03-24;
Topical;
Liquid;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
GOJO INDUSTRIES, INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=63657
DIGICLEAN ANTIBACTERIAL FOAM HAND SOAP;
02242846;
triclosan 0.3 %;
2000-11-15;
Topical;
Liquid;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
ECOLAB CO
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66676
KEYSTONE ANTIBACTERIAL FOAM HAND SOAP;
02244052;
triclosan 0.3 %;
2003-04-01;
Topical;
Liquid;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
ECOLAB CO
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=67995
WINNING HANDS FOAMING ANTIBACTERIAL HAND CLEANSER;
02250985;
triclosan 0.3 %;
2004-05-01;
Topical;
Solution;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
BETCO CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73591
QFS ANTIMICROBIAL HAND SOAP WITH TRICLOSAN;
02269694;
triclosan 0.3 %;
2005-10-01;
Topical;
Solution;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
GOJO INDUSTRIES, INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75505
PROVON MEDICATED FOAM HANDWASH WITH ADVANCED MOISTURIZERS;
02278146;
triclosan 0.3 %;
2007-02-15;
Topical (Household);
Liquid;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
GOJO INDUSTRIES, INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76373
PRIME SOURCE ANTIBACTERIAL FOAM SOAP;
02278154;
triclosan 0.3 %;
2007-01-08;
Topical;
Liquid;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
GOJO INDUSTRIES, INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76374
ANTIBACTERIAL CLEAN & SMOOTH;
02283816;
triclosan 0.3 %;
2006-12-01;
Topical;
Solution;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
ECOLAB CO
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76939
HFS ANTIMICROBIAL FOAM HAND SOAP WITH TRICLOSAN;
02286688;
triclosan 0.3 %;
2007-02-15;
Topical;
Liquid;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
GOJO INDUSTRIES, INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77213
GOJO ANTIBACTERIAL PLUM SCENT FOAM HANDWASH TRICLOSAN LIQUID;
02375133;
triclosan 0.3 % / w/w;
2012-04-16;
Topical;
Liquid;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
GOJO INDUSTRIES, INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86054
GOJO ANTIBACTERIAL FOAM HANDWASH TRICLOSAN LIQUID;
02375168;
triclosan 0.3 % / w/w;
2012-04-16;
Topical;
Liquid;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
GOJO INDUSTRIES, INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86057
PRIME SOURCE ANTIBACTERIAL PLUM SCENT FOAM HANDWASH TRICLOSAN LIQUID;
02389029;
triclosan 0.3 % / w/w;
2012-12-26;
Topical (Household);
Liquid;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
GOJO INDUSTRIES, INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87455
BM-SAN;
02500930;
triclosan 0.3 % / w/w;
2020-07-30;
Topical (Commercial);
Solution;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
LES CHIMIQUES B.O.D. INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99058
ECOCARE 250;
02239311;
triclosan 0.30 %;
1999-04-30;
Topical;
Liquid;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
ECOLAB CO
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=62780
ANTIBACTERIAL LOTION SOAP;
02249340;
triclosan 0.4 %;
2007-09-17;
Topical;
Liquid;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
CHARLOTTE PRODUCTS LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73418
ANTI-BAC – ASP 0.5%;
02219433;
triclosan 0.5 %;
1999-09-30;
Topical;
Spray;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
BENTFIELD EUROPE BV
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=37869
VALOUR ANTISEPTIC HAND CLEANSER;
02248405;
triclosan 0.5 %;
2003-10-25;
Topical;
Liquid;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
QWATRO CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72751
GENTLE FRESH DEFENSE;
02251604;
triclosan 0.5 %;
2004-04-29;
Topical;
Liquid;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
STATE INDUSTRIAL PRODUCTS
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73652
INO-F ANTIBAC ANTIBACTERIAL HAND SOAP;
02267373;
triclosan 0.5 %;
2005-04-21;
Topical;
Liquid;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
GROUPE DISSAN INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75280
ENRICHED FOAM ANTIBACTERIAL SOAP;
02315513;
triclosan 0.5 %;
2010-05-04;
Topical;
Liquid;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
RUBBERMAID COMMERCIAL PRODUCTS LLC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80105
SPRAY ANTIBACTERIAL SOAP;
02315505;
triclosan 0.5 % / w/w;
2010-05-04;
Topical;
Liquid;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
RUBBERMAID COMMERCIAL PRODUCTS LLC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80104
ANTI-BAC FOAM SOAP;
02245467;
triclosan 0.50 %;
2004-03-24;
Topical;
Liquid;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
BENTFIELD EUROPE BV
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=69527
MAR-TRIENTINE;
02504855;
trientine hydrochloride 250 mg;
2020-11-10;
Oral;
Capsule;
64:00.00 – HEAVY METAL ANTAGONISTS;
Prescription;
MARCAN PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99424
AKLIEF;
02494175;
trifarotene 50 mcg / g;
2019-11-28;
Topical;
Cream;
84:92.00 – MISC. SKIN AND MUCOUS MEMBRANE AGENTS;
Prescription;
GALDERMA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98421
TRIFLUOPERAZINE;
00326836;
trifluoperazine (trifluoperazine hydrochloride) 10 mg;
1975-12-31;
Oral;
Tablet;
28:16.08.24 – PHENOTHIAZINES;
Prescription;
AA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=2300
TRIFLUOPERAZINE;
00595942;
trifluoperazine (trifluoperazine hydrochloride) 20 mg;
1984-12-31;
Oral;
Tablet;
28:16.08.24 – PHENOTHIAZINES;
Prescription;
AA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=5732
TRIFLUOPERAZINE;
00312746;
trifluoperazine (trifluoperazine hydrochloride) 5 mg;
1975-12-31;
Oral;
Tablet;
28:16.08.24 – PHENOTHIAZINES;
Prescription;
AA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=2209
VIROPTIC;
00687456;
trifluridine 1 %;
1987-12-31;
Ophthalmic;
Solution;
52:04.20 – ANTIVIRALS;
Prescription;
BAUSCH HEALTH, CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=8203
DOJOLVI;
02512556;
triheptanoin 100 % / w/w;
2021-04-01;
Oral;
Liquid;
40:20.00 – CALORIC AGENTS;
Prescription Recommended;
ULTRAGENYX PHARMACEUTICAL INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=100183
TRIHEXYPHENIDYL;
00545058;
trihexyphenidyl hydrochloride 2 mg;
1982-12-31;
Oral;
Tablet;
28:36.08 – ANTICHOLINERGIC AGENTS;
Prescription;
AA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=4901
TRIHEXYPHENIDYL;
00545074;
trihexyphenidyl hydrochloride 5 mg;
1982-12-31;
Oral;
Tablet;
28:36.08 – ANTICHOLINERGIC AGENTS;
Prescription;
AA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=4903
TRIMEBUTINE;
02245663;
trimebutine maleate 100 mg;
2002-10-21;
Oral;
Tablet;
12:08.08 – ANTIMUSCARINICS ANTISPASMODICS , 56:32.00 – PROKINETIC AGENTS;
Prescription;
AA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=69763
TRIMEBUTINE;
02245664;
trimebutine maleate 200 mg;
2002-10-21;
Oral;
Tablet;
12:08.08 – ANTIMUSCARINICS ANTISPASMODICS , 56:32.00 – PROKINETIC AGENTS;
Prescription;
AA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=69764
PANECTYL TAB 2.5MG;
01926306;
trimeprazine (trimeprazine tartrate) 2.5 mg;
1959-12-31;
Oral;
Tablet;
04:04.12 – PHENOTHIAZINE DERIVATIVES;
Prescription;
ERFA CANADA 2012 INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=12419
PANECTYL TAB 5MG;
01926292;
trimeprazine (trimeprazine tartrate) 5 mg;
1959-12-31;
Oral;
Tablet;
04:04.12 – PHENOTHIAZINE DERIVATIVES;
Prescription;
ERFA CANADA 2012 INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=12651
TRIMETHOPRIM TABLETS;
02243116;
trimethoprim 100 mg;
2001-01-01;
Oral;
Tablet;
08:36.00 – URINARY ANTI-INFECTIVES;
Prescription;
AA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66985
TRIMETHOPRIM TABLETS;
02243117;
trimethoprim 200 mg;
2001-07-30;
Oral;
Tablet;
08:36.00 – URINARY ANTI-INFECTIVES;
Prescription;
AA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66986
TRIMIPRAMINE;
00740829;
trimipramine (trimipramine maleate) 100 mg;
1987-12-31;
Oral;
Tablet;
28:16.04.28 – TRICYCLICS AND OTHER NOREPINEPHRINE-REUPTAKE INHIBITORS;
Prescription;
AA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=8106
TRIMIPRAMINE;
00740799;
trimipramine (trimipramine maleate) 12.5 mg;
1987-12-31;
Oral;
Tablet;
28:16.04.28 – TRICYCLICS AND OTHER NOREPINEPHRINE-REUPTAKE INHIBITORS;
Prescription;
AA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=8065
TRIMIPRAMINE;
00740802;
trimipramine (trimipramine maleate) 25 mg;
1987-12-31;
Oral;
Tablet;
28:16.04.28 – TRICYCLICS AND OTHER NOREPINEPHRINE-REUPTAKE INHIBITORS;
Prescription;
AA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=8066
TRIMIPRAMINE;
00740810;
trimipramine (trimipramine maleate) 50 mg;
1987-12-31;
Oral;
Tablet;
28:16.04.28 – TRICYCLICS AND OTHER NOREPINEPHRINE-REUPTAKE INHIBITORS;
Prescription;
AA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=8067
TRIMIPRAMINE;
02070987;
trimipramine (trimipramine maleate) 75 mg;
1994-12-31;
Oral;
Capsule;
28:16.04.28 – TRICYCLICS AND OTHER NOREPINEPHRINE-REUPTAKE INHIBITORS;
Prescription;
AA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=15592
TRELSTAR;
02243856;
triptorelin (triptorelin pamoate) 11.25 mg / vial;
2005-12-15;
Intramuscular;
Powder For Suspension, Sustained-Release;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
KNIGHT THERAPEUTICS INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=67797
TRELSTAR;
02412322;
triptorelin (triptorelin pamoate) 22.5 mg / vial;
2013-10-16;
Intramuscular;
Powder For Suspension, Sustained-Release;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
KNIGHT THERAPEUTICS INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89690
TRELSTAR;
02240000;
triptorelin (triptorelin pamoate) 3.75 mg / vial;
2005-12-15;
Intramuscular;
Powder For Suspension, Sustained-Release;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
KNIGHT THERAPEUTICS INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=63507
DECAPEPTYL;
02389282;
triptorelin acetate 0.1 mg / ml;
2012-08-09;
Subcutaneous;
Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
FERRING INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87478
MYOFLEX REGULAR STRENGTH;
02152827;
trolamine salicylate 10 % / w/w;
1996-12-31;
Topical;
Cream;
28:08.04.24 – SALICYLATES;
Otc;
EXZELL PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=42699
NO ODOUR PAIN RELIEF CREAM;
02358131;
trolamine salicylate 13.3 %;
2012-03-07;
Topical;
Cream;
28:08.04.24 – SALICYLATES;
Otc;
CRLS
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84320
MUSCLE & JOINT NO ODOUR REGULAR STRENGTH;
02473143;
trolamine salicylate 13.3 %;
2018-08-31;
Topical;
Cream;
28:08.04.24 – SALICYLATES;
Otc;
CHURCH & DWIGHT CANADA CORP
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96250
EXTRA STRENGTH ASPERCREME CREME RUB 15%;
02074702;
trolamine salicylate 15 %;
1984-12-31;
Topical;
Cream;
28:08.04.24 – SALICYLATES;
Otc;
SANOFI CONSUMER HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=42373
MYOFLEX EXTRA STRENGTH;
02226022;
trolamine salicylate 15 % / w/w;
1989-12-30;
Topical;
Cream;
28:08.04.24 – SALICYLATES;
Otc;
EXZELL PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=33476
MUSCLE & JOINT NO ODOUR EXTRA STRENGTH;
02473135;
trolamine salicylate 20 %;
2018-09-24;
Topical;
Cream;
28:08.04.24 – SALICYLATES;
Otc;
CHURCH & DWIGHT CANADA CORP
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96248
MYOFLEX MAXIMUM STRENGTH;
02244573;
trolamine salicylate 20 % / w/w;
2002-03-01;
Topical;
Cream;
28:08.04.24 – SALICYLATES;
Otc;
EXZELL PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=68558
ULTRA STRENGTH PAIN RELIEF RUB;
02413442;
trolamine salicylate 20 % / w/w;
2017-03-27;
Topical;
Cream;
28:08.04.24 – SALICYLATES;
Otc;
CRLS
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89811
MYDRIACYL;
00000981;
tropicamide 0.5 % / w/v;
1951-12-31;
Ophthalmic;
Solution;
52:24.00 – MYDRIATICS;
Prescription;
ALCON CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=260
MYDRIACYL;
00001007;
tropicamide 1 % / w/v;
1969-12-31;
Ophthalmic;
Solution;
52:24.00 – MYDRIATICS;
Prescription;
ALCON CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=780
MINIMS TROPICAMIDE;
02148536;
tropicamide 1 % / w/v;
1995-12-31;
Ophthalmic;
Drops;
52:24.00 – MYDRIATICS;
Prescription;
BAUSCH HEALTH, CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18758
TROSEC;
02275066;
trospium chloride 20 mg;
2006-04-04;
Oral;
Tablet;
86:12.04 – Antimuscarinics;
Prescription;
SUNOVION PHARMACEUTICALS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76057
MAR-TROSPIUM;
02488353;
trospium chloride 20 mg;
2019-06-21;
Oral;
Tablet;
86:12.04 – Antimuscarinics;
Prescription;
MARCAN PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97846
D.O.R.C. VISION BLUE;
02279525;
trypan blue 0.06 %;
2006-09-06;
Intraocular;
Drops;
36:58.00 – OCULAR DISORDERS;
Ethical;
DUTCH OPHTHALMIC RESEARCH CENTER INTERNATIONAL BV
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76514
TRYPTAN TAB 1000MG;
00654531;
tryptophan 1 g;
1986-12-31;
Oral;
Tablet;
28:16.04.92 – MISCELLANEOUS ANTIDEPRESSANTS;
Prescription;
VALEANT CANADA LP/VALEANT CANADA S.E.C.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=7264
TEVA-TRYPTOPHAN;
02237250;
tryptophan 1 g;
1998-08-07;
Oral;
Tablet;
28:16.04.92 – MISCELLANEOUS ANTIDEPRESSANTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=60571
APO-TRYPTOPHAN;
02248539;
tryptophan 1 g;
2003-12-09;
Oral;
Tablet;
28:16.04.92 – MISCELLANEOUS ANTIDEPRESSANTS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72893
TRYPTAN TAB 250MG;
02239326;
tryptophan 250 mg;
1999-01-06;
Oral;
Tablet;
28:16.04.92 – MISCELLANEOUS ANTIDEPRESSANTS;
Prescription;
VALEANT CANADA LP/VALEANT CANADA S.E.C.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=62795
TRYPTAN CAP 500MG;
00718149;
tryptophan 500 mg;
1986-12-31;
Oral;
Capsule;
28:16.04.92 – MISCELLANEOUS ANTIDEPRESSANTS;
Prescription;
VALEANT CANADA LP/VALEANT CANADA S.E.C.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=7263
TRYPTAN TAB 500MG;
02029456;
tryptophan 500 mg;
1994-12-31;
Oral;
Tablet;
28:16.04.92 – MISCELLANEOUS ANTIDEPRESSANTS;
Prescription;
VALEANT CANADA LP/VALEANT CANADA S.E.C.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=15485
TEVA-TRYPTOPHAN;
02240333;
tryptophan 500 mg;
1999-09-28;
Oral;
Tablet;
28:16.04.92 – MISCELLANEOUS ANTIDEPRESSANTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=63872
TEVA-TRYPTOPHAN;
02240334;
tryptophan 500 mg;
2000-02-23;
Oral;
Capsule;
28:16.04.92 – MISCELLANEOUS ANTIDEPRESSANTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=63873
APO-TRYPTOPHAN;
02248538;
tryptophan 500 mg;
2003-12-09;
Oral;
Tablet;
28:16.04.92 – MISCELLANEOUS ANTIDEPRESSANTS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72892
APO-TRYPTOPHAN;
02248540;
tryptophan 500 mg;
2003-12-09;
Oral;
Capsule;
28:16.04.92 – MISCELLANEOUS ANTIDEPRESSANTS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72895
TRYPTAN TAB 750MG;
02239327;
tryptophan 750 mg;
1999-01-06;
Oral;
Tablet;
28:16.04.92 – MISCELLANEOUS ANTIDEPRESSANTS;
Prescription;
VALEANT CANADA LP/VALEANT CANADA S.E.C.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=62796
APO-TRYPTOPHAN;
02458721;
tryptophan 750 mg;
2017-02-06;
Oral;
Tablet;
28:16.04 – ANTIDEPRESSANTS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94588
TUKYSA;
02499835;
tucatinib 150 mg;
2020-08-27;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
SEATTLE GENETICS, INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98956
TUKYSA;
02499827;
tucatinib 50 mg;
2020-10-08;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
SEATTLE GENETICS, INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98955
ZONOVATE;
02435209;
turoctocog alfa 1000 unit / vial;
2018-03-23;
Intravenous;
Kit , Powder For Solution;
20:28.16 – HEMOSTATICS;
Schedule D;
NOVO NORDISK CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91948
ZONOVATE;
02435217;
turoctocog alfa 1500 unit / vial;
2018-03-23;
Intravenous;
Kit , Powder For Solution;
20:28.16 – HEMOSTATICS;
Schedule D;
NOVO NORDISK CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91949
ZONOVATE;
02435225;
turoctocog alfa 2000 unit / vial;
2018-03-23;
Intravenous;
Kit , Powder For Solution;
20:28.16 – HEMOSTATICS;
Schedule D;
NOVO NORDISK CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91950
ZONOVATE;
02435187;
turoctocog alfa 250 unit / vial;
2018-03-23;
Intravenous;
Kit , Powder For Solution;
20:28.16 – HEMOSTATICS;
Schedule D;
NOVO NORDISK CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91946
ZONOVATE;
02435233;
turoctocog alfa 3000 unit / vial;
2018-03-23;
Intravenous;
Kit , Powder For Solution;
20:28.16 – HEMOSTATICS;
Schedule D;
NOVO NORDISK CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91951
ZONOVATE;
02435195;
turoctocog alfa 500 unit / vial;
2018-03-23;
Intravenous;
Kit , Powder For Solution;
20:28.16 – HEMOSTATICS;
Schedule D;
NOVO NORDISK CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91947
ELLA;
02436329;
ulipristal acetate 30 mg;
2015-09-01;
Oral;
Tablet;
68:12.00 – CONTRACEPTIVES;
Prescription;
LABORATOIRE HRA PHARMA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92065
INCRUSE ELLIPTA;
02423596;
umeclidinium (umeclidinium bromide) 62.5 mcg / act;
2015-04-27;
Inhalation;
Powder;
12:08.08 – ANTIMUSCARINICS ANTISPASMODICS;
Prescription;
GLAXOSMITHKLINE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90830
RINVOQ;
02495155;
upadacitinib 15 mg;
2020-01-16;
Oral;
Tablet (Extended-Release);
92:36.00 – DISEASE-MODIFYING ANTIRHEUMATIC AGENTS;
Prescription;
ABBVIE CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98509
URSO;
02238984;
ursodiol 250 mg;
1998-11-08;
Oral;
Tablet;
56:14.00 – CHOLELITHOLYTIC AGENTS;
Prescription;
APTALIS PHARMA CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=62432
PMS-URSODIOL C;
02273497;
ursodiol 250 mg;
2006-05-01;
Oral;
Tablet;
56:14.00 – CHOLELITHOLYTIC AGENTS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75898
GLN-URSODIOL;
02426900;
ursodiol 250 mg;
2016-04-04;
Oral;
Tablet;
56:14.00 – CHOLELITHOLYTIC AGENTS;
Prescription;
GLENMARK PHARMACEUTICALS CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91144
JAMP-URSODIOL;
02472392;
ursodiol 250 mg;
2018-09-28;
Oral;
Tablet;
56:14.00 – CHOLELITHOLYTIC AGENTS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96170
URSO DS;
02245894;
ursodiol 500 mg;
2003-02-03;
Oral;
Tablet;
56:14.00 – CHOLELITHOLYTIC AGENTS;
Prescription;
APTALIS PHARMA CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=70011
PMS-URSODIOL C;
02273500;
ursodiol 500 mg;
2006-05-01;
Oral;
Tablet;
56:14.00 – CHOLELITHOLYTIC AGENTS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75899
GLN-URSODIOL;
02426919;
ursodiol 500 mg;
2016-04-04;
Oral;
Tablet;
56:14.00 – CHOLELITHOLYTIC AGENTS;
Prescription;
GLENMARK PHARMACEUTICALS CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91146
JAMP-URSODIOL;
02472406;
ursodiol 500 mg;
2018-09-28;
Oral;
Tablet;
56:14.00 – CHOLELITHOLYTIC AGENTS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96171
STELARA;
02320673;
ustekinumab 45 mg / 0.5 ml;
2009-01-05;
Subcutaneous;
Solution;
84:92.00 – MISC. SKIN AND MUCOUS MEMBRANE AGENTS , 92:20.00 – Immunomodulatory Agents;
Prescription , Schedule D;
JANSSEN INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80608
STELARA;
02459671;
ustekinumab 5 mg / ml;
2016-12-21;
Intravenous;
Solution;
84:92.00 – MISC. SKIN AND MUCOUS MEMBRANE AGENTS , 92:20.00 – Immunomodulatory Agents;
Prescription , Schedule D;
JANSSEN INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94698
STELARA;
02320681;
ustekinumab 90 mg / 1.0 ml;
2013-01-07;
Subcutaneous;
Solution;
84:92.00 – MISC. SKIN AND MUCOUS MEMBRANE AGENTS , 92:20.00 – Immunomodulatory Agents;
Prescription , Schedule D;
JANSSEN INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80609
SANDOZ VALACYCLOVIR;
02347091;
valacyclovir (valacyclovir hydrochloride monohydrate) 500 mg;
2015-07-21;
Oral;
Tablet;
08:18.32 – NUCLEOSIDES AND NUCLEOTIDES;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83249
VALTREX;
02246559;
valacyclovir (valacyclovir hydrochloride) 1000 mg;
2005-05-09;
Oral;
Tablet;
08:18.32 – NUCLEOSIDES AND NUCLEOTIDES;
Prescription;
GLAXOSMITHKLINE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=70742
MYLAN-VALACYCLOVIR;
02351560;
valacyclovir (valacyclovir hydrochloride) 1000 mg;
2010-05-25;
Oral;
Tablet;
08:18.32 – NUCLEOSIDES AND NUCLEOTIDES;
Prescription;
MYLAN PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83684
APO-VALACYCLOVIR;
02354705;
valacyclovir (valacyclovir hydrochloride) 1000 mg;
2011-10-21;
Oral;
Tablet;
08:18.32 – NUCLEOSIDES AND NUCLEOTIDES;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83987
PMS-VALACYCLOVIR;
02381230;
valacyclovir (valacyclovir hydrochloride) 1000 mg;
2012-03-13;
Oral;
Tablet;
08:18.32 – NUCLEOSIDES AND NUCLEOTIDES;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86701
VALTREX;
02219492;
valacyclovir (valacyclovir hydrochloride) 500 mg;
1996-12-31;
Oral;
Tablet;
08:18.32 – NUCLEOSIDES AND NUCLEOTIDES;
Prescription;
GLAXOSMITHKLINE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=20218
APO-VALACYCLOVIR;
02295822;
valacyclovir (valacyclovir hydrochloride) 500 mg;
2008-05-23;
Oral;
Tablet;
08:18.32 – NUCLEOSIDES AND NUCLEOTIDES;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78118
PMS-VALACYCLOVIR;
02298457;
valacyclovir (valacyclovir hydrochloride) 500 mg;
2008-05-16;
Oral;
Tablet;
08:18.32 – NUCLEOSIDES AND NUCLEOTIDES;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78376
PRO-VALACYCLOVIR;
02315173;
valacyclovir (valacyclovir hydrochloride) 500 mg;
2009-02-10;
Oral;
Tablet;
08:18.32 – NUCLEOSIDES AND NUCLEOTIDES;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80073
RIVA-VALACYCLOVIR;
02316447;
valacyclovir (valacyclovir hydrochloride) 500 mg;
2008-10-27;
Oral;
Tablet;
08:18.32 – NUCLEOSIDES AND NUCLEOTIDES;
Prescription;
LABORATOIRE RIVA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80195
MYLAN-VALACYCLOVIR;
02351579;
valacyclovir (valacyclovir hydrochloride) 500 mg;
2010-05-25;
Oral;
Tablet;
08:18.32 – NUCLEOSIDES AND NUCLEOTIDES;
Prescription;
MYLAN PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83683
TEVA-VALACYCLOVIR;
02357534;
valacyclovir (valacyclovir hydrochloride) 500 mg;
2010-10-01;
Oral;
Tablet;
08:18.32 – NUCLEOSIDES AND NUCLEOTIDES;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84264
AURO-VALACYCLOVIR;
02405040;
valacyclovir (valacyclovir hydrochloride) 500 mg;
2013-05-30;
Oral;
Tablet;
08:18.32 – NUCLEOSIDES AND NUCLEOTIDES;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88988
JAMP VALACYCLOVIR;
02440598;
valacyclovir (valacyclovir hydrochloride) 500 mg;
2021-04-13;
Oral;
Tablet;
08:18.32 – NUCLEOSIDES AND NUCLEOTIDES;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92496
JAMP-VALACYCLOVIR;
02441454;
valacyclovir (valacyclovir hydrochloride) 500 mg;
2015-10-14;
Oral;
Tablet;
08:18.32 – NUCLEOSIDES AND NUCLEOTIDES;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92583
VALACYCLOVIR;
02442000;
valacyclovir (valacyclovir hydrochloride) 500 mg;
2015-10-14;
Oral;
Tablet;
08:18.32 – NUCLEOSIDES AND NUCLEOTIDES;
Prescription;
SIVEM PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92637
VALACYCLOVIR;
02454645;
valacyclovir (valacyclovir hydrochloride) 500 mg;
2016-06-10;
Oral;
Tablet;
08:18.32 – NUCLEOSIDES AND NUCLEOTIDES;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94135
VALCYTE;
02245777;
valganciclovir (valganciclovir hydrochloride) 450 mg;
2002-07-16;
Oral;
Tablet;
08:18.32 – NUCLEOSIDES AND NUCLEOTIDES;
Prescription;
HOFFMANN-LA ROCHE LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=69890
TEVA-VALGANCICLOVIR;
02413825;
valganciclovir (valganciclovir hydrochloride) 450 mg;
2014-11-27;
Oral;
Tablet;
08:18.32 – NUCLEOSIDES AND NUCLEOTIDES;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89847
AURO-VALGANCICLOVIR;
02435179;
valganciclovir (valganciclovir hydrochloride) 450 mg;
2015-04-10;
Oral;
Tablet;
08:18.32 – NUCLEOSIDES AND NUCLEOTIDES;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91945
MINT-VALGANCICLOVIR;
02495457;
valganciclovir (valganciclovir hydrochloride) 450 mg;
2020-05-27;
Oral;
Tablet;
08:18.32 – NUCLEOSIDES AND NUCLEOTIDES;
Prescription;
MINT PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98537
VALCYTE;
02306085;
valganciclovir (valganciclovir hydrochloride) 50 mg / ml;
2008-08-13;
Oral;
Powder For Solution;
08:18.32 – NUCLEOSIDES AND NUCLEOTIDES;
Prescription;
HOFFMANN-LA ROCHE LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79164
EPIVAL;
00596418;
valproic acid (divalproex sodium) 125 mg;
1984-12-31;
Oral;
Tablet (Enteric-Coated);
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
BGP PHARMA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=5676
APO-DIVALPROEX;
02239698;
valproic acid (divalproex sodium) 125 mg;
1999-03-24;
Oral;
Tablet (Enteric-Coated);
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=63179
MYLAN-DIVALPROEX;
02458926;
valproic acid (divalproex sodium) 125 mg;
2017-04-21;
Oral;
Tablet (Enteric-Coated);
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
MYLAN PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94597
EPIVAL;
00596426;
valproic acid (divalproex sodium) 250 mg;
1984-12-31;
Oral;
Tablet (Enteric-Coated);
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
BGP PHARMA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=5677
MYLAN-DIVALPROEX;
02458934;
valproic acid (divalproex sodium) 250 mg;
2017-05-21;
Oral;
Tablet (Enteric-Coated);
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
MYLAN PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94598
APO-DIVALPROEX;
02239699;
valproic acid (divalproex sodium) 250 mg / ect;
1999-03-24;
Oral;
Tablet (Enteric-Coated);
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=63180
EPIVAL;
00596434;
valproic acid (divalproex sodium) 500 mg;
1984-12-31;
Oral;
Tablet (Enteric-Coated);
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
BGP PHARMA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=5678
MYLAN-DIVALPROEX;
02459019;
valproic acid (divalproex sodium) 500 mg;
2017-04-11;
Oral;
Tablet (Enteric-Coated);
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
MYLAN PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94599
APO-DIVALPROEX;
02239700;
valproic acid (divalproex sodium) 500 mg / ect;
1999-03-24;
Oral;
Tablet (Enteric-Coated);
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=63181
DEPAKENE;
00443832;
valproic acid (sodium valproate) 250 mg / 5 ml;
1978-12-31;
Oral;
Solution;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
BGP PHARMA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=3156
PMS-VALPROIC ACID;
02236807;
valproic acid (sodium valproate) 250 mg / 5 ml;
1997-11-20;
Oral;
Solution;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=60096
APO-VALPROIC;
02238370;
valproic acid (sodium valproate) 250 mg / 5 ml;
1998-07-15;
Oral;
Solution;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=61782
PMS-VALPROIC ACID;
02230768;
valproic acid 250 mg;
1997-02-27;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=50031
APO-VALPROIC;
02238048;
valproic acid 250 mg;
1998-06-01;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=61432
PMS-VALPROIC ACID E.C.;
02229628;
valproic acid 500 mg;
1996-12-13;
Oral;
Capsule (Enteric-Coated);
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=47553
DIOVAN 160MG TABLETS;
02244782;
valsartan 160 mg;
2003-01-24;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=68772
TEVA-VALSARTAN;
02356678;
valsartan 160 mg;
2011-02-16;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84180
SANDOZ VALSARTAN;
02356767;
valsartan 160 mg;
2011-01-27;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84189
TARO-VALSARTAN;
02363119;
valsartan 160 mg;
2011-02-16;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
SUN PHARMA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84813
VALSARTAN;
02366967;
valsartan 160 mg;
2012-07-20;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85178
VALSARTAN;
02367742;
valsartan 160 mg;
2011-05-30;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85258
AURO-VALSARTAN;
02414236;
valsartan 160 mg;
2014-02-06;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89889
DIOVAN;
02289504;
valsartan 320 mg;
2007-02-14;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77486
TEVA-VALSARTAN;
02356686;
valsartan 320 mg;
2011-02-16;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84181
SANDOZ VALSARTAN;
02356775;
valsartan 320 mg;
2011-01-27;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84190
VALSARTAN;
02366975;
valsartan 320 mg;
2012-07-20;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85179
VALSARTAN;
02367750;
valsartan 320 mg;
2011-05-30;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85259
AURO-VALSARTAN;
02414244;
valsartan 320 mg;
2014-02-06;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89890
DIOVAN;
02270528;
valsartan 40 mg;
2005-11-01;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75588
TEVA-VALSARTAN;
02356643;
valsartan 40 mg;
2011-02-16;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84178
SANDOZ VALSARTAN;
02356740;
valsartan 40 mg;
2011-01-27;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84187
TARO-VALSARTAN;
02363062;
valsartan 40 mg;
2011-02-16;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
SUN PHARMA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84808
VALSARTAN;
02366940;
valsartan 40 mg;
2012-07-20;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85176
VALSARTAN;
02367726;
valsartan 40 mg;
2011-05-30;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85256
AURO-VALSARTAN;
02414201;
valsartan 40 mg;
2014-02-06;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89887
DIOVAN 80MG TABLETS;
02244781;
valsartan 80 mg;
2003-01-24;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=68771
TEVA-VALSARTAN;
02356651;
valsartan 80 mg;
2011-02-16;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84179
SANDOZ VALSARTAN;
02356759;
valsartan 80 mg;
2011-01-27;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84188
TARO-VALSARTAN;
02363100;
valsartan 80 mg;
2011-02-16;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
SUN PHARMA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84812
VALSARTAN;
02366959;
valsartan 80 mg;
2012-07-20;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85177
VALSARTAN;
02367734;
valsartan 80 mg;
2011-05-30;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85257
AURO-VALSARTAN;
02414228;
valsartan 80 mg;
2014-02-06;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89888
VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP;
02139383;
vancomycin (vancomycin hydrochloride) 1 g / vial;
1992-12-31;
Intravenous;
Powder For Solution;
08:12.28.16 – GLYCOPEPTIDES;
Prescription;
FRESENIUS KABI CANADA LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19705
VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP;
02230192;
vancomycin (vancomycin hydrochloride) 1 g / vial;
2000-03-31;
Intravenous;
Powder For Solution;
08:12.28.16 – GLYCOPEPTIDES;
Prescription;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=48885
VANCOMYCIN HYDROCHLORIDE FOR INJECTION USP;
02342863;
vancomycin (vancomycin hydrochloride) 1 g / vial;
2010-09-23;
Intravenous;
Powder For Solution;
08:12.28.16 – GLYCOPEPTIDES;
Prescription;
STERIMAX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82836
VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP;
02394634;
vancomycin (vancomycin hydrochloride) 1 g / vial;
2014-03-18;
Intravenous;
Powder For Solution;
-;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87977
JAMP-VANCOMYCIN;
02420309;
vancomycin (vancomycin hydrochloride) 1 g / vial;
2014-09-22;
Intravenous;
Powder For Solution;
08:12.28.16 – GLYCOPEPTIDES;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90489
VANCOMYCIN HYDROCHLORIDE FOR INJECTION USP;
02435721;
vancomycin (vancomycin hydrochloride) 1 g / vial;
2017-07-17;
Intravenous;
Powder For Solution;
08:12.28.16 – GLYCOPEPTIDES;
Prescription;
GENERIC MEDICAL PARTNERS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92007
VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP;
02502607;
vancomycin (vancomycin hydrochloride) 1 g / vial;
2021-01-14;
Intravenous;
Powder For Solution;
08:12.28.16 – GLYCOPEPTIDES;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99217
VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP;
02241807;
vancomycin (vancomycin hydrochloride) 10 g / vial;
2000-07-10;
Intravenous;
Powder For Solution;
08:12.28.16 – GLYCOPEPTIDES;
Prescription;
FRESENIUS KABI CANADA LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=65472
VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP;
02378345;
vancomycin (vancomycin hydrochloride) 10 g / vial;
2015-10-05;
Intravenous;
Powder For Solution;
08:12.28.16 – GLYCOPEPTIDES;
Prescription;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86416
VANCOMYCIN HYDROCHLORIDE FOR INJECTION USP;
02405830;
vancomycin (vancomycin hydrochloride) 10 g / vial;
2013-06-12;
Intravenous;
Powder For Solution;
08:12.28.16 – GLYCOPEPTIDES;
Prescription;
STERIMAX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89060
VANCOMYCIN INJECTION USP IN 0.9% SODIUM CHLORIDE;
02487071;
vancomycin (vancomycin hydrochloride) 1000 mg / 200 ml;
2021-01-11;
Intravenous;
Solution;
08:12.28.16 – GLYCOPEPTIDES;
Prescription;
BAXTER CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97722
VANCOCIN;
00800430;
vancomycin (vancomycin hydrochloride) 125 mg;
1989-12-31;
Oral;
Capsule;
08:12.28.16 – GLYCOPEPTIDES;
Prescription;
SEARCHLIGHT PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=9594
VANCOMYCIN HYDROCHLORIDE CAPSULES, USP;
02406497;
vancomycin (vancomycin hydrochloride) 125 mg;
2021-01-25;
Oral;
Capsule;
08:12.28.16 – GLYCOPEPTIDES;
Prescription;
STRIDES PHARMA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89119
JAMP-VANCOMYCIN;
02407744;
vancomycin (vancomycin hydrochloride) 125 mg;
2014-03-26;
Oral;
Capsule;
08:12.28.16 – GLYCOPEPTIDES;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89245
VANCOCIN;
00788716;
vancomycin (vancomycin hydrochloride) 250 mg;
1989-12-31;
Oral;
Capsule;
08:12.28.16 – GLYCOPEPTIDES;
Prescription;
SEARCHLIGHT PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=9593
VANCOMYCIN HYDROCHLORIDE CAPSULES, USP;
02406500;
vancomycin (vancomycin hydrochloride) 250 mg;
2021-01-25;
Oral;
Capsule;
08:12.28.16 – GLYCOPEPTIDES;
Prescription;
STRIDES PHARMA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89120
JAMP-VANCOMYCIN;
02407752;
vancomycin (vancomycin hydrochloride) 250 mg;
2014-03-26;
Oral;
Capsule;
08:12.28.16 – GLYCOPEPTIDES;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89246
VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP;
02139243;
vancomycin (vancomycin hydrochloride) 5 g / vial;
1996-08-14;
Intravenous;
Powder For Solution;
08:12.28.16 – GLYCOPEPTIDES;
Prescription;
FRESENIUS KABI CANADA LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43933
VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP;
02394642;
vancomycin (vancomycin hydrochloride) 5 g / vial;
2013-02-14;
Intravenous;
Powder For Solution;
-;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87978
VANCOMYCIN HYDROCHLORIDE FOR INJECTION USP;
02405822;
vancomycin (vancomycin hydrochloride) 5 g / vial;
2020-10-19;
Intravenous;
Powder For Solution;
08:12.28.16 – GLYCOPEPTIDES;
Prescription;
STERIMAX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89059
JAMP-VANCOMYCIN;
02420317;
vancomycin (vancomycin hydrochloride) 5 g / vial;
2014-09-22;
Intravenous;
Powder For Solution;
08:12.28.16 – GLYCOPEPTIDES;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90490
VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP;
02139375;
vancomycin (vancomycin hydrochloride) 500 mg / vial;
1992-12-31;
Intravenous;
Powder For Solution;
08:12.28.16 – GLYCOPEPTIDES;
Prescription;
FRESENIUS KABI CANADA LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19703
VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP;
02230191;
vancomycin (vancomycin hydrochloride) 500 mg / vial;
2000-03-31;
Intravenous;
Powder For Solution;
08:12.28.16 – GLYCOPEPTIDES;
Prescription;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=48884
VANCOMYCIN HYDROCHLORIDE FOR INJECTION USP;
02342855;
vancomycin (vancomycin hydrochloride) 500 mg / vial;
2010-09-23;
Intravenous;
Powder For Solution;
08:12.28.16 – GLYCOPEPTIDES;
Prescription;
STERIMAX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82835
VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP;
02394626;
vancomycin (vancomycin hydrochloride) 500 mg / vial;
2014-03-18;
Intravenous;
Powder For Solution;
-;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87976
VANCOMYCIN HYDROCHLORIDE FOR INJECTION USP;
02435713;
vancomycin (vancomycin hydrochloride) 500 mg / vial;
2017-07-27;
Intravenous;
Powder For Solution;
08:12.28.16 – GLYCOPEPTIDES;
Prescription;
GENERIC MEDICAL PARTNERS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92006
VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP;
02502593;
vancomycin (vancomycin hydrochloride) 500 mg / vial;
2021-01-14;
Intravenous;
Powder For Solution;
08:12.28.16 – GLYCOPEPTIDES;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99216
CAPRELSA;
02378582;
vandetanib 100 mg;
2012-02-23;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
SANOFI GENZYME, A DIVISION OF SANOFI-AVENTIS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86437
CAPRELSA;
02378590;
vandetanib 300 mg;
2012-02-23;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
SANOFI GENZYME, A DIVISION OF SANOFI-AVENTIS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86438
MYLAN-VARDENAFIL;
02464225;
vardenafil (vardenafil hydrochloride trihydrate) 10 mg;
2018-11-01;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
MYLAN PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95239
JAMP-VARDENAFIL ODT;
02476088;
vardenafil (vardenafil hydrochloride trihydrate) 10 mg;
2019-06-06;
Oral;
Tablet (Orally Disintegrating);
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96702
MYLAN-VARDENAFIL;
02464233;
vardenafil (vardenafil hydrochloride trihydrate) 20 mg;
2018-11-01;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
MYLAN PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95240
MYLAN-VARDENAFIL;
02464209;
vardenafil (vardenafil hydrochloride trihydrate) 5 mg;
2018-11-01;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
MYLAN PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95236
LEVITRA;
02250470;
vardenafil (vardenafil hydrochloride) 10 mg;
2004-03-17;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
BAYER INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73527
STAXYN;
02372436;
vardenafil (vardenafil hydrochloride) 10 mg;
2011-08-25;
Oral;
Tablet (Orally Disintegrating);
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
BAYER INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85755
APO-VARDENAFIL;
02471655;
vardenafil (vardenafil hydrochloride) 10 mg;
2018-12-21;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96087
JAMP-VARDENAFIL;
02475685;
vardenafil (vardenafil hydrochloride) 10 mg;
2018-11-01;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96606
LEVITRA;
02250489;
vardenafil (vardenafil hydrochloride) 20 mg;
2004-03-17;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
BAYER INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73528
APO-VARDENAFIL;
02471663;
vardenafil (vardenafil hydrochloride) 20 mg;
2018-12-21;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96088
JAMP-VARDENAFIL;
02475693;
vardenafil (vardenafil hydrochloride) 20 mg;
2018-11-01;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96607
APO-VARDENAFIL;
02471647;
vardenafil (vardenafil hydrochloride) 5 mg;
2018-12-21;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96086
JAMP-VARDENAFIL;
02475677;
vardenafil (vardenafil hydrochloride) 5 mg;
2018-11-01;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96605
CHAMPIX;
02291177;
varenicline (varenicline tartrate) 0.5 mg;
2007-04-11;
Oral;
Tablet;
12:92.00 – MISCELLANEOUS AUTONOMIC DRUGS;
Prescription;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77655
APO-VARENICLINE;
02419882;
varenicline (varenicline tartrate) 0.5 mg;
2018-05-02;
Oral;
Tablet;
12:92.00 – MISCELLANEOUS AUTONOMIC DRUGS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90450
TEVA-VARENICLINE;
02426226;
varenicline (varenicline tartrate) 0.5 mg;
2019-04-23;
Oral;
Tablet;
12:92.00 – MISCELLANEOUS AUTONOMIC DRUGS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91083
CHAMPIX;
02291185;
varenicline (varenicline tartrate) 1 mg;
2007-04-11;
Oral;
Tablet;
12:92.00 – MISCELLANEOUS AUTONOMIC DRUGS;
Prescription;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77656
APO-VARENICLINE;
02419890;
varenicline (varenicline tartrate) 1 mg;
2018-05-02;
Oral;
Tablet;
12:92.00 – MISCELLANEOUS AUTONOMIC DRUGS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90451
TEVA-VARENICLINE;
02426234;
varenicline (varenicline tartrate) 1 mg;
2019-04-23;
Oral;
Tablet;
12:92.00 – MISCELLANEOUS AUTONOMIC DRUGS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91084
VARIZIG;
02442183;
varicella zoster immunoglobulin (human) 125 unit / vial;
2015-08-14;
Intramuscular , Intravenous;
Solution;
80:04.00 – SERUMS;
Schedule D;
SAOL THERAPEUTICS RESEARCH LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92654
SHINGRIX;
02468425;
varicella-zoster virus glycoprotein e antigen 50 mcg / 0.5 ml;
2018-01-02;
Intramuscular;
Suspension;
80:12.00 – VACCINES;
Schedule D;
GLAXOSMITHKLINE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95685
VARIVAX III;
02246081;
varicella-zoster virus vaccine live attenuated (oka/merck strain) 1350 unit / 0.5 ml;
2002-12-02;
Subcutaneous;
Powder For Solution;
80:12.00 – VACCINES;
Schedule D;
MERCK CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=70216
ZOSTAVAX II;
02375516;
varicella-zoster virus vaccine live attenuated (oka/merck strain) 19400 pfu / 0.65 ml;
2014-05-26;
Subcutaneous;
Powder For Suspension;
80:12.00 – VACCINES;
Schedule D;
MERCK CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86093
VASOPRESSIN INJECTION;
02139502;
vasopressin 20 unit / ml;
1996-08-14;
Intramuscular , Subcutaneous;
Solution;
68:28.00 – PITUITARY;
Prescription;
FRESENIUS KABI CANADA LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=31359
VASOPRESSIN INJECTION USP;
02247938;
vasopressin 20 unit / ml;
2003-12-10;
Intramuscular , Subcutaneous;
Solution;
68:28.00 – PITUITARY;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72248
ENTYVIO;
02497875;
vedolizumab 108 mg / 0.68 ml;
2020-11-20;
Subcutaneous;
Solution;
56:92.00 – MISCELLANEOUS GI DRUGS;
Prescription , Schedule D;
TAKEDA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98766
ENTYVIO;
02497867;
vedolizumab 108 mg / 0.68 ml;
2020-07-08;
Subcutaneous;
Solution;
56:92.00 – MISCELLANEOUS GI DRUGS;
Prescription , Schedule D;
TAKEDA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98767
ENTYVIO;
02436841;
vedolizumab 300 mg / vial;
2015-04-21;
Intravenous;
Powder For Solution;
56:92.00 – MISCELLANEOUS GI DRUGS;
Prescription , Schedule D;
TAKEDA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92117
VPRIV;
02357119;
velaglucerase alfa 400 unit / vial;
2010-11-22;
Intravenous;
Powder For Solution;
44:00.00 – ENZYMES;
Prescription , Schedule D;
TAKEDA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84221
ZELBORAF;
02380242;
vemurafenib 240 mg;
2012-03-05;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
HOFFMANN-LA ROCHE LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86606
VENCLEXTA;
02458039;
venetoclax 10 mg;
2016-10-31;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
ABBVIE CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94509
VENCLEXTA;
02458055;
venetoclax 100 mg;
2016-10-31;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
ABBVIE CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94511
VENCLEXTA;
02458047;
venetoclax 50 mg;
2016-10-31;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
ABBVIE CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94510
EFFEXOR XR;
02237282;
venlafaxine (venlafaxine hydrochloride) 150 mg;
1998-03-04;
Oral;
Capsule (Extended Release);
28:16.04.16 – SELECTIVE SEROTONIN AND NOREPINEPHRINE-REUPTAKE INHIBITORS;
Prescription;
UPJOHN CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=60603
TEVA-VENLAFAXINE XR;
02275058;
venlafaxine (venlafaxine hydrochloride) 150 mg;
2006-12-01;
Oral;
Capsule (Extended Release);
28:16.04.16 – SELECTIVE SEROTONIN AND NOREPINEPHRINE-REUPTAKE INHIBITORS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76056
PMS-VENLAFAXINE XR;
02278561;
venlafaxine (venlafaxine hydrochloride) 150 mg;
2007-08-17;
Oral;
Capsule (Extended Release);
28:16.04.16 – SELECTIVE SEROTONIN AND NOREPINEPHRINE-REUPTAKE INHIBITORS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76415
ACT VENLAFAXINE XR;
02304333;
venlafaxine (venlafaxine hydrochloride) 150 mg;
2008-02-13;
Oral;
Capsule (Extended Release);
28:16.04.16 – SELECTIVE SEROTONIN AND NOREPINEPHRINE-REUPTAKE INHIBITORS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78962
SANDOZ VENLAFAXINE XR;
02310333;
venlafaxine (venlafaxine hydrochloride) 150 mg;
2008-05-09;
Oral;
Capsule (Extended Release);
28:16.04.16 – SELECTIVE SEROTONIN AND NOREPINEPHRINE-REUPTAKE INHIBITORS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79598
APO-VENLAFAXINE XR;
02331705;
venlafaxine (venlafaxine hydrochloride) 150 mg;
2013-04-16;
Oral;
Capsule (Extended Release);
28:16.04.16 – SELECTIVE SEROTONIN AND NOREPINEPHRINE-REUPTAKE INHIBITORS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81740
VENLAFAXINE XR;
02339269;
venlafaxine (venlafaxine hydrochloride) 150 mg;
2010-02-03;
Oral;
Capsule (Extended Release);
28:16.04.16 – SELECTIVE SEROTONIN AND NOREPINEPHRINE-REUPTAKE INHIBITORS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82487
VENLAFAXINE XR;
02354748;
venlafaxine (venlafaxine hydrochloride) 150 mg;
2010-07-27;
Oral;
Capsule (Extended Release);
28:16.04.16 – SELECTIVE SEROTONIN AND NOREPINEPHRINE-REUPTAKE INHIBITORS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83990
TARO-VENLAFAXINE XR;
02380099;
venlafaxine (venlafaxine hydrochloride) 150 mg;
2012-02-16;
Oral;
Capsule (Extended Release);
28:16.04.16 – SELECTIVE SEROTONIN AND NOREPINEPHRINE-REUPTAKE INHIBITORS;
Prescription;
SUN PHARMA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86593
VENLAFAXINE XR;
02385945;
venlafaxine (venlafaxine hydrochloride) 150 mg;
2012-06-10;
Oral;
Capsule (Extended Release);
28:16.04.16 – SELECTIVE SEROTONIN AND NOREPINEPHRINE-REUPTAKE INHIBITORS;
Prescription;
SIVEM PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87155
AURO-VENLAFAXINE XR;
02452855;
venlafaxine (venlafaxine hydrochloride) 150 mg;
2016-03-14;
Oral;
Capsule (Extended Release);
28:16.04.16 – SELECTIVE SEROTONIN AND NOREPINEPHRINE-REUPTAKE INHIBITORS;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93926
M-VENLAFAXINE XR;
02471302;
venlafaxine (venlafaxine hydrochloride) 150 mg;
2018-03-07;
Oral;
Capsule (Extended Release);
28:16.04.16 – SELECTIVE SEROTONIN AND NOREPINEPHRINE-REUPTAKE INHIBITORS;
Prescription;
MANTRA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96041
VENLAFAXINE XR;
02489694;
venlafaxine (venlafaxine hydrochloride) 150 mg;
2019-08-07;
Oral;
Capsule (Extended Release);
28:16.04.16 – SELECTIVE SEROTONIN AND NOREPINEPHRINE-REUPTAKE INHIBITORS;
Prescription;
LABORATOIRE RIVA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97976
EFFEXOR XR;
02237279;
venlafaxine (venlafaxine hydrochloride) 37.5 mg;
1998-03-04;
Oral;
Capsule (Extended Release);
28:16.04.16 – SELECTIVE SEROTONIN AND NOREPINEPHRINE-REUPTAKE INHIBITORS;
Prescription;
UPJOHN CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=60600
TEVA-VENLAFAXINE XR;
02275023;
venlafaxine (venlafaxine hydrochloride) 37.5 mg;
2006-12-01;
Oral;
Capsule (Extended Release);
28:16.04.16 – SELECTIVE SEROTONIN AND NOREPINEPHRINE-REUPTAKE INHIBITORS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76054
PMS-VENLAFAXINE XR;
02278545;
venlafaxine (venlafaxine hydrochloride) 37.5 mg;
2007-08-17;
Oral;
Capsule (Extended Release);
28:16.04.16 – SELECTIVE SEROTONIN AND NOREPINEPHRINE-REUPTAKE INHIBITORS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76413
ACT VENLAFAXINE XR;
02304317;
venlafaxine (venlafaxine hydrochloride) 37.5 mg;
2008-02-13;
Oral;
Capsule (Extended Release);
28:16.04.16 – SELECTIVE SEROTONIN AND NOREPINEPHRINE-REUPTAKE INHIBITORS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78960
SANDOZ VENLAFAXINE XR;
02310317;
venlafaxine (venlafaxine hydrochloride) 37.5 mg;
2008-05-09;
Oral;
Capsule (Extended Release);
28:16.04.16 – SELECTIVE SEROTONIN AND NOREPINEPHRINE-REUPTAKE INHIBITORS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79596
APO-VENLAFAXINE XR;
02331683;
venlafaxine (venlafaxine hydrochloride) 37.5 mg;
2013-04-16;
Oral;
Capsule (Extended Release);
28:16.04.16 – SELECTIVE SEROTONIN AND NOREPINEPHRINE-REUPTAKE INHIBITORS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81738
VENLAFAXINE XR;
02339242;
venlafaxine (venlafaxine hydrochloride) 37.5 mg;
2010-02-03;
Oral;
Capsule (Extended Release);
28:16.04.16 – SELECTIVE SEROTONIN AND NOREPINEPHRINE-REUPTAKE INHIBITORS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82485
VENLAFAXINE XR;
02354713;
venlafaxine (venlafaxine hydrochloride) 37.5 mg;
2010-07-27;
Oral;
Capsule (Extended Release);
28:16.04.16 – SELECTIVE SEROTONIN AND NOREPINEPHRINE-REUPTAKE INHIBITORS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83988
TARO-VENLAFAXINE XR;
02380072;
venlafaxine (venlafaxine hydrochloride) 37.5 mg;
2012-02-17;
Oral;
Capsule (Extended Release);
28:16.04.16 – SELECTIVE SEROTONIN AND NOREPINEPHRINE-REUPTAKE INHIBITORS;
Prescription;
SUN PHARMA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86591
VENLAFAXINE XR;
02385929;
venlafaxine (venlafaxine hydrochloride) 37.5 mg;
2012-06-10;
Oral;
Capsule (Extended Release);
28:16.04.16 – SELECTIVE SEROTONIN AND NOREPINEPHRINE-REUPTAKE INHIBITORS;
Prescription;
SIVEM PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87153
AURO-VENLAFAXINE XR;
02452839;
venlafaxine (venlafaxine hydrochloride) 37.5 mg;
2016-03-14;
Oral;
Capsule (Extended Release);
28:16.04.16 – SELECTIVE SEROTONIN AND NOREPINEPHRINE-REUPTAKE INHIBITORS;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93924
M-VENLAFAXINE XR;
02471280;
venlafaxine (venlafaxine hydrochloride) 37.5 mg;
2018-03-07;
Oral;
Capsule (Extended Release);
28:16.04.16 – SELECTIVE SEROTONIN AND NOREPINEPHRINE-REUPTAKE INHIBITORS;
Prescription;
MANTRA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96039
VENLAFAXINE XR;
02489678;
venlafaxine (venlafaxine hydrochloride) 37.5 mg;
2019-08-07;
Oral;
Capsule (Extended Release);
28:16.04.16 – SELECTIVE SEROTONIN AND NOREPINEPHRINE-REUPTAKE INHIBITORS;
Prescription;
LABORATOIRE RIVA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97974
EFFEXOR XR;
02237280;
venlafaxine (venlafaxine hydrochloride) 75 mg;
1998-03-04;
Oral;
Capsule (Extended Release);
28:16.04.16 – SELECTIVE SEROTONIN AND NOREPINEPHRINE-REUPTAKE INHIBITORS;
Prescription;
UPJOHN CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=60601
TEVA-VENLAFAXINE XR;
02275031;
venlafaxine (venlafaxine hydrochloride) 75 mg;
2006-12-01;
Oral;
Capsule (Extended Release);
28:16.04.16 – SELECTIVE SEROTONIN AND NOREPINEPHRINE-REUPTAKE INHIBITORS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76055
PMS-VENLAFAXINE XR;
02278553;
venlafaxine (venlafaxine hydrochloride) 75 mg;
2007-08-17;
Oral;
Capsule (Extended Release);
28:16.04.16 – SELECTIVE SEROTONIN AND NOREPINEPHRINE-REUPTAKE INHIBITORS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76414
ACT VENLAFAXINE XR;
02304325;
venlafaxine (venlafaxine hydrochloride) 75 mg;
2008-02-13;
Oral;
Capsule (Extended Release);
28:16.04.16 – SELECTIVE SEROTONIN AND NOREPINEPHRINE-REUPTAKE INHIBITORS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78961
SANDOZ VENLAFAXINE XR;
02310325;
venlafaxine (venlafaxine hydrochloride) 75 mg;
2008-05-09;
Oral;
Capsule (Extended Release);
28:16.04.16 – SELECTIVE SEROTONIN AND NOREPINEPHRINE-REUPTAKE INHIBITORS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79597
APO-VENLAFAXINE XR;
02331691;
venlafaxine (venlafaxine hydrochloride) 75 mg;
2013-04-16;
Oral;
Capsule (Extended Release);
28:16.04.16 – SELECTIVE SEROTONIN AND NOREPINEPHRINE-REUPTAKE INHIBITORS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81739
VENLAFAXINE XR;
02339250;
venlafaxine (venlafaxine hydrochloride) 75 mg;
2010-02-03;
Oral;
Capsule (Extended Release);
28:16.04.16 – SELECTIVE SEROTONIN AND NOREPINEPHRINE-REUPTAKE INHIBITORS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82486
VENLAFAXINE XR;
02354721;
venlafaxine (venlafaxine hydrochloride) 75 mg;
2010-07-27;
Oral;
Capsule (Extended Release);
28:16.04.16 – SELECTIVE SEROTONIN AND NOREPINEPHRINE-REUPTAKE INHIBITORS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83989
TARO-VENLAFAXINE XR;
02380080;
venlafaxine (venlafaxine hydrochloride) 75 mg;
2012-02-17;
Oral;
Capsule (Extended Release);
28:16.04.16 – SELECTIVE SEROTONIN AND NOREPINEPHRINE-REUPTAKE INHIBITORS;
Prescription;
SUN PHARMA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86592
VENLAFAXINE XR;
02385937;
venlafaxine (venlafaxine hydrochloride) 75 mg;
2012-06-10;
Oral;
Capsule (Extended Release);
28:16.04.16 – SELECTIVE SEROTONIN AND NOREPINEPHRINE-REUPTAKE INHIBITORS;
Prescription;
SIVEM PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87154
AURO-VENLAFAXINE XR;
02452847;
venlafaxine (venlafaxine hydrochloride) 75 mg;
2016-03-14;
Oral;
Capsule (Extended Release);
28:16.04.16 – SELECTIVE SEROTONIN AND NOREPINEPHRINE-REUPTAKE INHIBITORS;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93925
M-VENLAFAXINE XR;
02471299;
venlafaxine (venlafaxine hydrochloride) 75 mg;
2018-03-07;
Oral;
Capsule (Extended Release);
28:16.04.16 – SELECTIVE SEROTONIN AND NOREPINEPHRINE-REUPTAKE INHIBITORS;
Prescription;
MANTRA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96040
VENLAFAXINE XR;
02489686;
venlafaxine (venlafaxine hydrochloride) 75 mg;
2019-08-07;
Oral;
Capsule (Extended Release);
28:16.04.16 – SELECTIVE SEROTONIN AND NOREPINEPHRINE-REUPTAKE INHIBITORS;
Prescription;
LABORATOIRE RIVA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97975
APO-VERAP TABLET 120MG;
00782491;
verapamil hydrochloride 120 mg;
1989-12-31;
Oral;
Tablet;
24:28.92 – MISCELLANEOUS CALCIUM-CHANNEL BLOCKING AGENTS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=9940
ISOPTIN SR;
01907123;
verapamil hydrochloride 120 mg;
1991-12-31;
Oral;
Tablet (Extended-Release);
24:28.92 – MISCELLANEOUS CALCIUM-CHANNEL BLOCKING AGENTS;
Prescription;
BGP PHARMA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=11534
MYLAN-VERAPAMIL SR;
02210347;
verapamil hydrochloride 120 mg;
1996-12-31;
Oral;
Tablet (Extended-Release);
24:28.92 – MISCELLANEOUS CALCIUM-CHANNEL BLOCKING AGENTS;
Prescription;
MYLAN PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=20018
MYLAN-VERAPAMIL;
02237922;
verapamil hydrochloride 120 mg;
1998-05-11;
Oral;
Tablet;
24:28.92 – MISCELLANEOUS CALCIUM-CHANNEL BLOCKING AGENTS;
Prescription;
MYLAN PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=61287
ISOPTIN SR;
01934317;
verapamil hydrochloride 180 mg;
1994-04-21;
Oral;
Tablet (Extended-Release);
24:28.92 – MISCELLANEOUS CALCIUM-CHANNEL BLOCKING AGENTS;
Prescription;
BGP PHARMA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=15585
MYLAN-VERAPAMIL SR;
02450488;
verapamil hydrochloride 180 mg;
2016-06-29;
Oral;
Tablet (Extended-Release);
24:28.92 – MISCELLANEOUS CALCIUM-CHANNEL BLOCKING AGENTS;
Prescription;
MYLAN PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93662
VERAPAMIL HYDROCHLORIDE INJECTION USP;
00839299;
verapamil hydrochloride 2.5 mg / ml;
1994-12-31;
Intravenous;
Solution;
24:28.92 – MISCELLANEOUS CALCIUM-CHANNEL BLOCKING AGENTS;
Prescription;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=17234
VERAPAMIL HYDROCHLORIDE INJECTION USP;
02166739;
verapamil hydrochloride 2.5 mg / ml;
1995-12-31;
Intravenous;
Liquid;
24:28.92 – MISCELLANEOUS CALCIUM-CHANNEL BLOCKING AGENTS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18614
ISOPTIN SR;
00742554;
verapamil hydrochloride 240 mg;
1988-12-31;
Oral;
Tablet (Extended-Release);
24:28.92 – MISCELLANEOUS CALCIUM-CHANNEL BLOCKING AGENTS;
Prescription;
BGP PHARMA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=9264
MYLAN-VERAPAMIL SR;
02450496;
verapamil hydrochloride 240 mg;
2016-09-01;
Oral;
Tablet (Extended-Release);
24:28.92 – MISCELLANEOUS CALCIUM-CHANNEL BLOCKING AGENTS;
Prescription;
MYLAN PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93663
APO-VERAP TAB 80MG;
00782483;
verapamil hydrochloride 80 mg;
1989-12-31;
Oral;
Tablet;
24:28.92 – MISCELLANEOUS CALCIUM-CHANNEL BLOCKING AGENTS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10034
MYLAN-VERAPAMIL;
02237921;
verapamil hydrochloride 80 mg;
1998-05-25;
Oral;
Tablet;
24:28.92 – MISCELLANEOUS CALCIUM-CHANNEL BLOCKING AGENTS;
Prescription;
MYLAN PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=61286
BRINAVESS;
02462400;
vernakalant hydrochloride 20 mg / ml;
2018-01-23;
Intravenous;
Solution;
24:04.04.20 – CLASS III ANTIARRYTHMICS;
Prescription;
CIPHER PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95016
VISUDYNE;
02242367;
verteporfin 15 mg / vial;
2000-06-26;
Intravenous;
Powder For Solution;
52:92.00 – EENT DRUGS, MISCELLANEOUS;
Prescription;
CHEPLAPHARM ARZNEIMITTEL GMBH
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66078
SABRIL;
02065819;
vigabatrin 500 mg;
1994-12-31;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
LUNDBECK PHARMACEUTICALS LLC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=15532
SABRIL;
02068036;
vigabatrin 500 mg / sachet;
1997-08-20;
Oral;
Powder For Solution;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
LUNDBECK PHARMACEUTICALS LLC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43682
VIIBRYD;
02443724;
vilazodone hydrochloride 10 mg;
2018-01-31;
Oral;
Tablet;
28:16.04.24 – SEROTONIN MODULATORS;
Prescription;
ALLERGAN INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92846
VIIBRYD;
02443732;
vilazodone hydrochloride 20 mg;
2018-01-31;
Oral;
Tablet;
28:16.04.24 – SEROTONIN MODULATORS;
Prescription;
ALLERGAN INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92847
VIIBRYD;
02443740;
vilazodone hydrochloride 40 mg;
2018-01-31;
Oral;
Tablet;
28:16.04.24 – SEROTONIN MODULATORS;
Prescription;
ALLERGAN INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92848
VINBLASTINE SULFATE INJECTION;
02183056;
vinblastine sulfate 1 mg / ml;
1998-04-14;
Intravenous;
Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=44270
VINBLASTINE SULPHATE INJECTION;
02401460;
vinblastine sulfate 1 mg / ml;
2013-02-08;
Intravenous;
Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88636
VINCRISTINE SULFATE INJECTION;
02143305;
vincristine sulfate 1 mg / ml;
1995-12-31;
Intravenous;
Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19756
VINCRISTINE SULFATE INJECTION USP;
02183013;
vincristine sulfate 1 mg / ml;
1997-08-07;
Intravenous;
Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=44267
VINORELBINE TARTRATE FOR INJECTION;
02257777;
vinorelbine (vinorelbine tartrate) 10 mg / ml;
2004-12-22;
Intravenous;
Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74301
VINORELBINE TARTRATE FOR INJECTION;
02271214;
vinorelbine (vinorelbine tartrate) 10 mg / ml;
2007-05-09;
Intravenous;
Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75669
VINORELBINE INJECTION, USP;
02431130;
vinorelbine (vinorelbine tartrate) 10 mg / ml;
2017-08-01;
Intravenous;
Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
GENERIC MEDICAL PARTNERS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91557
ERIVEDGE;
02409267;
vismodegib 150 mg;
2013-08-09;
Oral;
Capsule;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
HOFFMANN-LA ROCHE LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89398
VITAMIN B12;
00521515;
vitamin b12 1000 mcg / ml;
1978-12-31;
Intramuscular , Subcutaneous;
Solution;
88:08.00 – VITAMIN B COMPLEX;
Ethical;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=4432
CYANOCOBALAMIN INJECTION USP;
01987003;
vitamin b12 1000 mcg / ml;
1992-12-31;
Intramuscular , Subcutaneous;
Solution;
88:08.00 – VITAMIN B COMPLEX;
Ethical;
STERIMAX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13324
CYANOCOBALAMIN INJECTION, USP;
02413795;
vitamin b12 1000 mcg / ml;
2014-07-25;
Intramuscular , Subcutaneous;
Solution;
88:08.00 – VITAMIN B COMPLEX;
Ethical;
STRIDES PHARMA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89842
CYANOCOBALAMIN INJECTION USP;
02463393;
vitamin b12 1000 mcg / ml;
2018-01-16;
Intramuscular , Subcutaneous;
Liquid;
88:08.00 – VITAMIN B COMPLEX;
Ethical;
TELIGENT OU
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95136
SANDOZ D-FORTE;
02237450;
vitamin d2 50000 unit;
1999-12-30;
Oral;
Capsule;
88:16.00 – VITAMIN D;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=60784
D-FORTE;
02465426;
vitamin d2 50000 unit;
2017-08-16;
Oral;
Capsule;
88:16.00 – VITAMIN D;
Prescription;
EURO-PHARM INTERNATIONAL CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95360
SANDOZ D 10 000;
02253178;
vitamin d3 (cholecalciferol) 10000 unit;
2005-04-06;
Oral;
Capsule;
88:16.00 – VITAMIN D;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73813
EURO D 10 000;
02464594;
vitamin d3 (cholecalciferol) 10000 unit;
2017-08-16;
Oral;
Capsule;
88:16.00 – VITAMIN D;
Prescription;
EURO-PHARM INTERNATIONAL CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95272
D-TABS 10000UNIT;
00821772;
vitamin d3 10000 unit;
1992-12-31;
Oral;
Tablet;
88:16.00 – VITAMIN D;
Prescription;
LABORATOIRE RIVA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=12345
JAMP-VITAMIN D;
02379007;
vitamin d3 10000 unit;
2012-05-02;
Oral;
Tablet;
88:16.00 – VITAMIN D;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86482
VIDEXTRA;
02417685;
vitamin d3 10000 unit;
2014-03-20;
Oral;
Tablet;
88:16.00 – VITAMIN D;
Prescription;
ORIMED PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90230
VITAMINE D 10 000;
02417995;
vitamin d3 10000 unit;
2014-01-16;
Oral;
Tablet;
88:16.00 – VITAMIN D;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90259
JAMP-VITAMIN D;
02449099;
vitamin d3 10000 unit;
2015-11-20;
Oral;
Capsule;
88:16.00 – VITAMIN D;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93491
AG-VITAMIN D;
02498944;
vitamin d3 10000 unit;
2020-12-21;
Oral;
Tablet;
88:16.00 – VITAMIN D;
Prescription;
ANGITA PHARMA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98866
LUXA-D;
02442256;
vitamin d3 2000 unit;
2015-07-31;
Oral;
Capsule;
88:16.00 – VITAMIN D;
Prescription;
ORIMED PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92661
EURO-D 50000 IU;
02371502;
vitamin d3 50000 unit;
2011-08-09;
Oral;
Capsule;
88:16.00 – VITAMIN D;
Prescription;
EURO-PHARM INTERNATIONAL CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85666
JAMP-VITAMIN D;
02449110;
vitamin d3 50000 unit;
2016-06-23;
Oral;
Capsule;
88:16.00 – VITAMIN D;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93493
VITAMIN K1 INJ 10MG/ML USP;
00804312;
vitamin k1 10 mg / ml;
1989-12-31;
Intramuscular , Intravenous , Subcutaneous;
Emulsion;
88:24.00 – VITAMIN K ACTIVITY;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=9994
VITAMIN K1 INJ 1MG/0.5ML USP;
00781878;
vitamin k1 2 mg / ml;
1989-12-31;
Intramuscular , Intravenous , Subcutaneous;
Emulsion;
88:24.00 – VITAMIN K ACTIVITY;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=9993
VFEND;
02256479;
voriconazole 200 mg;
2004-11-12;
Oral;
Tablet;
08:14.08 – AZOLES;
Prescription;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74171
TEVA-VORICONAZOLE;
02396874;
voriconazole 200 mg;
2014-03-31;
Oral;
Tablet;
08:14.08 – AZOLES;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88189
SANDOZ VORICONAZOLE;
02399253;
voriconazole 200 mg;
2014-04-02;
Oral;
Tablet;
08:14.08 – AZOLES;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88416
VFEND FOR INJECTION;
02256487;
voriconazole 200 mg / vial;
2004-11-12;
Intravenous;
Powder For Solution;
08:14.08 – AZOLES;
Prescription;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74172
VORICONAZOLE FOR INJECTION;
02381966;
voriconazole 200 mg / vial;
2014-04-30;
Intravenous;
Powder For Solution;
08:14.08 – AZOLES;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86783
VORICONAZOLE FOR INJECTION;
02477696;
voriconazole 200 mg / vial;
2019-07-23;
Intravenous;
Powder For Solution;
08:14.08 – AZOLES;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96863
VFEND;
02279991;
voriconazole 200 mg / 5 ml;
2008-07-17;
Oral;
Powder For Suspension;
08:14.08 – AZOLES;
Prescription;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76561
VFEND;
02256460;
voriconazole 50 mg;
2004-11-12;
Oral;
Tablet;
08:14.08 – AZOLES;
Prescription;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74170
TEVA-VORICONAZOLE;
02396866;
voriconazole 50 mg;
2014-03-31;
Oral;
Tablet;
08:14.08 – AZOLES;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88187
SANDOZ VORICONAZOLE;
02399245;
voriconazole 50 mg;
2014-04-02;
Oral;
Tablet;
08:14.08 – AZOLES;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88415
ZOLINZA;
02327619;
vorinostat 100 mg;
2009-06-29;
Oral;
Capsule;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
MERCK CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81300
TRINTELLIX;
02432927;
vortioxetine (vortioxetine hydrobromide) 10 mg;
2014-10-28;
Oral;
Tablet;
28:16.04.24 – SEROTONIN MODULATORS;
Prescription;
LUNDBECK CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91733
TRINTELLIX;
02432943;
vortioxetine (vortioxetine hydrobromide) 20 mg;
2014-10-28;
Oral;
Tablet;
28:16.04.24 – SEROTONIN MODULATORS;
Prescription;
LUNDBECK CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91735
TRINTELLIX;
02432919;
vortioxetine (vortioxetine hydrobromide) 5 mg;
2014-10-28;
Oral;
Tablet;
28:16.04.24 – SEROTONIN MODULATORS;
Prescription;
LUNDBECK CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91732
TARO-WARFARIN;
02242680;
warfarin sodium 1 mg;
2000-08-09;
Oral;
Tablet;
20:12.04.08 – COUMARIN DERIVATIVES;
Prescription;
TARO PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66470
APO-WARFARIN;
02242924;
warfarin sodium 1 mg;
2000-10-16;
Oral;
Tablet;
20:12.04.08 – COUMARIN DERIVATIVES;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66762
TARO-WARFARIN;
02242687;
warfarin sodium 10 mg;
2000-08-09;
Oral;
Tablet;
20:12.04.08 – COUMARIN DERIVATIVES;
Prescription;
TARO PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66477
APO-WARFARIN;
02242929;
warfarin sodium 10 mg;
2000-10-16;
Oral;
Tablet;
20:12.04.08 – COUMARIN DERIVATIVES;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66767
TARO-WARFARIN;
02242681;
warfarin sodium 2 mg;
2000-08-09;
Oral;
Tablet;
20:12.04.08 – COUMARIN DERIVATIVES;
Prescription;
TARO PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66471
APO-WARFARIN;
02242925;
warfarin sodium 2 mg;
2000-10-16;
Oral;
Tablet;
20:12.04.08 – COUMARIN DERIVATIVES;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66763
TARO-WARFARIN;
02242682;
warfarin sodium 2.5 mg;
2000-08-09;
Oral;
Tablet;
20:12.04.08 – COUMARIN DERIVATIVES;
Prescription;
TARO PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66472
APO-WARFARIN;
02242926;
warfarin sodium 2.5 mg;
2000-10-16;
Oral;
Tablet;
20:12.04.08 – COUMARIN DERIVATIVES;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66764
TARO-WARFARIN;
02242683;
warfarin sodium 3 mg;
2000-08-09;
Oral;
Tablet;
20:12.04.08 – COUMARIN DERIVATIVES;
Prescription;
TARO PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66473
APO-WARFARIN;
02245618;
warfarin sodium 3 mg;
2002-04-23;
Oral;
Tablet;
20:12.04.08 – COUMARIN DERIVATIVES;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=69718
TARO-WARFARIN;
02242684;
warfarin sodium 4 mg;
2000-08-09;
Oral;
Tablet;
20:12.04.08 – COUMARIN DERIVATIVES;
Prescription;
TARO PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66474
APO-WARFARIN;
02242927;
warfarin sodium 4 mg;
2000-10-16;
Oral;
Tablet;
20:12.04.08 – COUMARIN DERIVATIVES;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66765
TARO-WARFARIN;
02242685;
warfarin sodium 5 mg;
2000-08-09;
Oral;
Tablet;
20:12.04.08 – COUMARIN DERIVATIVES;
Prescription;
TARO PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66475
APO-WARFARIN;
02242928;
warfarin sodium 5 mg;
2000-10-16;
Oral;
Tablet;
20:12.04.08 – COUMARIN DERIVATIVES;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66766
TARO-WARFARIN;
02242686;
warfarin sodium 6 mg;
2000-08-09;
Oral;
Tablet;
20:12.04.08 – COUMARIN DERIVATIVES;
Prescription;
TARO PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66476
TARO-WARFARIN;
02242697;
warfarin sodium 7.5 mg;
2000-08-09;
Oral;
Tablet;
20:12.04.08 – COUMARIN DERIVATIVES;
Prescription;
TARO PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66492
HYMENOPTERA VENOM PRODUCT-WASP VENOM PROTEIN (550 MCG);
02220091;
wasp venom protein 550 mcg / vial;
1997-12-16;
Subcutaneous;
Powder For Solution;
92:05.00* – ALLERGENIC EXTRACTS;
Schedule D;
JUBILANT HOLLISTERSTIER LLC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43272
STERILE WATER FOR INJECTION USP;
02276097;
water 1 ml;
2009-08-31;
Intravascular;
Liquid;
40:50.00* – DILUENTS;
Otc;
MERCK CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76176
STERILE WATER FOR IRRIGATION USP;
00038229;
water 100 %;
1964-12-31;
Intraperitoneal , Irrigation , Topical;
Liquid;
40:36.00 – IRRIGATING SOLUTIONS;
Ethical;
ICU MEDICAL CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=229
STERILE WATER FOR INJECTION USP;
00038245;
water 100 %;
1951-12-31;
Intravenous;
Solution;
40:50.00* – DILUENTS;
Ethical;
ICU MEDICAL CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=1734
STERILE WATER FOR INJECTION USP;
00402257;
water 100 %;
1978-12-31;
Intramuscular , Intravenous , Subcutaneous;
Liquid;
40:50.00* – DILUENTS;
Ethical;
OMEGA LABORATORIES LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=3383
STERILE WATER FOR IRRIGATION USP;
00498785;
water 100 %;
1980-12-31;
Intraperitoneal , Irrigation;
Liquid;
40:36.00 – IRRIGATING SOLUTIONS;
Ethical;
ICU MEDICAL CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=3822
STERILE WATER FOR IRRIGATION, USP;
00799998;
water 100 %;
1989-12-31;
Irrigation;
Liquid;
40:36.00 – IRRIGATING SOLUTIONS;
Ethical;
BAXTER CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=9831
STERILE WATER FOR INJECTION USP;
01927930;
water 100 %;
1992-12-31;
Intravenous;
Liquid;
40:50.00* – DILUENTS;
Ethical;
B. BRAUN MEDICAL INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13509
STERILE WATER FOR INJECTION, USP;
02014882;
water 100 %;
1994-12-31;
Intravenous;
Liquid;
40:50.00* – DILUENTS;
Ethical;
BAXTER CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=15867
BACTERIOSTATIC WATER FOR INJECTION USP;
02131536;
water 100 %;
1994-12-31;
Intramuscular , Intravenous , Subcutaneous;
Liquid;
40:50.00* – DILUENTS;
Ethical;
OMEGA LABORATORIES LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=17402
STERILE WATER FOR INJECTION USP;
02214733;
water 100 %;
1996-12-31;
Intravenous;
Liquid;
40:50.00* – DILUENTS;
Ethical;
BAXTER HEALTHCARE CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19812
STERILE WATER FOR INJECTION USP;
02142546;
water 100 %;
1994-12-15;
Intramuscular , Intraperitoneal , Intravenous , Subcutaneous;
Solution;
40:50.00* – DILUENTS;
Ethical;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=31491
STERILE WATER FOR INJECTION USP;
02299186;
water 100 %;
2008-06-06;
Intramuscular , Intravenous , Subcutaneous;
Solution;
40:50.00* – DILUENTS;
Ethical;
TELIGENT OU
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78457
STERILE DILUENT FOR MERCK SHARP & DOHME CORP. LIVE ATTENUATED VIRUS VACCINES;
02380811;
water 100 %;
2012-12-19;
Parenteral (Unspecified);
Liquid;
40:50.00* – DILUENTS;
Ethical;
MERCK CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86658
STERILISED WATER FOR INJECTIONS;
02470861;
water 100 % / v/v;
2018-11-01;
Intramuscular , Intravenous , Subcutaneous;
Solution;
40:50.00* – DILUENTS;
Ethical;
CELLCHEM PHARMACEUTICALS INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95977
BACTERIOSTATIC WATER FOR INJECTION USP;
00038202;
water 30 ml / 30 ml;
1952-12-31;
Intramuscular , Intravenous , Subcutaneous;
Solution;
40:50.00* – DILUENTS;
Ethical;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=117
BACTERIOSTATIC WATER FOR INJECTION USP-PRE-FILLED SYRINGE;
02215721;
water 99.1 %;
1996-07-30;
Intracavernosal;
Liquid;
40:50.00* – DILUENTS;
Ethical;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=20354
HYMENOPTERA VENOM PRODUCT-WHITE-FACED HORNET VENOM PROTEIN (550 MCG);
02220105;
white faced hornet venom protein 550 mcg / vial;
1997-12-06;
Subcutaneous;
Powder For Solution;
92:05.00* – ALLERGENIC EXTRACTS;
Schedule D;
JUBILANT HOLLISTERSTIER LLC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43273
WHITE PETROLEUM JELLY USP OINTMENT;
00741515;
white petrolatum 100 %;
1988-12-31;
Topical;
Ointment;
84:24.12 – BASIC OINTMENTS AND PROTECTANTS;
Otc;
CANADIAN CUSTOM PACKAGING COMPANY
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=9587
WHITE PETROLEUM JELLY 100% BP;
00745790;
white petrolatum 100 %;
1989-12-31;
Topical;
Ointment;
84:24.12 – BASIC OINTMENTS AND PROTECTANTS;
Otc;
H.J. SUTTON INDUSTRIES LTD.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10314
PETROLATUM BLANC ONT USP;
00790516;
white petrolatum 100 %;
1951-12-31;
Topical;
Ointment;
84:24.12 – BASIC OINTMENTS AND PROTECTANTS;
Otc;
LABORATOIRE ATLAS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=41756
WHITE PETROLEUM JELLY U.S.P.;
02239087;
white petrolatum 100 %;
2000-04-28;
Topical;
Ointment;
84:24.12 – BASIC OINTMENTS AND PROTECTANTS;
Otc;
LABORATOIRES DELON (1990) INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=62542
MEDI-WHITE PETROLEUM JELLY;
02267691;
white petrolatum 100 %;
2006-06-06;
Topical;
Ointment;
84:24.12 – BASIC OINTMENTS AND PROTECTANTS;
Otc;
MEDISCA PHARMACEUTIQUE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75311
COMPLIMENTS WHITE PETROLEUM JELLY;
02305178;
white petrolatum 100 %;
2009-05-31;
Topical;
Ointment;
84:24.12 – BASIC OINTMENTS AND PROTECTANTS;
Otc;
GEMINI PACKAGING LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79066
PETROLEUM JELLY;
02408821;
white petrolatum 100 %;
2014-03-06;
Topical;
Ointment;
84:24.12 – BASIC OINTMENTS AND PROTECTANTS;
Otc;
CRLS
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89358
DIABETICS’ DRY SKIN RELIEF FOOT CREAM;
02418347;
white petrolatum 30 % / w/w;
2015-02-23;
Topical;
Cream;
84:24.12 – BASIC OINTMENTS AND PROTECTANTS;
Otc;
SANOFI CONSUMER HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90292
CRITIC-AID CLEAR;
02277778;
white petrolatum 71.5 % / w/w;
2006-10-13;
Topical;
Ointment;
84:24.12 – BASIC OINTMENTS AND PROTECTANTS;
Otc;
COLOPLAST A/S
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76338
COLD & ALLERGY RELIEF WITH MOISTURIZERS;
02246023;
xylometazoline hydrochloride 0.1 %;
2003-02-01;
Nasal;
Spray;
52:32.00 – VASOCONSTRICTORS;
Otc;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=70149
BALMINIL DECONGEST;
02300257;
xylometazoline hydrochloride 0.1 %;
2007-12-14;
Nasal;
Solution;
52:32.00 – VASOCONSTRICTORS;
Otc;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78557
OTRIVIN MEDICATED COMPLETE NASAL CARE;
02331403;
xylometazoline hydrochloride 0.1 %;
2010-08-02;
Nasal;
Spray;
52:32.00 – VASOCONSTRICTORS;
Otc;
GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81710
OTRIVIN MEDICATED COLD & ALLERGY RELIEF WITH MOISTURIZERS;
02208903;
xylometazoline hydrochloride 0.1 % / w/v;
1996-10-15;
Nasal;
Spray;
52:32.00 – VASOCONSTRICTORS;
Otc;
GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=36767
OTRIVIN MEDICATED COLD & ALLERGY RELIEF;
00653330;
xylometazoline hydrochloride 0.1 % / w/v;
1961-12-31;
Nasal;
Spray;
52:32.00 – VASOCONSTRICTORS;
Otc;
GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=41684
DECONGEST NASAL;
02300265;
xylometazoline hydrochloride 0.1 % / w/v;
2007-12-20;
Nasal;
Solution;
52:32.00 – VASOCONSTRICTORS;
Otc;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78558
COLD AND ALLERGY DECONGESTANT NASAL SPRAY;
02351927;
xylometazoline hydrochloride 0.1 % / w/v;
2011-10-01;
Nasal;
Spray;
52:32.00 – VASOCONSTRICTORS;
Otc;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83716
DECONGESTANT NASAL SPRAY;
02452812;
xylometazoline hydrochloride 0.1 % / w/v;
2017-03-07;
Nasal;
Spray;
52:32.00 – VASOCONSTRICTORS;
Otc;
CRLS
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93922
NASAL DECONGESTANT SPRAY WITH MOISTURIZERS;
02452863;
xylometazoline hydrochloride 0.1 % / w/v;
2017-02-27;
Nasal;
Spray;
52:32.00 – VASOCONSTRICTORS;
Otc;
CRLS
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93927
YF-VAX;
00428833;
yellow fever vaccine 109648 pfu / 0.5 ml;
1978-12-31;
Subcutaneous;
Powder For Solution;
80:12.00 – VACCINES;
Schedule D;
SANOFI PASTEUR LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=2964
HYMENOPTERA VENOM PRODUCTS-YELLOW HORNET VENOM PROTEIN (550 MCG);
02220083;
yellow hornet venom protein 550 mcg / vial;
1997-12-16;
Subcutaneous;
Powder For Solution;
92:05.00* – ALLERGENIC EXTRACTS;
Schedule D;
JUBILANT HOLLISTERSTIER LLC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43271
HYMENOPTERA VENOM PRODUCT – YELLOW JACKET VENOM PROTEIN (550 MCG);
02220113;
yellow jacket venom protein 550 mcg / vial;
1997-12-16;
Subcutaneous;
Powder For Solution;
92:05.00* – ALLERGENIC EXTRACTS;
Schedule D;
JUBILANT HOLLISTERSTIER LLC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43274
YOHIMBINE TAB 5.4MG;
01901885;
yohimbine hydrochloride 5.4 mg;
1991-12-31;
Oral;
Tablet;
92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
Prescription;
ODAN LABORATORIES LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=12016
RELENZA;
02240863;
zanamivir 5 mg / act;
1999-12-07;
Inhalation , Oral;
Powder;
08:18.28 – NEURAMINIDASE INHIBITORS;
Prescription;
GLAXOSMITHKLINE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=64454
BRUKINSA;
02512963;
zanubrutinib 80 mg;
2021-03-30;
Oral;
Capsule;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
BEIGENE SWITZERLAND GMBH
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=100221
RETROVIR (AZT);
01902644;
zidovudine 10 mg / ml;
1991-12-31;
Intravenous;
Liquid;
08:18.08.20 – NUCLEOSIDE AND NUCLEOTIDE REVERSE TRANSCRIPTASE INHIBITORS;
Prescription;
VIIV HEALTHCARE ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=11342
RETROVIR (AZT);
01902660;
zidovudine 100 mg;
1990-12-31;
Oral;
Capsule;
08:18.08.20 – NUCLEOSIDE AND NUCLEOTIDE REVERSE TRANSCRIPTASE INHIBITORS;
Prescription;
VIIV HEALTHCARE ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=11300
APO-ZIDOVUDINE;
01946323;
zidovudine 100 mg;
1992-12-31;
Oral;
Capsule;
08:18.08.20 – NUCLEOSIDE AND NUCLEOTIDE REVERSE TRANSCRIPTASE INHIBITORS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=12839
RETROVIR (AZT);
01902652;
zidovudine 50 mg / 5 ml;
1991-12-31;
Oral;
Syrup;
08:18.08.20 – NUCLEOSIDE AND NUCLEOTIDE REVERSE TRANSCRIPTASE INHIBITORS;
Prescription;
VIIV HEALTHCARE ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=11942
MICRO ZN;
00787019;
zinc (zinc sulfate) 1 mg / ml;
1992-12-31;
Intravenous;
Solution;
40:12.00 – REPLACEMENT PREPARATIONS;
Ethical;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13451
MICRO ZN;
00787000;
zinc (zinc sulfate) 5 mg / ml;
1992-12-31;
Intravenous;
Solution;
40:12.00 – REPLACEMENT PREPARATIONS;
Ethical;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13416
ZELDOX;
02298597;
ziprasidone (ziprasidone hydrochloride monohydrate) 20 mg;
2008-01-04;
Oral;
Capsule;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
UPJOHN CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78389
AURO-ZIPRASIDONE;
02449544;
ziprasidone (ziprasidone hydrochloride monohydrate) 20 mg;
2018-03-19;
Oral;
Capsule;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93537
ZELDOX;
02298600;
ziprasidone (ziprasidone hydrochloride monohydrate) 40 mg;
2008-01-04;
Oral;
Capsule;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
UPJOHN CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78392
AURO-ZIPRASIDONE;
02449552;
ziprasidone (ziprasidone hydrochloride monohydrate) 40 mg;
2018-03-19;
Oral;
Capsule;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93538
ZELDOX;
02298619;
ziprasidone (ziprasidone hydrochloride monohydrate) 60 mg;
2008-01-04;
Oral;
Capsule;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
UPJOHN CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78393
AURO-ZIPRASIDONE;
02449560;
ziprasidone (ziprasidone hydrochloride monohydrate) 60 mg;
2018-03-19;
Oral;
Capsule;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93539
ZELDOX;
02298627;
ziprasidone (ziprasidone hydrochloride monohydrate) 80 mg;
2008-01-04;
Oral;
Capsule;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
UPJOHN CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78394
AURO-ZIPRASIDONE;
02449579;
ziprasidone (ziprasidone hydrochloride monohydrate) 80 mg;
2018-03-19;
Oral;
Capsule;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93540
ZOMETA CONCENTRATE;
02248296;
zoledronic acid (zoledronic acid monohydrate) 4 mg / 5 ml;
2004-10-14;
Intravenous;
Solution;
92:24.00 – BONE RESORPTION INHIBITORS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72636
ZOLEDRONIC ACID – Z;
02401606;
zoledronic acid (zoledronic acid monohydrate) 4 mg / 5 ml;
2014-01-15;
Intravenous;
Solution;
92:24.00 – BONE RESORPTION INHIBITORS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88649
ZOLEDRONIC ACID FOR INJECTION;
02407639;
zoledronic acid (zoledronic acid monohydrate) 4 mg / 5 ml;
2014-02-26;
Intravenous;
Solution;
92:24.00 – BONE RESORPTION INHIBITORS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89236
TARO-ZOLEDRONIC ACID CONCENTRATE;
02415186;
zoledronic acid (zoledronic acid monohydrate) 4 mg / 5 ml;
2014-02-26;
Intravenous;
Solution;
92:24.00 – BONE RESORPTION INHIBITORS;
Prescription;
TARO PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89980
ZOLEDRONIC ACID FOR INJECTION CONCENTRATE;
02422425;
zoledronic acid (zoledronic acid monohydrate) 4 mg / 5 ml;
2014-05-28;
Intravenous;
Solution;
92:24.00 – BONE RESORPTION INHIBITORS;
Prescription;
DR REDDY’S LABORATORIES LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90711
ZOLEDRONIC ACID FOR INJECTION;
02434458;
zoledronic acid (zoledronic acid monohydrate) 4 mg / 5 ml;
2016-02-10;
Intravenous;
Solution;
92:24.00 – BONE RESORPTION INHIBITORS;
Prescription;
FRESENIUS KABI CANADA LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91878
ZOLEDRONIC ACID FOR INJECTION;
02444739;
zoledronic acid (zoledronic acid monohydrate) 4 mg / 5 ml;
2016-04-27;
Intravenous;
Solution;
92:24.00 – BONE RESORPTION INHIBITORS;
Prescription;
JUNO PHARMACEUTICALS CORP.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92989
ZOLEDRONIC ACID FOR INJECTION;
02472805;
zoledronic acid (zoledronic acid monohydrate) 4 mg / 5 ml;
2019-01-29;
Intravenous;
Solution;
92:24.00 – BONE RESORPTION INHIBITORS;
Prescription;
MARCAN PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96212
JAMP-ZOLEDRONIC ACID;
02482525;
zoledronic acid (zoledronic acid monohydrate) 4 mg / 5 ml;
2020-01-20;
Intravenous;
Solution;
92:24.00 – BONE RESORPTION INHIBITORS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97282
ACLASTA;
02269198;
zoledronic acid (zoledronic acid monohydrate) 5 mg / 100 ml;
2005-08-22;
Intravenous;
Solution;
92:24.00 – BONE RESORPTION INHIBITORS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75458
TARO-ZOLEDRONIC ACID;
02415100;
zoledronic acid (zoledronic acid monohydrate) 5 mg / 100 ml;
2014-04-02;
Intravenous;
Solution;
92:24.00 – BONE RESORPTION INHIBITORS;
Prescription;
TARO PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89972
ZOLEDRONIC ACID INJECTION;
02422433;
zoledronic acid (zoledronic acid monohydrate) 5 mg / 100 ml;
2014-05-28;
Intravenous;
Solution;
92:24.00 – BONE RESORPTION INHIBITORS;
Prescription;
DR REDDY’S LABORATORIES LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90712
ZOMIG;
02238660;
zolmitriptan 2.5 mg;
1998-09-30;
Oral;
Tablet;
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
ASTRAZENECA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=62089
ZOMIG RAPIMELT;
02243045;
zolmitriptan 2.5 mg;
2001-03-05;
Oral;
Tablet (Orally Disintegrating);
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
ASTRAZENECA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66907
TEVA-ZOLMITRIPTAN;
02313960;
zolmitriptan 2.5 mg;
2011-06-07;
Oral;
Tablet;
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79948
PMS-ZOLMITRIPTAN ODT;
02324768;
zolmitriptan 2.5 mg;
2011-06-07;
Oral;
Tablet (Orally Disintegrating);
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81019
TEVA-ZOLMITRIPTAN OD;
02342545;
zolmitriptan 2.5 mg;
2011-06-07;
Oral;
Tablet (Orally Disintegrating);
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82803
SANDOZ ZOLMITRIPTAN;
02362988;
zolmitriptan 2.5 mg;
2011-06-07;
Oral;
Tablet;
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84796
SANDOZ ZOLMITRIPTAN ODT;
02362996;
zolmitriptan 2.5 mg;
2011-06-07;
Oral;
Tablet (Orally Disintegrating);
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84797
MINT-ZOLMITRIPTAN;
02419521;
zolmitriptan 2.5 mg;
2014-03-18;
Oral;
Tablet;
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
MINT PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90415
NAT-ZOLMITRIPTAN;
02421534;
zolmitriptan 2.5 mg;
2015-02-17;
Oral;
Tablet;
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
NATCO PHARMA (CANADA) INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90614
JAMP-ZOLMITRIPTAN;
02421623;
zolmitriptan 2.5 mg;
2014-03-13;
Oral;
Tablet;
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90627
JAMP-ZOLMITRIPTAN ODT;
02428237;
zolmitriptan 2.5 mg;
2014-09-14;
Oral;
Tablet (Orally Disintegrating);
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91271
ZOLMITRIPTAN;
02442655;
zolmitriptan 2.5 mg;
2015-10-14;
Oral;
Tablet;
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92700
ZOLMITRIPTAN ODT;
02442671;
zolmitriptan 2.5 mg;
2015-10-14;
Oral;
Tablet (Orally Disintegrating);
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92701
CCP-ZOLMITRIPTAN;
02458780;
zolmitriptan 2.5 mg;
2019-01-04;
Oral;
Tablet;
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
CELLCHEM PHARMACEUTICALS INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94593
JAMP ZOLMITRIPTAN;
02477106;
zolmitriptan 2.5 mg;
2020-02-21;
Oral;
Tablet;
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96780
AURO-ZOLMITRIPTAN;
02481030;
zolmitriptan 2.5 mg;
2020-03-18;
Oral;
Tablet;
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97162
NRA-ZOLMITRIPTAN;
02489392;
zolmitriptan 2.5 mg;
2020-07-06;
Oral;
Tablet;
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
NORA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97948
ZOMIG NASAL SPRAY;
02248992;
zolmitriptan 2.5 mg / act;
2004-12-23;
Nasal , Oral;
Spray;
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
ASTRAZENECA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73377
ZOMIG NASAL SPRAY;
02248993;
zolmitriptan 5.0 mg / act;
2004-12-23;
Nasal , Oral;
Spray;
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
ASTRAZENECA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73378
SUBLINOX;
02370433;
zolpidem tartrate 10 mg;
2011-11-29;
Sublingual;
Tablet (Orally Disintegrating);
28:24.92 – MISCELLANEOUS ANXIOLYTICS SEDATIVES AND HYPNOTICS;
Targeted (Cdsa Iv);
BAUSCH HEALTH, CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85559
APO-ZOLPIDEM ODT;
02434946;
zolpidem tartrate 10 mg;
2015-02-13;
Sublingual;
Tablet (Orally Disintegrating);
28:24.92 – MISCELLANEOUS ANXIOLYTICS SEDATIVES AND HYPNOTICS;
Targeted (Cdsa Iv);
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91923
PMS-ZOLPIDEM ODT;
02436183;
zolpidem tartrate 10 mg;
2016-12-13;
Sublingual;
Tablet (Orally Disintegrating);
28:24.92 – MISCELLANEOUS ANXIOLYTICS SEDATIVES AND HYPNOTICS;
Targeted (Cdsa Iv);
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92052
MINT-ZOLPIDEM ODT;
02472848;
zolpidem tartrate 10 mg;
2021-03-19;
Sublingual;
Tablet (Orally Disintegrating);
28:24.92 – MISCELLANEOUS ANXIOLYTICS SEDATIVES AND HYPNOTICS;
Targeted (Cdsa Iv);
MINT PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96217
SUBLINOX;
02391678;
zolpidem tartrate 5 mg;
2013-01-28;
Sublingual;
Tablet (Orally Disintegrating);
28:24.92 – MISCELLANEOUS ANXIOLYTICS SEDATIVES AND HYPNOTICS;
Targeted (Cdsa Iv);
BAUSCH HEALTH, CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87699
APO-ZOLPIDEM ODT;
02436159;
zolpidem tartrate 5 mg;
2015-02-13;
Sublingual;
Tablet (Orally Disintegrating);
28:24.92 – MISCELLANEOUS ANXIOLYTICS SEDATIVES AND HYPNOTICS;
Targeted (Cdsa Iv);
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92048
PMS-ZOLPIDEM ODT;
02436175;
zolpidem tartrate 5 mg;
2016-12-13;
Sublingual;
Tablet (Orally Disintegrating);
28:24.92 – MISCELLANEOUS ANXIOLYTICS SEDATIVES AND HYPNOTICS;
Targeted (Cdsa Iv);
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92051
MINT-ZOLPIDEM ODT;
02472821;
zolpidem tartrate 5 mg;
2021-03-19;
Sublingual;
Tablet (Orally Disintegrating);
28:24.92 – MISCELLANEOUS ANXIOLYTICS SEDATIVES AND HYPNOTICS;
Targeted (Cdsa Iv);
MINT PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96216
PMS-ZOPICLONE;
02458543;
zopiclone 3.75 mg;
2017-01-01;
Oral;
Tablet;
28:24.92 – MISCELLANEOUS ANXIOLYTICS SEDATIVES AND HYPNOTICS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94567
MAR-ZOPICLONE;
02468115;
zopiclone 3.75 mg;
2018-08-20;
Oral;
Tablet;
28:24.92 – MISCELLANEOUS ANXIOLYTICS SEDATIVES AND HYPNOTICS;
Prescription;
MARCAN PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95649
JAMP-ZOPICLONE TABLETS;
02468395;
zopiclone 3.75 mg;
2018-09-26;
Oral;
Tablet;
28:24.92 – MISCELLANEOUS ANXIOLYTICS SEDATIVES AND HYPNOTICS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95682
AG-ZOPICLONE;
02475820;
zopiclone 3.75 mg;
2018-12-21;
Oral;
Tablet;
28:24.92 – MISCELLANEOUS ANXIOLYTICS SEDATIVES AND HYPNOTICS;
Prescription;
ANGITA PHARMA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96652
M-ZOPICLONE;
02482800;
zopiclone 3.75 mg;
2019-02-06;
Oral;
Tablet;
28:24.92 – MISCELLANEOUS ANXIOLYTICS SEDATIVES AND HYPNOTICS;
Prescription;
MANTRA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97321
PMS-ZOPICLONE;
02243426;
zopiclone 5 mg;
2001-02-15;
Oral;
Tablet;
28:24.92 – MISCELLANEOUS ANXIOLYTICS SEDATIVES AND HYPNOTICS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=67334
APO-ZOPICLONE;
02245077;
zopiclone 5 mg;
2002-06-04;
Oral;
Tablet;
28:24.92 – MISCELLANEOUS ANXIOLYTICS SEDATIVES AND HYPNOTICS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=69081
TEVA-ZOPICLONE;
02246534;
zopiclone 5 mg;
2002-12-18;
Oral;
Tablet;
28:24.92 – MISCELLANEOUS ANXIOLYTICS SEDATIVES AND HYPNOTICS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=70717
TARO-ZOPICLONE;
02267918;
zopiclone 5 mg;
2005-07-05;
Oral;
Tablet;
28:24.92 – MISCELLANEOUS ANXIOLYTICS SEDATIVES AND HYPNOTICS;
Prescription;
SUN PHARMA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75330
ACT ZOPICLONE;
02271931;
zopiclone 5 mg;
2005-11-11;
Oral;
Tablet;
28:24.92 – MISCELLANEOUS ANXIOLYTICS SEDATIVES AND HYPNOTICS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75747
RIVA-ZOPICLONE;
02278030;
zopiclone 5 mg;
2006-10-10;
Oral;
Tablet;
28:24.92 – MISCELLANEOUS ANXIOLYTICS SEDATIVES AND HYPNOTICS;
Prescription;
LABORATOIRE RIVA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76362
PRO-ZOPICLONE;
02313065;
zopiclone 5 mg;
2008-07-09;
Oral;
Tablet;
28:24.92 – MISCELLANEOUS ANXIOLYTICS SEDATIVES AND HYPNOTICS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79861
ZOPICLONE;
02344122;
zopiclone 5 mg;
2010-02-25;
Oral;
Tablet;
28:24.92 – MISCELLANEOUS ANXIOLYTICS SEDATIVES AND HYPNOTICS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82952
ZOPICLONE;
02385821;
zopiclone 5 mg;
2012-06-11;
Oral;
Tablet;
28:24.92 – MISCELLANEOUS ANXIOLYTICS SEDATIVES AND HYPNOTICS;
Prescription;
SIVEM PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87144
MAR-ZOPICLONE;
02386771;
zopiclone 5 mg;
2013-04-17;
Oral;
Tablet;
28:24.92 – MISCELLANEOUS ANXIOLYTICS SEDATIVES AND HYPNOTICS;
Prescription;
MARCAN PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87237
MINT-ZOPICLONE;
02391716;
zopiclone 5 mg;
2012-10-10;
Oral;
Tablet;
28:24.92 – MISCELLANEOUS ANXIOLYTICS SEDATIVES AND HYPNOTICS;
Prescription;
MINT PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87703
JAMP-ZOPICLONE TABLETS;
02406969;
zopiclone 5 mg;
2014-01-08;
Oral;
Tablet;
28:24.92 – MISCELLANEOUS ANXIOLYTICS SEDATIVES AND HYPNOTICS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89162
PRIVA-ZOPICLONE;
02425874;
zopiclone 5 mg;
2015-06-03;
Oral;
Tablet;
28:24.92 – MISCELLANEOUS ANXIOLYTICS SEDATIVES AND HYPNOTICS;
Prescription;
PHARMAPAR INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91052
M-ZOPICLONE;
02467941;
zopiclone 5 mg;
2018-04-16;
Oral;
Tablet;
28:24.92 – MISCELLANEOUS ANXIOLYTICS SEDATIVES AND HYPNOTICS;
Prescription;
MANTRA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95631
ZOPICLONE;
02468492;
zopiclone 5 mg;
2018-08-07;
Oral;
Tablet;
28:24.92 – MISCELLANEOUS ANXIOLYTICS SEDATIVES AND HYPNOTICS;
Prescription;
ALTAMED PHARMA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95692
AG-ZOPICLONE;
02475839;
zopiclone 5 mg;
2018-07-25;
Oral;
Tablet;
28:24.92 – MISCELLANEOUS ANXIOLYTICS SEDATIVES AND HYPNOTICS;
Prescription;
ANGITA PHARMA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96656
NRA-ZOPICLONE;
02477378;
zopiclone 5 mg;
2018-08-30;
Oral;
Tablet;
28:24.92 – MISCELLANEOUS ANXIOLYTICS SEDATIVES AND HYPNOTICS;
Prescription;
NORA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96835
BIO-ZOPICLONE;
02481006;
zopiclone 5 mg;
2019-06-10;
Oral;
Tablet;
28:24.92 – MISCELLANEOUS ANXIOLYTICS SEDATIVES AND HYPNOTICS;
Prescription;
BIOMED PHARMA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97135
IMOVANE;
02216167;
zopiclone 5.0 mg;
1998-02-10;
Oral;
Tablet;
28:24.92 – MISCELLANEOUS ANXIOLYTICS SEDATIVES AND HYPNOTICS;
Prescription;
SANOFI-AVENTIS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43171
IMOVANE;
01926799;
zopiclone 7.5 mg;
1990-12-31;
Oral;
Tablet;
28:24.92 – MISCELLANEOUS ANXIOLYTICS SEDATIVES AND HYPNOTICS;
Prescription;
SANOFI-AVENTIS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=12426
SANDOZ ZOPICLONE TABLET;
02008203;
zopiclone 7.5 mg;
1996-12-31;
Oral;
Tablet;
28:24.92 – MISCELLANEOUS ANXIOLYTICS SEDATIVES AND HYPNOTICS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19922
APO-ZOPICLONE;
02218313;
zopiclone 7.5 mg;
1996-09-19;
Oral;
Tablet;
28:24.92 – MISCELLANEOUS ANXIOLYTICS SEDATIVES AND HYPNOTICS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43233
PMS-ZOPICLONE;
02240606;
zopiclone 7.5 mg;
1999-08-04;
Oral;
Tablet;
28:24.92 – MISCELLANEOUS ANXIOLYTICS SEDATIVES AND HYPNOTICS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=64177
TEVA-ZOPICLONE;
02242481;
zopiclone 7.5 mg;
2001-04-18;
Oral;
Tablet;
28:24.92 – MISCELLANEOUS ANXIOLYTICS SEDATIVES AND HYPNOTICS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66208
TARO-ZOPICLONE;
02267926;
zopiclone 7.5 mg;
2005-07-05;
Oral;
Tablet;
28:24.92 – MISCELLANEOUS ANXIOLYTICS SEDATIVES AND HYPNOTICS;
Prescription;
SUN PHARMA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75331
ACT ZOPICLONE;
02271958;
zopiclone 7.5 mg;
2005-11-11;
Oral;
Tablet;
28:24.92 – MISCELLANEOUS ANXIOLYTICS SEDATIVES AND HYPNOTICS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75748
RIVA-ZOPICLONE;
02278049;
zopiclone 7.5 mg;
2008-11-14;
Oral;
Tablet;
28:24.92 – MISCELLANEOUS ANXIOLYTICS SEDATIVES AND HYPNOTICS;
Prescription;
LABORATOIRE RIVA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76363
ZOPICLONE;
02282445;
zopiclone 7.5 mg;
2010-02-25;
Oral;
Tablet;
28:24.92 – MISCELLANEOUS ANXIOLYTICS SEDATIVES AND HYPNOTICS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76809
PRO-ZOPICLONE;
02313073;
zopiclone 7.5 mg;
2008-07-09;
Oral;
Tablet;
28:24.92 – MISCELLANEOUS ANXIOLYTICS SEDATIVES AND HYPNOTICS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79862
ZOPICLONE;
02385848;
zopiclone 7.5 mg;
2012-06-11;
Oral;
Tablet;
28:24.92 – MISCELLANEOUS ANXIOLYTICS SEDATIVES AND HYPNOTICS;
Prescription;
SIVEM PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87145
MAR-ZOPICLONE;
02386798;
zopiclone 7.5 mg;
2013-04-17;
Oral;
Tablet;
28:24.92 – MISCELLANEOUS ANXIOLYTICS SEDATIVES AND HYPNOTICS;
Prescription;
MARCAN PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87238
MINT-ZOPICLONE;
02391724;
zopiclone 7.5 mg;
2012-10-10;
Oral;
Tablet;
28:24.92 – MISCELLANEOUS ANXIOLYTICS SEDATIVES AND HYPNOTICS;
Prescription;
MINT PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87704
JAMP-ZOPICLONE TABLETS;
02406977;
zopiclone 7.5 mg;
2014-11-19;
Oral;
Tablet;
28:24.92 – MISCELLANEOUS ANXIOLYTICS SEDATIVES AND HYPNOTICS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89163
PRIVA-ZOPICLONE;
02425882;
zopiclone 7.5 mg;
2015-06-03;
Oral;
Tablet;
28:24.92 – MISCELLANEOUS ANXIOLYTICS SEDATIVES AND HYPNOTICS;
Prescription;
PHARMAPAR INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91053
M-ZOPICLONE;
02467968;
zopiclone 7.5 mg;
2018-04-16;
Oral;
Tablet;
28:24.92 – MISCELLANEOUS ANXIOLYTICS SEDATIVES AND HYPNOTICS;
Prescription;
MANTRA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95632
ZOPICLONE;
02469154;
zopiclone 7.5 mg;
2018-08-07;
Oral;
Tablet;
28:24.92 – MISCELLANEOUS ANXIOLYTICS SEDATIVES AND HYPNOTICS;
Prescription;
ALTAMED PHARMA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95781
AG-ZOPICLONE;
02475847;
zopiclone 7.5 mg;
2018-07-25;
Oral;
Tablet;
28:24.92 – MISCELLANEOUS ANXIOLYTICS SEDATIVES AND HYPNOTICS;
Prescription;
ANGITA PHARMA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96657
NRA-ZOPICLONE;
02477386;
zopiclone 7.5 mg;
2018-08-30;
Oral;
Tablet;
28:24.92 – MISCELLANEOUS ANXIOLYTICS SEDATIVES AND HYPNOTICS;
Prescription;
NORA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96836
BIO-ZOPICLONE;
02481014;
zopiclone 7.5 mg;
2019-06-10;
Oral;
Tablet;
28:24.92 – MISCELLANEOUS ANXIOLYTICS SEDATIVES AND HYPNOTICS;
Prescription;
BIOMED PHARMA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97136
CLOPIXOL TABLETS 10MG;
02230402;
zuclopenthixol (zuclopenthixol hydrochloride) 10 mg;
1997-05-02;
Oral;
Tablet;
28:16.08.32 – THIOXANTHENES;
Prescription;
LUNDBECK CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=49241
CLOPIXOL TABLETS 25MG;
02230403;
zuclopenthixol (zuclopenthixol hydrochloride) 25 mg;
1997-05-02;
Oral;
Tablet;
28:16.08.32 – THIOXANTHENES;
Prescription;
LUNDBECK CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=49242
CLOPIXOL-ACUPHASE 50MG/ML;
02230405;
zuclopenthixol acetate 50 mg / ml;
1997-05-02;
Intramuscular;
Solution;
28:16.08.32 – THIOXANTHENES;
Prescription;
LUNDBECK CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=49244
CLOPIXOL DEPOT 200MG/ML;
02230406;
zuclopenthixol decanoate 200 mg / ml;
1997-05-02;
Intramuscular;
Solution;
28:16.08.32 – THIOXANTHENES;
Prescription;
LUNDBECK CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=49245

NOTICE

This page contains a copy of information from Health Canada’s Drug Product Database.
The author of this website is not responsible for any incomplete or erroneous information that may be found in the Health Canada database and / or on this page.

The AHFS class of active ingredients is regularly reassigned. The information on this page doesn’t always reflect these changes.

© All rights reserved. Pharmaceuticals database and data extracts.
Health Canada. Adapted and reproduced with permission from the Minister of Health, 2019.

⇡ Return to top

AVIS

Cette page contient une copie des informations de la base de données sur les produits pharmaceutiques de Santé Canada.
L’auteure de ce site web n’est pas responsable des informations incomplètes ou erronées qui pourraient être trouvées dans la base de données de Santé Canada et/ou sur cette page.


La classe AHFS des ingrédients actifs fait régulièrement l’objet de réaffectations.
Les informations sur cette page ne reflète pas toujours ces changements;

© Tous droits réservés. Base de données sur les produits pharmaceutiques et extraits de données.
Santé Canada. Adapté et reproduit avec la permission du ministre de la Santé, 2019.

⇡ Retour en haut